MRC Centre for Global Infectious Disease Analysis (MRC GIDA)
Lead Research Organisation:
IMPERIAL COLLEGE LONDON
Department Name: School of Public Health
Abstract
The COVID-19 pandemic has clearly illustrated the potential impact that emerging infectious diseases can have on health and on society. Being better prepared for future threats is therefore a key priority for public health agencies and governments globally. At the same time, it is important that efforts continue to decrease the burden of illness and death from infectious diseases that continue to plague many countries - particularly those with lower income and resources. Scientists have a key role to play in supporting these wider initiatives. As well as developing new drugs or vaccines for specific diseases, science can also help to understand how these new tools should best be deployed, where they will have maximum benefit and what is needed to achieve broader goals of elimination.
Our Centre for Global Infectious Disease Analysis undertakes epidemiological research across a range of infectious diseases, with a focus on applying these to help inform public health control. A key feature of the Centre is our translational work; we collaborate closely with public health agencies in the UK (such as the UK Health Security Agency) and internationally (including as a Collaborating Centre with the World Health Organisation) to help address questions that they have identified and to provide information that helps them to provide advice to governments and local agencies. Our work supporting the COVID-19 pandemic response was clearly visible globally through the reports that we contributed and the information that we generated to support decision-making. However, alongside this we also continue to work on key global diseases - such as HIV, tuberculosis and malaria - helping to understand how limited resources can be used to greatest effect to reduce cases and deaths.
The aim of the Centre will be to continue to support the broader activities that bring together the underpinning science undertaken by Centre scientists in order to ensure that our outputs can be translated to support public health decisions. To do this we will bring together our research under four thematic areas - i) preparedness and response to emerging threats; ii) global health; iii) vaccines and therapeutics (drugs or new monoclonal antibody treatments) and iv) the intersection between genomic and epidemiological data. By doing so, we will bring together groups working on different diseases to consider a combined approach to tackling these global issues. We will also collaborate extensively with other scientists and the wider academic community to factor in broader issues affecting societies to evaluate their impact on infectious diseases - including changes in climate and the environment, behavioural responses in light of the pandemic, and economics.
We will additionally work in three areas to enable the translation and communication of our science:
1. By supporting a team of software engineers who will help to build sustainable, open-source computer code as well as user-friendly interfaces to our models, supporting their wider uptake within the scientific community and more broadly.
2. By creating a "Translational Modelling Hub" focused on generating outputs for public health partners, and also supporting the wider communication of activities across society.
3. Supporting training including postgraduate education, short-courses aimed at public health professionals (in the UK and abroad) and capacity-strengthening in epidemiology through our global network of academic and public health partners.
Our Centre for Global Infectious Disease Analysis undertakes epidemiological research across a range of infectious diseases, with a focus on applying these to help inform public health control. A key feature of the Centre is our translational work; we collaborate closely with public health agencies in the UK (such as the UK Health Security Agency) and internationally (including as a Collaborating Centre with the World Health Organisation) to help address questions that they have identified and to provide information that helps them to provide advice to governments and local agencies. Our work supporting the COVID-19 pandemic response was clearly visible globally through the reports that we contributed and the information that we generated to support decision-making. However, alongside this we also continue to work on key global diseases - such as HIV, tuberculosis and malaria - helping to understand how limited resources can be used to greatest effect to reduce cases and deaths.
The aim of the Centre will be to continue to support the broader activities that bring together the underpinning science undertaken by Centre scientists in order to ensure that our outputs can be translated to support public health decisions. To do this we will bring together our research under four thematic areas - i) preparedness and response to emerging threats; ii) global health; iii) vaccines and therapeutics (drugs or new monoclonal antibody treatments) and iv) the intersection between genomic and epidemiological data. By doing so, we will bring together groups working on different diseases to consider a combined approach to tackling these global issues. We will also collaborate extensively with other scientists and the wider academic community to factor in broader issues affecting societies to evaluate their impact on infectious diseases - including changes in climate and the environment, behavioural responses in light of the pandemic, and economics.
We will additionally work in three areas to enable the translation and communication of our science:
1. By supporting a team of software engineers who will help to build sustainable, open-source computer code as well as user-friendly interfaces to our models, supporting their wider uptake within the scientific community and more broadly.
2. By creating a "Translational Modelling Hub" focused on generating outputs for public health partners, and also supporting the wider communication of activities across society.
3. Supporting training including postgraduate education, short-courses aimed at public health professionals (in the UK and abroad) and capacity-strengthening in epidemiology through our global network of academic and public health partners.
Technical Summary
The COVID-19 pandemic has highlighted the threat that infectious diseases pose to societies whilst the rapid global spread of monkeypox, the identification of polio in the UK and US, and the emergence of Marburg viral haemorrhagic fever in Ghana are timely reminders of the challenges that lay ahead. Over the last 15 years, the MRC Centre for Global Infectious Disease Analysis has been at the forefront of the development and application of data analysis and modelling across a wide range of pathogens. A key feature of our approach is our close links with public health agencies in the UK and internationally, enabling rapid translation of scientific insights into actionable public health support.
During this award, we aim to catalyse our inter-disciplinary approach across four research-based themes:
a) Preparedness and Response to Emerging Threats: Building the epidemiological tools required nationally and internationally to respond to new threats.
b) Global Health Analytics: Supporting strategies to control and eliminate endemic diseases.
c) Vaccines and Therapeutics: Supporting the development pipeline for new products and evaluating the retrospective and prospective impact of existing products in reducing disease burden.
d) Pathogen Genomic Epidemiology: Developing genomics data to support better surveillance of emerging threats and to inform vaccine development, alongside analytical methods that integrate genomic and epidemiological data to inform public health policy.
Through three underpinning pillars - research software engineering, translation and communication (including a dedicated Translational Modelling Hub) and training and capacity strengthening - we will enable rapid communication and uptake of our outputs to external partners - including the academic community, public health agencies and wider society.
During this award, we aim to catalyse our inter-disciplinary approach across four research-based themes:
a) Preparedness and Response to Emerging Threats: Building the epidemiological tools required nationally and internationally to respond to new threats.
b) Global Health Analytics: Supporting strategies to control and eliminate endemic diseases.
c) Vaccines and Therapeutics: Supporting the development pipeline for new products and evaluating the retrospective and prospective impact of existing products in reducing disease burden.
d) Pathogen Genomic Epidemiology: Developing genomics data to support better surveillance of emerging threats and to inform vaccine development, alongside analytical methods that integrate genomic and epidemiological data to inform public health policy.
Through three underpinning pillars - research software engineering, translation and communication (including a dedicated Translational Modelling Hub) and training and capacity strengthening - we will enable rapid communication and uptake of our outputs to external partners - including the academic community, public health agencies and wider society.
Organisations
- IMPERIAL COLLEGE LONDON (Lead Research Organisation)
- Congo National Institute of Biomedical Research (Collaboration)
- Foreign Commonwealth and Development Office (FCDO) (Collaboration)
- Kwame Nkrumah University of Science and Technology (KNUST) (Collaboration)
- Kilimanjaro Christian Medical University College (Collaboration)
- Johns Hopkins University (Collaboration)
- Moi University (Collaboration)
- Public Health Agency of Canada (Collaboration)
- World Bank Group (Collaboration)
- UNICEF (Collaboration)
- Global Fund to Fight AIDS, Tuberculosis and Malaria (Collaboration)
- Pasteur Institute, Paris (Collaboration)
- University of Stellenbosch (Collaboration)
- University of Copenhagen (Collaboration)
- University of Malaya (Collaboration)
- Drugs for Neglected Diseases initiative (DNDi) (Collaboration)
- Burnet Institute (Collaboration)
- Gadjah Mada University (Collaboration)
- Heidelberg University (Collaboration)
- Institut de Recherche en Sciences de la Santé (Collaboration)
- University of Nairobi (Collaboration)
- McGill University (Collaboration)
- The National Institute of Public Health of Mexico (INSP) (Collaboration)
- University of Cape Town (Collaboration)
- UNIVERSITY OF OXFORD (Collaboration)
- University of Bristol (Collaboration)
- Armed Forces Research Institute of Medical Sciences (Collaboration)
- Bill and Melinda Gates Foundation (Collaboration)
- Princeton University (Collaboration)
- London School of Hygiene and Tropical Medicine (LSHTM) (Collaboration)
- Mount Kenya University (Collaboration)
- UNIVERSITY OF EDINBURGH (Collaboration)
- Ifakara Health Institute (Collaboration)
- Oriole Global Health (Collaboration)
- Government of Thailand (Collaboration)
- Infectious Diseases Research Collaboration (IDRC) (Collaboration)
- European Centre for Disease Prevention and Control (ECDC) (Collaboration)
- Programme PAC-CI (Collaboration)
- Academy of Medical Sciences (AMS) (Collaboration)
- International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) (Collaboration)
- Kamuzu University of Health Sciences (Collaboration)
- University of California, Berkeley (Collaboration)
- Rigshospitalet (Collaboration)
- Makerere University (Collaboration)
- UK Health Security Agency (Collaboration)
- Institute of Development Research (IRD) (Collaboration)
- Joint United Nations Programme on HIV/AIDS (UNAIDS) (Collaboration)
- University of Virginia (UVa) (Collaboration)
- Institute for Disease Modeling (Collaboration)
- Centers for Disease Control and Prevention (CDC) (Collaboration)
- National Institute for Biological Standards and Control (NIBSC) (Collaboration)
- Government of South Africa (Collaboration)
- Neglected Tropical Diseases Modelling Consortium (Collaboration)
- Duke University (Collaboration)
- Pan American Health Organization (Collaboration)
- National Institute of Health, Mozambique (Collaboration)
- University of San Francisco Quito (Collaboration)
- MINISTRY OF PUBLIC HEALTH (Collaboration)
- BioFire Diagnostics, LLC (Collaboration)
- Centro de Investigação em Saúde de Manhiça (Collaboration)
- Christian Medical College, Vellore (Collaboration)
- PATH (Collaboration)
- UNISA (Collaboration)
- Malaria Consortium (Collaboration)
- National Malaria Control Programme (Collaboration)
- National School of Public Health - FIOCRUZ (Collaboration)
- Merck (Collaboration)
- Swiss Tropical & Public Health Institute (Collaboration)
- Avenir Health (Collaboration)
- Pasteur Institute of Madagascar (Collaboration)
- University of Ibadan (Collaboration)
- International Centre of Insect Physiology and Ecology (icipe) (Collaboration)
- Pasteur Institute In Cambodia (Collaboration)
- Harvard University (Collaboration)
- Medical Research Council (MRC) (Collaboration)
- University of Colorado (Collaboration)
- Foundation for Innovative New Diagnostics (FIND) (Collaboration)
- Central University of Venezuela (Collaboration)
- United Nations (UN) (Collaboration)
- National Institute of Health and Medical Research (INSERM) (Collaboration)
- International Epidemiologic Databases to Evaluate AIDS (IeDEA) (Collaboration)
- Pontifical Xavierian University (Collaboration)
- Instituto de Salud Global de Barcelona (Collaboration)
- Tropical Medicine Foundation Doctor Heitor Vieira Dourado (Collaboration)
- University College London (Collaboration)
- Human Sciences Research Council (HSRC) (Collaboration)
- ETH Zurich (Collaboration)
- Biomedical Research and Training Institute (BRTI) (Collaboration)
- Centre for Infectious Disease Research in Zambia (Collaboration)
- National Institute of Health, Pakistan (Collaboration)
- National University of Singapore (Collaboration)
- Noguchi Memorial Institute for Medical Research (NMRR) (Collaboration)
- GlaxoSmithKline (GSK) (Collaboration)
- PACCI (Collaboration)
- Government of the United States of America (Collaboration)
- Rakai Health Sciences Program (Collaboration)
- University of Cambridge (Collaboration)
- Wits Health Consortium (Collaboration)
- CLINTON HEALTH ACCESS INITIATIVE (Collaboration)
- Lombardy and Emilia Romagna Experimental Zootechnic Institute (IZSLER) (Collaboration)
- National Malaria Control Programme, Tanzania (Collaboration)
- Ministry of Health (Collaboration)
- National Center for Scientific and Technological Research (CNRST) (Collaboration)
- International Federation of Red Cross and Crescents (Collaboration)
- Pasteur Institute Dakar (Collaboration)
- Armauer Hansen Research Institute (Collaboration)
- Gavi (Collaboration)
- United States President's Emergency Plan for AIDS Relief (Collaboration)
- Indian Institute of Technology Bombay (Collaboration)
- University of Geneva (Collaboration)
- University of Dar es Salaam (Collaboration)
- World Health Organization (WHO) (Collaboration)
- Ghana Health Service (Collaboration)
- State University of New York (Collaboration)
- Coalition for Epidemic Preparedness Innovations (Collaboration)
- Ministry of Health Malawi (Collaboration)
- University of Ilorin (Collaboration)
- Nanyang Technological University (Collaboration)
- University of Lomé (Collaboration)
- National Centre for Research and Training on Malaria (Collaboration)
- Institute for Health Metrics and Evaluation (IHME) (Collaboration)
- Medicines Development for Global Health (Collaboration)
- Regional Health Authority of Emilia-Romagna (Collaboration)
- University of Thiès (Collaboration)
- University of Washington (Collaboration)
- University of Kinshasa (Collaboration)
- Kampala International University (Collaboration)
- Liverpool School of Tropical Medicine (Collaboration)
People |
ORCID iD |
| Azra Ghani (Principal Investigator) |
Publications
Abraham D
(2025)
Wastewater surveillance for Salmonella Typhi and its association with seroincidence of enteric fever in Vellore, India.
in PLoS neglected tropical diseases
Al-Jawabreh R
(2024)
Strongyloides questions-a research agenda for the future.
in Philosophical transactions of the Royal Society of London. Series B, Biological sciences
Allorant A
(2024)
Temporal Trends and Determinants of HIV Testing at Antenatal Care in Sub-Saharan Africa: A Pooled Analysis of Population-Based Surveys (2005-2021).
in Journal of acquired immune deficiency syndromes (1999)
Amaral LJ
(2025)
Reaching elimination of onchocerciasis transmission with long-term vector control and ivermectin treatment in Togo.
in Nature communications
AMR-X Collaborators
(2024)
System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework.
in The Lancet. Microbe
Ananth S
(2025)
Healthcare worker views on antimicrobial resistance in chronic respiratory disease.
in Antimicrobial resistance and infection control
Andersen ZJ
(2023)
Long-Term Exposure to AIR Pollution and COVID-19 Mortality and Morbidity in DENmark: Who Is Most Susceptible? (AIRCODEN).
in Research report (Health Effects Institute)
Anderson R
(2023)
Measuring mortality arising from the Covid-19 pandemic and the impact of vaccination.
in European journal of epidemiology
| Title | Additional file 1 of Healthcare worker views on antimicrobial resistance in chronic respiratory disease |
| Description | Additional file 1: Figure S1 Background details for survey respondentsArea of work.Patient population managed.Disease area primarily managed.How often respondents prescribed antimicrobials and/or review antimicrobial prescriptions and/or advise patients regarding antimicrobial use. |
| Type Of Art | Image |
| Year Produced | 2025 |
| URL | https://springernature.figshare.com/articles/figure/Additional_file_1_of_Healthcare_worker_views_on_... |
| Title | Additional file 2 of Healthcare worker views on antimicrobial resistance in chronic respiratory disease |
| Description | Additional file 2: Figure S2 Frequency with which respondents see patients die due to a lack of treatment options as a result of antimicrobial resistance. |
| Type Of Art | Image |
| Year Produced | 2025 |
| URL | https://springernature.figshare.com/articles/figure/Additional_file_2_of_Healthcare_worker_views_on_... |
| Title | Additional file 3 of Healthcare worker views on antimicrobial resistance in chronic respiratory disease |
| Description | Additional file 3: Figure S3 Respondents' views on the importance of various factors in the acquisition of antimicrobial resistancein chronic lung disease. |
| Type Of Art | Image |
| Year Produced | 2025 |
| URL | https://springernature.figshare.com/articles/figure/Additional_file_3_of_Healthcare_worker_views_on_... |
| Title | Additional file 4 of Healthcare worker views on antimicrobial resistance in chronic respiratory disease |
| Description | Additional file 4: Figure S4 Composition of the respondents' regional antimicrobial stewardship teams. |
| Type Of Art | Image |
| Year Produced | 2025 |
| URL | https://springernature.figshare.com/articles/figure/Additional_file_4_of_Healthcare_worker_views_on_... |
| Title | Additional file 5 of Healthcare worker views on antimicrobial resistance in chronic respiratory disease |
| Description | Additional file 5: Figure S5 Priorities for improving regional outcomes of antimicrobial-resistantinfections in chronic respiratory disease. |
| Type Of Art | Image |
| Year Produced | 2025 |
| URL | https://springernature.figshare.com/articles/figure/Additional_file_5_of_Healthcare_worker_views_on_... |
| Title | Morphology of RMV7 variant colonies |
| Description | These photos showing colonies of RMV7wt, RMV7domi and RMV7rare grown on agar plate were captured using phase contrast microscopy (under 4x and 10x magnifications). |
| Type Of Art | Image |
| Year Produced | 2022 |
| URL | https://figshare.com/articles/figure/Morphology_of_RMV7_variant_colonies/19779070 |
| Title | Video summary of the network |
| Description | This short video presents the main goals of our network and our plans for accomplishing them. |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2023 |
| Impact | N/A |
| URL | https://www.youtube.com/watch?v=G1ejzcoJURU |
| Description | Advancing Policy-Relevant Modelling at the Measles & Rubella Transmission Modelling Workshop |
| Geographic Reach | Asia |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | This engagement strengthened capacity-building efforts, equipping public health officials with better modelling skills to forecast disease transmission and vaccine impact. These improvements support regional vaccine policy planning, ensuring effective outbreak prevention. |
| Description | Assessing the Return-on-Investment for Typhoid and Cholera Vaccines to Guide Policy Decisions |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | - This ROI report was used to support policy and funding discussions, helping decision-makers understand the long-term financial benefits of investing in these vaccines. - The findings contributed to cost-effectiveness evaluations, supporting vaccine prioritization in low-resource settings. |
| Description | COVID work incluenced policy globally |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | https://doi.org/10.1186/s12961-024-01236-1 |
| Description | Citation in WHO SOPs |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | Improved response to poliovirus outbreaks |
| URL | https://iris.who.int/handle/10665/363627 |
| Description | Coalition for Epidemic Preparedness Innovations |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Creation of vaccines for COVID-19, Ebola and Chikungunya |
| Description | Collaborative Surveillance Investment Case Workshop for Informal WHO Technical Working Group, Berlin December |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Contributing to WHO's IA2030 Project Team to Shape Global Immunization Strategy |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | VIMC's contributions have helped WHO refine its immunization targets, leading to better tracking and evaluation of vaccine coverage worldwide. This strengthens global vaccination campaigns, directly reducing morbidity and mortality. |
| Description | Contributions to Global Fund Results Reporting and Investment Case |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | The extensive use of our research in these outputs spotlights the role of Health System Strengthening, and explains how investments in the Global Fund can contribute to improve health in populations, especially in low-income countries. |
| URL | https://www.theglobalfund.org/en/investment-case/ |
| Description | Cost-effectiveness modelling analysis of targeted use of the 4CMenB meningitis B vaccine to protect men who have sex with men against gonorrhoea leads to the NHS launching the world's first national gonorrhoea vaccination programme |
| Geographic Reach | National |
| Policy Influence Type | Citation in other policy documents |
| Impact | In May 2025 the UK announced the world's first national gonorrhoea vaccination programme, targeting the group we recommended (higher-risk men who have sex with men) using the approach we recommended, with cost-effectiveness analysis being the only paper cited in the policy announcement. The announcement stated "Analysis led by Imperial College London has suggested the vaccine known as 4CMenB could avert up to 100,000 cases of gonorrhoea and save the NHS over £7.9 million over the next decade, if high uptake is achieved and an ongoing programme is confirmed", citing Whittles et al. Lancet ID 2022 (https://doi.org/10.1016/S1473-3099(21)00744-1). The roll-out of this programme began in August 2025. The modelling analysis considered men who have sex with men (MSM) and found that to be cost-effective vaccination would have to target higher-risk individuals, and we examined realistic strategies for achieving this (based on diagnosis history and self-reported risk behaviour). Robust modelling analysis was critical because this vaccine was designed to protect against meningitis B rather than gonorrhoea and only partially protective against gonorrhoea (~30-40%) so a policy decision requires careful assessment of costs and benefits. We found that effective targeting was essential to be cost-effective, but we had carefully examined realistic strategies that could actually be implemented. Peter White presented this work to the Joint Committee on Vaccination and Immunisation (JCVI) in September 2023, and in November 2023 JCVI advised offering vaccination to higher-risk MSM via sexual health clinics, which is the approach that we advocated. Prof White then liaised with DHSC economists to develop the ministerial brief and contributed to a paper summarising the epidemiological evidence presented to JCVI in another paper: Ladhani et al. Lancet Infectious Diseases 2024;24(9):e576-e583; doi.org/10.1016/S1473-3099(24)00031-8. |
| URL | https://www.england.nhs.uk/2025/05/nhs-and-local-government-to-roll-out-world-first-vaccine-programm... |
| Description | Engaging with civil service policymakers to develop a UK version of an integrated model to support decision-making |
| Geographic Reach | National |
| Policy Influence Type | Contribution to new or improved professional practice |
| Description | Enhancing Global Vaccine Policy Through Expanded Impact Estimates and Modelling |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | - The vaccine impact estimates were used by Gavi, WHO, and UNICEF to refine funding allocations and immunization strategies in low- and middle-income countries. - The inclusion of malaria and COVID-19 modelling helped shape discussions on global health priorities, ensuring policymakers had data-driven evidence to guide resource distribution and policy implementation. |
| Description | Evidence submitted to WHO's Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) and International Coordinating Group (ICG) on Vaccine Provision |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | https://pubmed.ncbi.nlm.nih.gov/41176964/ |
| Description | Funding Committee Agency for Health Quality and Assessment of Catalonia (AQuAS) |
| Geographic Reach | Europe |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Each year, we allocate 8-11 million Euros to researchers in Spain to conduct research on health and healthcare delivery. |
| Description | GRIDMAP |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Gates Consultation meeting: Exploring sexual network structure and other drivers of forecasted estimates in HIV models |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Global Fund Investment Case |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | https://www.theglobalfund.org/en/investment-case/ |
| Description | HIV Modelling Consortium |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | Supported improved interpretation of modelling outputs used in national HIV planning and strengthened alignment between modelling assumptions and policy needs. Participation in technical advisory meetings and incorporation of modelling approaches within multi-model synthesis and policy-oriented analyses. |
| Description | HPV vaccination |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in other policy documents |
| URL | https://www.rivm.nl/bibliotheek/rapporten/2024-0217.pdf |
| Description | HPV vaccination impact |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical reviews |
| URL | https://iris.who.int/server/api/core/bitstreams/fd0c15ff-4139-4cce-a13c-806dbe021005/content |
| Description | HPV-CC screening and treatment for WLHIV |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | https://iris.who.int/server/api/core/bitstreams/bbae5c5e-d56b-4499-bebe-26ebb8cb75c8/content |
| Description | Influencing Regional Immunization Strategies Through RITAG Presentation |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | This work helped shape vaccine rollout policies across Africa, leading to more efficient and targeted vaccine distribution. These improvements enhance public service delivery and accessibility to life-saving vaccines, ultimately reducing disease burden. |
| Description | Informing UK policy on using meningococcal B vaccines against gonorrhoea in MSM |
| Geographic Reach | National |
| Policy Influence Type | Citation in other policy documents |
| URL | https://www.gov.uk/government/publications/meningococcal-b-vaccination-for-the-prevention-of-gonorrh... |
| Description | Informing WHO Policy on Multivalent Meningococcal Conjugate Vaccine (MMCV) Use in the African Meningitis Belt |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in other policy documents |
| Impact | The VIMC Project Working Group (PWG), led by Prof. Caroline Trotter, influenced global vaccine policy through its research on multivalent meningococcal conjugate vaccines (MMCVs) in the African meningitis belt. Findings from the study, "Modelling of Strategies for Introduction and Routine Use of MMCVs", were presented to SAGE at WHO in Geneva and cited in the WHO position paper: "Meningococcal vaccines: the use of multivalent meningococcal conjugate vaccines in countries of the African meningitis belt" (January 2024). This work provided evidence-based guidance for policymakers, shaping vaccination strategies to improve outbreak prevention. By being referenced in WHO's official recommendations, it influences national immunization programs, guiding targeted vaccine deployment and improving public health responses. As countries adopt these recommendations, the research is expected to contribute to reduced meningitis cases and improved health outcomes in the region. |
| Description | Lancet Commission on Strengthening the Use of Epidemiological Modelling |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | The work is cited by the Ministry of Health Malawi in public fora and when engaging with external partners as an exemplar of the use of modelling evidence in decision-making. |
| Description | Led writing of one letter to Prime Minster and organised co-signing by 130 UK Global Health Professors. |
| Geographic Reach | National |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Description | Malaria Policy Advisory Group |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | This committee provides advice directly to the WHO Global Malaria Programme on all topics relevant to malaria control and elimination. WHO guidance has direct impact on the policies adopted by national government, which over the past year has included amendment of treatment protocols, advice on current and new prevention interventions, allocation of global donor funding and certification of malaria elimination. Member of the committee until 2024 |
| URL | https://www.who.int/malaria/mpac/en/ |
| Description | Malawi Ministry of Health Think Tanks |
| Geographic Reach | Africa |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | Use of modelling outputs in ministry-level discussions and requests for follow-up analyses and scenario exploration. |
| Description | Mathematical modelling workshop in Côte d'Ivoire |
| Geographic Reach | Africa |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | Questionnaires were administered before and after the workshop, and over 95% of workshop participants reported that the workshop improved their ability to use results of mathematical modelling studies to inform decisions. |
| Description | Member of a guidance committee - Gavi Vaccine Investment Strategy 2023 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | The investment strategy has directly impacted the vaccine provision offering from Gavi; most notably in the provision of mpox vaccines via emergencey response to Central Africa |
| Description | Member of the WHO guideline committee drafting the operational manual for Wolbachia |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Method guide for estimating the economic benefits of electronic vaccine logistic management information systems |
| Geographic Reach | Asia |
| Policy Influence Type | Contribution to new or improved professional practice |
| Description | Methods for estimating the effects of Non Pharmaceutical Interventions on COVID-19 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | https://royalsociety.org/topics-policy/projects/impact-non-pharmaceutical-interventions-on-covid-19-... |
| Description | Modellers Presenting to SAGE Working Groups |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | This work has directly informed WHO vaccine position papers, influencing global immunization recommendations. The insights have led to better vaccine allocation, optimizing health outcomes by ensuring vaccines are delivered to the right populations at the right time. |
| Description | Modelling Evidence Leads to Removal of 80% Rubella Vaccination Coverage Requirement by WHO SAGE |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | On 24th September 2024, these findings were presented to the Strategic Advisory Group of Experts on Immunization (SAGE) at WHO, an expert group responsible for global vaccine policy recommendations. After reviewing the modelling evidence, SAGE made a landmark decision to remove the 80% coverage threshold for rubella vaccination introduction in these remaining 19 countries. This decision: - Enabled faster introduction of rubella vaccines in previously ineligible countries. - Lowered CRS incidence, leading to improved health outcomes for newborns. - Provided a clearer path toward rubella elimination through higher global vaccination coverage. - By ensuring that scientific modelling influenced WHO vaccination guidelines, this work has directly shaped global rubella control strategies, with the potential for future rubella eradication once high, sustained coverage is achieved worldwide. |
| Description | Modelling Mini-Course |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | Researchers from government institutions and research institutes received training in how to generate evidence needed for public health responses. Many have continued research in the space, including new collaborations between Malawian research institutes and Imperial College London. |
| Description | Multiple letters to Ministers in FCDO and attendance to All Party Parliament Groups on Global Health Security. |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | National data on gaps in implementation of effective HIV prevention methods |
| Geographic Reach | Africa |
| Policy Influence Type | Contribution to a national consultation/review |
| Description | Nigeria CDC Technical Advisory Group |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Participation in Business Case for Moxidectin |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | The Ghana FDA has approved the use of Moxidectin for the treatment of onchocerciasis in populations aged 4 years and above. We have provided modelling results to support the superior effectiveness of Moxidectin compared to Ivermectin in mass drug administration programmes. We work closely with Medicines Development for Global Health (MDGH). |
| URL | https://tdr.who.int/newsroom/news/item/12-12-2024-moxidectin-approved-by-the-ghana-food-and-drugs-au... |
| Description | Participation in a guidance/advisory committee - Modelling to support the WHO reccommendation decision for the R21 malaria vaccine. |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Participation in the UK HIV Genomics Database Steering Committee |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Policy brief- HIV/STI prevention/care FSW |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | https://iris.who.int/server/api/core/bitstreams/30358b1b-8312-4106-803c-0683971204b9/content |
| Description | Policy impact of the Imperial College COVID19 Response Team |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | We collated all outputs published by the Imperial College COVID19 Response Team between 01-01-2020 and 24-02-2022 and conducted inductive thematic analysis. A systematic search of the Overton database identified policy document references, as an indicator of policy impact. We identified 620 outputs including preprints (16%), reports (29%), journal articles (37%) and news items (18%). More than half (56%) of all reports and preprints were subsequently peer-reviewed and published as a journal article after 202 days on average. Reports and preprints were crucial during the COVID-19 pandemic to the timely distribution of important research findings. One-fifth of ICCRT outputs (21%) were available to or considered by United Kingdom government meetings. Policy documents from 41 countries in 26 different languages referenced 43% of ICCRT outputs, with a mean time between publication and reference in the policy document of 256 days. We analysed a total of 1746 policy document references. Two-thirds (61%) of journal articles, 39% of preprints, 31% of reports and 16% of news items were referenced in one or more policy documents (these 217 outputs had a mean of 8 policy document references per output). The most frequent themes of the evidence produced by the ICCRT reflected the evidence-need for policy decision making, and evolved accordingly from the pre-vaccination phase [severity, healthcare demand and capacity, and non-pharmaceutical interventions (NPIs)] to the vaccination phase of the epidemic (variants and genomics). The work produced by the ICCRT affected global and domestic policy during the COVID-19 pandemic. The focus of evidence produced by the ICCRT corresponded with changing policy needs over time. The policy impact from ICCRT news items highlights the effectiveness of this unique communication strategy in addition to traditional research outputs, ensuring research informs policy decisions more effectively. |
| URL | https://health-policy-systems.biomedcentral.com/articles/10.1186/s12961-024-01236-1 |
| Description | Preparedness and Resilience for Emerging Threats (PRET) WHO Global Meeting, Geneva April |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | A call to action was drafted and subsequently published by WHO, and the work fed into the draft of the "Preparedness and Resilience for Emerging Threats Module 1: Planning for respiratory pathogen pandemics Version 1.0" |
| URL | https://www.who.int/news-room/events/detail/2023/04/24/default-calendar/pret-global-meeting-a-call-t... |
| Description | Preventive Ebola vaccination campaign for healthcare workers |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Providing Measles Burden Estimates to Support Global Immunization Strategies |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | - These estimates helped BMGF and other stakeholders assess the effectiveness of measles vaccination programs, ensuring better funding and resource allocation for measles prevention. - The reports were used to inform strategies for reducing measles mortality worldwide, supporting policy discussions on strengthening immunization programs. |
| Description | SPI-M meetings on mpox clade I planning scenarios |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Informed UKHSA policy and planning scenarios (thereby influencing public health) |
| URL | https://www.gov.uk/government/groups/scientific-pandemic-infections-group-on-modelling |
| Description | Securing a Recurring Presentation Slot at IVIR-AC to Inform WHO Vaccine Policy |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | By institutionalizing its presence at IVIR-AC, VIMC ensures ongoing access to WHO policymakers, allowing its models to shape global vaccine strategies. This improves the efficiency of vaccine delivery planning and strengthens WHO's regulatory processes for immunization programs. |
| Description | Supporting an economic evaluation of dengue vaccination policy in Thailand |
| Geographic Reach | Asia |
| Policy Influence Type | Contribution to a national consultation/review |
| Description | System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Description | Technical expert for updated WHO "Middle East respiratory syndrome: global summary and assessment of risk" |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| URL | https://www.who.int/publications/i/item/B09692 |
| Description | Thanzi Labwino - neglected tropical diseases |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Influenced training of practitioners or researchers |
| Impact | Improved capacity among policy users to interpret modelling results and incorporate quantitative evidence into planning processes. Follow-up engagement with trainees, continued collaboration requests, and integration of modelling approaches into partner institutional workstreams. |
| Description | UK Infected Blood Inquiry (2020 - 2022) |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| URL | https://www.infectedbloodinquiry.org.uk/sites/default/files/2023-06/Health%20Economics%20Expert%20Re... |
| Description | UKHSA TARZET mpox technical group |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Improved epidemic preparedness via risk assessment, preparedness and response activities for clade I mpox with a domestic UK focus. |
| URL | https://www.gov.uk/government/publications/monkeypox-outbreak-technical-briefings |
| Description | VIMC Presentation on Project Working Groups (PWGs) at IVIR-AC |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | This engagement helped WHO and its partners recognise the value of modelling consortia in shaping immunization policies, ensuring that modelling insights are now more consistently utilized in real-time policy decisions. |
| Description | WHO 2-24 Guidelines on hepatitis B - cost-effectiveness of simplified antiviral PMTCT strategies |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | https://www.who.int/publications/i/item/9789240090903 |
| Description | WHO Guideline Development Committee |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | WHO IRIS Laboratory testing for dengue virus: interim guidance, April 2025 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | https://iris.who.int/items/b286fa13-0c23-41aa-99c2-18dd0ab34092 |
| Description | WHO OTS |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | WHO Policy brief - HIV prevention among MSM |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | https://iris.who.int/server/api/core/bitstreams/c008afec-49b8-4543-970d-b26be611a185/content |
| Description | WHO Respiratory virus surveillance right-sizing |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Improved recommendations have improved cost-effectiveness and reliability of respiratory virus surveillance. |
| Description | WHO TAG-VE |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Advice provided by TAG-VE influences policy decisions regarding health provisions and non-pharmaceutical interventions for SARS-CoV-2. |
| URL | https://www.who.int/publications/m/item/terms-of-reference-for-the-technical-advisory-group-on-sars-... |
| Description | WHO Technical working group on triple EMTCT of HIV, Syphilis and Hepatitis B |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | WHO polio SAGE WG transition to IPV-only country risk assessment |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | WHO technical consultation on multiple first-line therapies for antimalarial drug resistance |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | The consultation (https://indico.un.org/event/1010896/) led to a new implementation guide (https://www.who.int/publications/i/item/9789240103603) published by WHO providing evidence-based guidance for countries on use of multiple first-line therapies to address the growing challenge of antimalarial drug resistance |
| URL | https://www.who.int/publications/i/item/9789240103603 |
| Description | WHO technical consultation to address the threat of pfhrp2 gene deletions |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Contributions in the meeting and following research underpinned the updated WHO protocol for surveillance of pfhrp2/3 (https://www.who.int/publications/i/item/9789240099951) for the Response plan to pfhrp2 gene deletions (https://www.who.int/publications/i/item/9789240101838). |
| URL | https://www.who.int/publications/i/item/9789240097919 |
| Description | WHO working group on novel pathogen surveillance for the Disease Control Priorities Manual (DCP4) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Description | WHO-Euro - Model-based investigation of factors sustaining mpox transmission in Europe |
| Geographic Reach | Europe |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| Description | WHO/Gavi modelling malaria vaccine doses |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Appropriate guidelines which prioritise the full 4-dose vaccine schedule to areas with highest malaria burden. Avoiding a situation where countries try to reach more children with a shorter 3-dose schedule, which we showed would often be less impactful given variation in malaria burden across countries. |
| URL | https://terrance.who.int/mediacentre/data/sage/SAGE_eYB_Sep2025.pdf |
| Description | World Health Organisation Guidelines Development Group for Vector Control |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | I work within the WHO Guidelines Development Group to develop recommendations for the use of new vector control tools against malaria. This recommendation is necessary to enable adoption of these tools by international organisations such as The Global Fund. Since joining the group in 2024 I have worked on new recommendations for new types of insecticide treated nets, indoor residual spraying and the use of spatial repellents. Over 280 million insecticide treated nets are distributed across the globe annually and to date have averted more cases of malaria than any other intervention. |
| URL | https://www.who.int/teams/global-malaria-programme/guideline-development-process |
| Description | World Health Organization global research priorities for sexually transmitted infections |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| URL | https://www.who.int/publications/i/item/WHO-UHL-SRH-2024.1 |
| Description | World Health Organization multi-model comparison of malaria interventions |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | World Health Summit Regional Meeting, Washington DC April |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | The World Health Summit is a unique international strategic forum for global health. Held annually in Berlin, with additional regional meetings, it brings together stakeholders from politics, science, the private sector, and civil society from around the world to set the agenda for a healthier future by inspiring innovative solutions for better health and well-being for all. As Alliance members, Imperial contributed to setting the agenda of the Summit. |
| URL | https://www.worldhealthsummit.org/ |
| Description | World Malaria Report 2024 |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in other policy documents |
| URL | https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2024 |
| Description | member of the Joint Committee on Vaccination and Immunisation |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | JCVI advises and makes recommendations to the UK government on which vaccines should be offered and on what schedules to the UK population. |
| URL | https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation |
| Guideline Title | Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV |
| Description | prevention of opportunistic infection in adolescents |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunisti... |
| Description | therapeutic HPV vaccine PPC |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | https://iris.who.int/server/api/core/bitstreams/4a4bb572-6cf7-4771-b5f0-e61197d2a6eb/content |
| Description | • International expeet supporting the development of Thailand's revised economic evaluation guideline (2026) |
| Geographic Reach | Asia |
| Policy Influence Type | Contribution to a national consultation/review |
| Description | A Delftia tsuruhatensis TC1-based intervention: Evaluating a novel tool for the control of leishmaniases, dengue and other arboviruses in laboratory and semi-field field settings |
| Amount | £264,318 (GBP) |
| Funding ID | PPIV000025 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2025 |
| End | 10/2028 |
| Description | A Multi-stage Malaria Vaccine for Control and Elimination |
| Amount | £496,097 (GBP) |
| Funding ID | 101190747 |
| Organisation | European Commission |
| Sector | Public |
| Country | Belgium |
| Start | 03/2025 |
| End | 02/2030 |
| Description | A novel cartridge-based sequencing solution for decentralized M. tuberculosis resistance detection |
| Amount | £5,374 (GBP) |
| Funding ID | 14677sc |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 06/2023 |
| End | 06/2028 |
| Description | AI2050 Compute Fund |
| Amount | £120,000 (GBP) |
| Organisation | Schmidt Futures |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 02/2026 |
| End | 01/2027 |
| Description | Accelerating infectious disease modelling using general purpose GPUs |
| Amount | £186,400 (GBP) |
| Funding ID | UKRI2681 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 07/2025 |
| End | 03/2026 |
| Description | Adaptation of Invasive Aedes to Climate Change: Integrating field derived vector data with mathematical models to enhance arbovirus risk predictions and control |
| Amount | £120,577 (GBP) |
| Funding ID | MRF-RGL-ICCH-23-215 |
| Organisation | Medical Research Council (MRC) |
| Department | Medical Research Foundation |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2025 |
| End | 12/2027 |
| Description | Advancing mpox outbreak control in Central Africa throughepidemiological modelling, data-driven insights, and capacitystrengthening |
| Amount | £649,441 (GBP) |
| Funding ID | UKRI2029 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2025 |
| End | 12/2026 |
| Description | Analytics to Support Interruption of VDPV Transmission Phase 2 |
| Amount | £906,339 (GBP) |
| Funding ID | INV-070128 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 08/2024 |
| End | 08/2027 |
| Description | Analytics to Support Interruption of Vaccine Derived Poliovirus Transmission |
| Amount | £422,235 (GBP) |
| Funding ID | INV-031605 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 04/2021 |
| End | 11/2025 |
| Description | Application of mathematical models to guide and evaluate malaria control and elimination programs |
| Amount | £1,639,694 (GBP) |
| Funding ID | INV-043624 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 05/2022 |
| End | 12/2026 |
| Description | Assessment of likely SMC effectiveness in target regions of Southern and Eastern Africa |
| Amount | £186,562 (GBP) |
| Funding ID | MC/UK/TECH/2023/013 |
| Organisation | Malaria Consortium |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2024 |
| End | 02/2025 |
| Description | Assessment of product dossiers for ITNs |
| Amount | £33,146 (GBP) |
| Funding ID | 2025/1600984-0 (PO No. 203728043) |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Switzerland |
| Start | 08/2025 |
| End | 12/2025 |
| Description | Blackfly trapping improved Simulium capture for onchocerciasis surveillance |
| Amount | £26,987 (GBP) |
| Funding ID | B646x4 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 12/2022 |
| End | 03/2026 |
| Description | CABBAGE: Comprehensive Assessment of Bacterial-Based AMR prediction from Genotypes |
| Amount | £914,298 (GBP) |
| Funding ID | MR/Z505547/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2025 |
| End | 12/2027 |
| Description | CEPI Phase 3: Assessing and predicting the public health benefits impact of CEPI's investments for SARS-X: Phase 1B |
| Amount | £144,712 (GBP) |
| Funding ID | Service Order 3 |
| Organisation | Coalition for Epidemic Preparedness Innovations |
| Sector | Learned Society |
| Country | Norway |
| Start | 03/2024 |
| End | 12/2024 |
| Description | Climate Sensitive Vector Borne Disease Intervention Tools |
| Amount | £519,891 (GBP) |
| Funding ID | 226072/Z/22/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 11/2022 |
| End | 10/2027 |
| Description | Control of Taenia solium in a hyper-endemic region of Uganda: Assessing optimal mass drug administration strategies in the human and porcine hosts |
| Amount | £2,134,276 (GBP) |
| Funding ID | 681 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2025 |
| End | 12/2029 |
| Description | Controlling emergent Anopheles stephensi in Ethiopia and Sudan (CEASE) |
| Amount | £3,552,923 (GBP) |
| Funding ID | 220870/Z/20/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2021 |
| End | 11/2025 |
| Description | Data and analysis ecosystem for eukaryotic pathogen targeted sequencing |
| Amount | £31,149 (GBP) |
| Funding ID | Subaward No: 15539sc |
| Organisation | University of North Carolina at Chapel Hill |
| Sector | Academic/University |
| Country | United States |
| Start | 05/2024 |
| End | 05/2025 |
| Description | Deep Learning Surrogates of Infectious Disease Models |
| Amount | £124,991 (GBP) |
| Funding ID | SBF0010\1221 |
| Organisation | Academy of Medical Sciences (AMS) |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 07/2025 |
| End | 08/2027 |
| Description | Delftia Tsuruhatensis TC1 based-intervention for interrupting malaria transmission in mosquitoes: a novel trial for evaluating alternative tools for control of vector-borne diseases (DEFEND) |
| Amount | £553,387 (GBP) |
| Funding ID | 101190813 |
| Organisation | European Commission |
| Sector | Public |
| Country | Belgium |
| Start | 06/2025 |
| End | 06/2030 |
| Description | Development and assessment of novel, high-throughput immunological assays to improve surveillance of spillover events for viral families of pandemic potential |
| Amount | £248,527 (GBP) |
| Funding ID | UKRI1045 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2025 |
| End | 03/2028 |
| Description | Development of phylogenetic analysis tools to track HIV transmissions for public health surveillance purposes |
| Amount | £38,708 (GBP) |
| Funding ID | 104683ED |
| Organisation | UK Health Security Agency |
| Sector | Public |
| Country | United Kingdom |
| Start | 06/2024 |
| End | 06/2026 |
| Description | Drivers of PSQ891 |
| Amount | £34,748 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 03/2025 |
| End | 09/2028 |
| Description | EDAM (Ethiopian Data Analytics and Modelling) Consortium |
| Amount | $3,839,406 (USD) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 08/2025 |
| End | 03/2029 |
| Description | EU4Health programme 2021-2027 |
| Amount | € 19,000,000 (EUR) |
| Funding ID | 101233259 |
| Organisation | European Commission |
| Sector | Public |
| Country | Belgium |
| Start | 11/2025 |
| End | 11/2028 |
| Description | Eliminating onchocerciasis with Moxidectin in endemic hotspots of Central Africa |
| Amount | € 4,986,011 (EUR) |
| Organisation | European Commission |
| Sector | Public |
| Country | Belgium |
| Start | 06/2025 |
| End | 06/2030 |
| Description | Eliminating onchocerciasis with Moxidectin in endemic hotspots of Central Africa (EMINENCE) |
| Amount | £299,488 (GBP) |
| Funding ID | 101190878 |
| Organisation | European Commission |
| Sector | Public |
| Country | Belgium |
| Start | 05/2025 |
| End | 05/2030 |
| Description | Epidemiological analyses and modelling to minimize risk of vaccine derived poliovirus emergence and spread |
| Amount | £195,538 (GBP) |
| Funding ID | 2024/15000224-0 PO:203504830 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Switzerland |
| Start | 07/2024 |
| End | 12/2025 |
| Description | Epidemiological modelling support to the Net Transition strategic initiative |
| Amount | £241,194 (GBP) |
| Funding ID | 202102265 (IPROJ) |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 03/2022 |
| End | 12/2024 |
| Description | Ervebo vaccine: Stockpiling And Vaccination Strategies For Ebola Response |
| Amount | £268,820 (GBP) |
| Funding ID | PO: 4500018155 |
| Organisation | Gavi |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 02/2025 |
| End | 12/2025 |
| Description | Establish the health impacts, costs and cost-effectiveness of Ervebo vaccination strategies for HCWs and FLWs |
| Amount | £38,269 (GBP) |
| Funding ID | 2023/1357778-1 (PO No. 203398267-1 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Switzerland |
| Start | 03/2024 |
| End | 06/2024 |
| Description | Ethiopian Data Analytics and Modeling (EDAM) Consortium |
| Amount | £2,647,866 (GBP) |
| Funding ID | INV-070433 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 07/2025 |
| End | 03/2029 |
| Description | Evaluation of the potential for rapid diagnostic testing (RDTs) for malaria within antenatal care to provide sustainable, dynamic and scalable malaria surveillance |
| Amount | £851,541 (GBP) |
| Funding ID | INV-005289 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2020 |
| End | 06/2025 |
| Description | GPS2: Global Pneumococcal Sequence surveillance 2.0 |
| Amount | £199,851 (GBP) |
| Organisation | Wellcome Sanger Institute |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2020 |
| End | 11/2025 |
| Description | GSK-Fleming Initiative Grand Challenge 1: Predicting future epidemiology |
| Amount | £1,512,780 (GBP) |
| Organisation | GlaxoSmithKline (GSK) |
| Sector | Private |
| Country | Global |
| Start | 11/2025 |
| End | 11/2028 |
| Description | Genomic surveillance of vector control trials |
| Amount | £221,517 (GBP) |
| Funding ID | PO# PPLS000233 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 03/2025 |
| End | 05/2027 |
| Description | Geospatial modelling of insecticide resistance in Anopheles vector populations to inform malaria control strategies |
| Amount | £124,856 (GBP) |
| Funding ID | SBF0010\1134 |
| Organisation | Academy of Medical Sciences (AMS) |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 07/2025 |
| End | 08/2027 |
| Description | HIV mortality and health seeking behaviors in Zimbabwe |
| Amount | £195,070 (GBP) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2023 |
| End | 07/2026 |
| Description | HPRU3 PSR024 |
| Amount | £724,615 (GBP) |
| Organisation | NIHR Health Protection Research Unit |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2025 |
| End | 03/2030 |
| Description | Harnessing male peer networks to enhance engagement with HIV prevention: A large-scale cluster randomized trial to increase HIV self-testing and PrEP uptake among men in Eastern Zimbabwe |
| Amount | $2,355,670 (USD) |
| Funding ID | 1R01MH133488-01 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 07/2023 |
| End | 05/2028 |
| Description | HetMal2 |
| Amount | £240,654 (GBP) |
| Funding ID | 101029EI |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 01/2025 |
| End | 09/2026 |
| Description | HetMal2 |
| Amount | £240,654 (GBP) |
| Funding ID | 101029EI |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 01/2025 |
| End | 12/2026 |
| Description | ICTRP-IDDO Project: Improving the Value and Usability of ICTRP database |
| Amount | £20,398 (GBP) |
| Funding ID | B9R05680 |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Switzerland |
| Start | 08/2023 |
| End | 12/2023 |
| Description | Impact and Cost effectiveness of Simplified Models of HBV Testing and Treatment in Low- and Middle Income Countries (LMICs) for the Center for Operational Research on Hepatitis B (COR[1]HEPB). |
| Amount | £83,995 (GBP) |
| Organisation | The Task Force for Global Health |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2025 |
| End | 05/2027 |
| Description | Impact of the US government's President's Malaria Initiative (PMI) funding on public health outcomes |
| Amount | £133,630 (GBP) |
| Funding ID | CHGMALMELIM39 |
| Organisation | Clinton Health Access Initiative |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 07/2024 |
| End | 06/2025 |
| Description | Improving Neonatal health Through Rapid malaria testing in Early Pregnancy with high-sensitivity Diagnostics (INTREPiD) |
| Amount | £24,530 (GBP) |
| Funding ID | Subaward No: 303004499 |
| Organisation | National Institutes of Health (NIH) |
| Sector | Public |
| Country | United States |
| Start | 03/2022 |
| End | 03/2027 |
| Description | Improving the accuracy of entomological measures of risk for vector borne diseases |
| Amount | |
| Funding ID | 2131872 |
| Organisation | Natural Environment Research Council |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2018 |
| End | 03/2022 |
| Description | Improving the efficacy of malaria prevention in an insecticide resistant Africa |
| Amount | £2,493,946 (GBP) |
| Funding ID | 200222/Z/15/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2016 |
| End | 10/2019 |
| Description | Innovations to improve polio surveillance speed & sensitivity: Phase 3 |
| Amount | £2,441,903 (GBP) |
| Funding ID | INV-070130 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2024 |
| End | 12/2027 |
| Description | JUNO2: Using genomics to understand invasiveness, transmission and regionally-distinct population structures |
| Amount | £273,934 (GBP) |
| Funding ID | S11140 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 05/2024 |
| End | 06/2028 |
| Description | Leveraging AI to optimise healthcare resource allocation in low-income countries |
| Amount | £270,280 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 12/2025 |
| End | 11/2029 |
| Description | Leveraging antenatal-based surveillance for malaria |
| Amount | £1,071,339 (GBP) |
| Funding ID | MR/L012189/1 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 04/2025 |
| End | 05/2028 |
| Description | Leveraging forecasts to optimise decision making |
| Amount | £79,635 (GBP) |
| Funding ID | 228271/Z/23/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2024 |
| End | 04/2025 |
| Description | Machine learning for blue line tracing and wastewater surveillance |
| Amount | £19,970 (GBP) |
| Funding ID | GR105124.SUB00001324 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 12/2024 |
| End | 11/2026 |
| Description | Mapping Genetic Markers of Drug Resistance in sub-Saharan Africa |
| Amount | £968,966 (GBP) |
| Funding ID | INV-067321 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 07/2025 |
| End | 09/2028 |
| Description | Mapping transmission pathways and reconstructing nosocomial outbreaks |
| Amount | SFr. 1,450,000 (CHF) |
| Organisation | Swiss National Science Foundation |
| Sector | Public |
| Country | Switzerland |
| Start | 03/2026 |
| End | 03/2029 |
| Description | Methodological development and support for UNAIDS annual HIV estimates |
| Amount | £178,677 (GBP) |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Sector | Public |
| Country | Global |
| Start | 06/2005 |
| End | 07/2026 |
| Description | Modélisation de l'impact épidémiologique potentiel du retrait du PEPFAR en Côte d'Ivoire, au Mali et au Sénégal |
| Amount | € 48,847 (EUR) |
| Organisation | French National Agency for Research on AIDS and Viral Hepatitis (ANRS) |
| Sector | Public |
| Country | France |
| Start | 03/2025 |
| End | 05/2025 |
| Description | Modelling health impacts and costs of a ring vaccination strategy for alternative outbreak scenarions and stockpile sizes |
| Amount | £40,226 (GBP) |
| Funding ID | 2023/1357271-0 (PO No. 203281477) |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Switzerland |
| Start | 09/2023 |
| End | 11/2023 |
| Description | Modelling support to the Investment Case for the 8th Replenishment (malaria) |
| Amount | £80,118 (GBP) |
| Funding ID | PO No. 2024-003036 |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 03/2024 |
| End | 12/2024 |
| Description | Modelling the potential public health impact of and target product profiles for an Epstein-Barr virus vaccine |
| Amount | £260,605 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 08/2025 |
| End | 09/2029 |
| Description | Modelling to Inform HIV Programmes in Sub-Saharan Africa (MIHPSA) Collaboration |
| Amount | $50,000 (USD) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 01/2025 |
| End | 03/2026 |
| Description | Models of microsporidia and malaria |
| Amount | £142,857 (GBP) |
| Organisation | Open Philanthropy Project |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 05/2025 |
| End | 12/2026 |
| Description | MoxiMultiDosePedMod |
| Amount | £51,125 (GBP) |
| Funding ID | RIA2017NCT-1843 |
| Organisation | European Commission |
| Sector | Public |
| Country | Belgium |
| Start | 07/2019 |
| End | 07/2025 |
| Description | NIHR HPRU in Health Analytics and Modelling (HPRU-HAM) |
| Amount | £1,638,998 (GBP) |
| Organisation | NIHR Health Protection Research Unit |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2025 |
| End | 03/2030 |
| Description | NTU-Imperial Collaboration Fund: Modelling sexually transmitted diseases for outbreak resilience |
| Amount | £16,000 (GBP) |
| Organisation | Imperial College London |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 03/2023 |
| End | 09/2024 |
| Description | Neglected Tropical Diseases Modelling Consortium |
| Amount | £643,291 (GBP) |
| Funding ID | CRR00630 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2021 |
| End | 10/2025 |
| Description | Novel methods to characterise the determinants of infectious disease transmission from large pathogen sequence datasets, and inform their practical implementation |
| Amount | £833,158 (GBP) |
| Funding ID | 321628/Z/24/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 08/2026 |
| End | 08/2031 |
| Description | Novel methods to characterise the determinants of infectious disease transmission from large pathogen sequence datasets, and inform their practical implementation (Cécile Tran Kiem) |
| Amount | £833,158 (GBP) |
| Funding ID | 321628/Z/24/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 08/2026 |
| End | 08/2031 |
| Description | Optimising seasonal malaria chemoprevention and seasonal vaccination in childhood to address the resurgent malaria burden in Africa |
| Amount | £916,159 (GBP) |
| Funding ID | 220658/Z/20/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2021 |
| End | 01/2026 |
| Description | Planning Integrated HIV surveillance to monitor progress |
| Amount | £63,027 (GBP) |
| Funding ID | 260394-5127639 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 06/2025 |
| End | 09/2026 |
| Description | Planning the Future for Networked HIV Modeling: The HIV Modelling Consortium |
| Amount | £38,465 (GBP) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 12/2024 |
| End | 03/2026 |
| Description | Projecting the public health, economic and educational benefits of advance vaccine investments with the DAEDALUS model |
| Amount | £209,962 (GBP) |
| Funding ID | Service Order #2 |
| Organisation | Coalition for Epidemic Preparedness Innovations |
| Sector | Learned Society |
| Country | Norway |
| Start | 09/2023 |
| End | 01/2025 |
| Description | Promoting scale and uptake of HIV prevention cascades |
| Amount | £411,894 (GBP) |
| Funding ID | INV-056609 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2023 |
| End | 04/2026 |
| Description | Provision of expert advice and development support for emerging infections genomics and metagenomics analysis |
| Amount | £233,101 (GBP) |
| Funding ID | PO: P5126118 |
| Organisation | UK Health Security Agency |
| Sector | Public |
| Country | United Kingdom |
| Start | 07/2024 |
| End | 03/2026 |
| Description | Quantifying the role of ES to infer circulation of multiple pathogens |
| Amount | £333,371 (GBP) |
| Funding ID | INV-049091 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 07/2023 |
| End | 12/2026 |
| Description | Reconstructing the transmission intensity of arboviruses across Africa and the impact of interventions in a changing climate |
| Amount | £2,072,800 (GBP) |
| Funding ID | 228185/Z/23/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 02/2024 |
| End | 07/2027 |
| Description | Research based updates: Soil-transmitted Helminths, Onchocerciasis Models |
| Amount | £23,889 (GBP) |
| Funding ID | B9R06580 |
| Organisation | University of Oxford |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 12/2025 |
| End | 03/2026 |
| Description | Research to Improve the Detection and Treatment of Latent Tuberculosis Infection (RID-TB) |
| Amount | £2,499,149 (GBP) |
| Funding ID | RP-PG-0217-20009 |
| Organisation | National Institute for Health and Care Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2018 |
| End | 12/2025 |
| Description | SCHEMA-Uganda |
| Amount | £745,000 (GBP) |
| Funding ID | NIHR169017 |
| Organisation | National Institute for Health and Care Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 02/2026 |
| End | 01/2028 |
| Description | SIMPLEGEN: A modeling approach to inform malaria genetic surveillance |
| Amount | £436,182 (GBP) |
| Funding ID | INV-031273 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 06/2021 |
| End | 01/2026 |
| Description | Schmidt Futures fellowship |
| Amount | £128,407 (GBP) |
| Funding ID | G-24-66835 |
| Organisation | Schmidt Futures |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 07/2024 |
| End | 12/2026 |
| Description | Seasonal R21 vaccination for malaria elimination |
| Amount | £20,103 (GBP) |
| Funding ID | DEX009 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2023 |
| End | 08/2026 |
| Description | Stockpiling and vaccination strategies for Ebola |
| Amount | £134,615 (GBP) |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Switzerland |
| Start | 06/2023 |
| End | 12/2023 |
| Description | Stockpiling and vaccination strategies for Ebola response |
| Amount | £390,000 (GBP) |
| Organisation | Gavi |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 02/2025 |
| End | 12/2025 |
| Description | Strategies for the efficient design of cluster randomised trials to evaluate novel interventions for infectious disease control |
| Amount | £512,018 (GBP) |
| Funding ID | NIHR172073 |
| Organisation | National Institute for Health and Care Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2025 |
| End | 09/2028 |
| Description | Strengthening health and disease modelling for public health decision making |
| Amount | £134,312 (GBP) |
| Funding ID | 320280/Z/24/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2025 |
| End | 05/2030 |
| Description | Support for ATSB trial analysis |
| Amount | £152,512 (GBP) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2024 |
| End | 12/2025 |
| Description | Sustainable outbreak analysis ecosystem with RECON |
| Amount | £50,000 (GBP) |
| Organisation | United Kingdom Research and Innovation |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2025 |
| End | 09/2026 |
| Description | Target Malaria IIIM 3 - Epi-Modelling |
| Amount | £639,409 (GBP) |
| Funding ID | INV-06606 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 03/2025 |
| End | 06/2030 |
| Description | Target Malaria Phase II grant - Epimodelling sub |
| Amount | £527,505 (GBP) |
| Funding ID | OPP1210755 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 03/2020 |
| End | 05/2026 |
| Description | Temperature and malaria transmission: anticipating the impact of climate change on the malaria burden |
| Amount | £150,072 (GBP) |
| Organisation | Medical Research Council (MRC) |
| Department | Medical Research Foundation |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 07/2023 |
| End | 07/2026 |
| Description | Testing the transmission-blocking efficacy of antimalarial compounds on mosquito nets for malaria control |
| Amount | £188,043 (GBP) |
| Funding ID | 263848-5131811 |
| Organisation | Open Philanthropy Project |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 04/2024 |
| End | 04/2027 |
| Description | Testing the transmission-blocking efficacy of antimalarial compounds on mosquito nets for malaria control |
| Amount | $369,600 (USD) |
| Funding ID | PB1233 |
| Organisation | Open Philanthropy Project |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2024 |
| End | 12/2026 |
| Description | Thanzi La Onze: Modelling Impacts of Investment into Health Systems Strengthening |
| Amount | £141,817 (GBP) |
| Funding ID | RCC012ODAICL01 |
| Organisation | Foreign Commonwealth and Development Office (FCDO) |
| Sector | Public |
| Country | United Kingdom |
| Start | 06/2024 |
| End | 06/2025 |
| Description | The Leverhulme Trust Research Centre for The Holobiont |
| Amount | £679,680 (GBP) |
| Funding ID | n/a |
| Organisation | The Leverhulme Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2022 |
| End | 09/2032 |
| Description | Tim Hallett/Shevanthi Nayagam BRC |
| Amount | £156,042 (GBP) |
| Organisation | Imperial College Healthcare NHS Trust |
| Sector | Hospitals |
| Country | United Kingdom |
| Start | 05/2025 |
| End | 05/2027 |
| Description | To develop specific technical content to be used in the assessment of product dossiers for ITNs |
| Amount | £38,253 (GBP) |
| Funding ID | 2024/1480131-0 (PO No. 203473650) |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Switzerland |
| Start | 06/2024 |
| End | 12/2024 |
| Description | To measure the potential impact of RSSH investments by Global Fund |
| Amount | £88,960 (GBP) |
| Funding ID | 2024-006252 |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 05/2024 |
| End | 11/2024 |
| Description | To support a project to update model predictions of the impact of a malaria transmission-blocking vaccine (Pfs230D1/Matrix M) delivered alone or in combination with R21 or RTS,S |
| Amount | £36,547 (GBP) |
| Organisation | Open Philanthropy Project |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 06/2024 |
| End | 07/2025 |
| Description | Tools for direct detection of AMR pathogens from sewage |
| Amount | £1,976,387 (GBP) |
| Funding ID | INV-047158 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2022 |
| End | 12/2027 |
| Description | Transforming the response to the HIV epidemics amongst key populations: Addressing structural factors for achieving HIV elimination |
| Amount | £688,021 (GBP) |
| Funding ID | R103598-101 86440 |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 06/2023 |
| End | 06/2031 |
| Description | Understanding dengue and Zika spread, immunity and clinical outcomes |
| Amount | £5,635,851 (GBP) |
| Funding ID | 316633/Z/24/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 07/2025 |
| End | 07/2030 |
| Description | Update MINT Tool |
| Amount | £22,041 (GBP) |
| Funding ID | 2025/1579467-0 (PO No. 203681468) |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Switzerland |
| Start | 05/2025 |
| End | 12/2025 |
| Description | Wastewater surveillance for pathogens with pandemic potential |
| Amount | £2,781,932 (GBP) |
| Funding ID | INV-076271 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 08/2024 |
| End | 08/2027 |
| Description | Wellcome Trust Joint Senior Investiogator Award - Informing strategies for malaria eradication: a combined epidemiological and economics approach |
| Amount | £1,409,484 (GBP) |
| Funding ID | 220900/Z/20/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2021 |
| End | 12/2026 |
| Title | Graph-based Nanopore Adaptive Sampling Typing (GNASTy) |
| Description | GNASTy (Graph-based Nanopore Adaptive Sampling Typing) is a novel method for pneumococcal serotype surveillance that combines Nanopore sequencing with real-time adaptive sampling technology. The method uses Nanopore adaptive sampling (NAS) to selectively enrich for the capsular biosynthetic locus (CBL) during sequencing by accepting or rejecting DNA fragments in real-time based on whether they match target sequences. The key innovation is the algorithm, which employs pangenome graph-based alignment using coloured compacted de Bruijn graphs rather than traditional linear genome alignment. This graph-based approach enables fast, accurate serotype identification, can detect co-carriage of multiple serotypes, and importantly, can identify novel serotypes not present in reference databases-outperforming standard linear alignment methods. The method is portable and increases the efficiency of using Nanopore sequencing for pneumococcal surveillance programs. |
| Type Of Material | Technology assay or reagent |
| Year Produced | 2025 |
| Provided To Others? | Yes |
| Impact | None to date. |
| URL | https://zenodo.org/records/13358697 |
| Title | Prevalence data and model simulation outputs for onchocerciasis morbidity modelling |
| Description | Development of morbidity sub-model integrated into individual-based, stochastic transmission model EPIONCHO-IBM. The morbidity out comes are: skin disease (reversible and irreversible); ocular disease (visual impairment and blindness). This complements development of morbidity sub-model for Onchocerciasis-Associated Epilepsy |
| Type Of Material | Model of mechanisms or symptoms - human |
| Year Produced | 2026 |
| Provided To Others? | Yes |
| Impact | Integration of morbidities (skin, ocular, neurological) into Burden of Disease models; collaboration with the Institute of Health Metrics and Evaluation (IHME) for Global Burden of Disease Study |
| Title | Thanzi la Onse |
| Description | We are developing a model that represents explicitly the generation of health gains in a population, which can be used to examine the effect of resource allocation, management and clinical practice, in order to contribute to informing decision-making. |
| Type Of Material | Model of mechanisms or symptoms - human |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | The model is being used by policy-makers in Malawi to inform their Health Sector Strategic Plan. We have also run analyses on-demand to aid government officials in Malawi to understand the impact of declining overseas aid, the expected health outcomes of investments in health system strengthening and expansion, and the effects of climate change on health service provision. |
| URL | https://www.tlomodel.org/index.html |
| Title | Virus genome sequencing infrastructure - Ministry of Health Angola |
| Description | Our team introduced portable Oxford Nanopore Technology sequencers, including the Mk1D MinION and sequencing laptops, at the Health Institute Research, Ministry of Health Angola. |
| Type Of Material | Improvements to research infrastructure |
| Year Produced | 2025 |
| Provided To Others? | Yes |
| Impact | First in-country generation of mpox, measles and dengue 3 viral genomes using targeted sequencing protocols. In-country improvement in Pathogen X detection through training in untargeted metagenomic sequencing protocols. |
| Title | Additional file 1: of Onchocerciasis transmission in Ghana: the human blood index of sibling species of the Simulium damnosum complex |
| Description | Bird species recorded in the study. (XLSX 24Â kb) |
| Type Of Material | Database/Collection of data |
| Year Produced | 2016 |
| Provided To Others? | Yes |
| Impact | Dataset on potential blood hosts of simuliid blackflies in southern Ghana. |
| URL | https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Onchocerciasis_transmissio... |
| Title | Additional file 2: of Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis |
| Description | A zip-file, which includes the computer simulation program itself (with the JAVA program code embedded in it), batch files used to run the model, PDF documentation of the XML input, and example input and output files. Instructions on how to run the model are provided in Additional file 1 (ONCHOSIM simulation program.zip). (DOCX 15 kb) |
| Type Of Material | Database/Collection of data |
| Year Produced | 2015 |
| Provided To Others? | Yes |
| Impact | Availability of the model code for the stochastic ONCHOSIM transmission dynamics model. |
| URL | https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Required_duration_of_mass_... |
| Title | Additional file 4: of Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis |
| Description | Source EPIONCHO code, written in programming language C (EPIONCHO.c). (C 30 kb) |
| Type Of Material | Database/Collection of data |
| Year Produced | 2015 |
| Provided To Others? | Yes |
| Impact | Code for deterministic version of the EPIONCHO transmission model. |
| URL | https://springernature.figshare.com/articles/dataset/Additional_file_4_of_Required_duration_of_mass_... |
| Title | Additional file 5: of Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis |
| Description | R script needed to run the simulations presented in this paper (EPIONCHO.R). (R 5 kb) |
| Type Of Material | Database/Collection of data |
| Year Produced | 2015 |
| Provided To Others? | Yes |
| Impact | Availability of model code for the deterministic version of EPIONCHO. |
| URL | https://springernature.figshare.com/articles/dataset/Additional_file_5_of_Required_duration_of_mass_... |
| Title | Brazilian municipal health policies during the COVID-19 pandemic |
| Description | This dataset deals with the need to monitor and share information about fragmented policies designed to tackle health crises like the COVID-19 pandemic. Quantifying these initiatives and how they varied across municipalities can help us to understand the effectiveness of interventions in reducing virus transmission. We offer information over time on a series of measures to encourage social distancing, implement the vaccination programme, provide infrastructure to treat infected people, and facilitate how local governments would eventually ease these measures. This information can contribute to the institutional learning of health systems worldwide, assisting in future situations where a highly contagious virus challenges society. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2024 |
| Provided To Others? | Yes |
| Impact | Dataset was already useful for investigate severity of the SARS-CoV-2 P.1/Gamma Variant of Concern (https://www.nature.com/articles/s41591-022-01807-1). |
| URL | https://doi.org/10.5061/dryad.v6wwpzh5h |
| Title | CADDE Workshop on Portable Metagenomics for Pathogen Surveillance |
| Description | This is the official repository of CADDE Workshop on Portable Metagenomics for Pathogen Surveillance. Here you will find extra material about the presentations and activities of the workshop. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2023 |
| Provided To Others? | Yes |
| Impact | Used to train >50 early career researchers in metagenomics for public health (Brazil, 2023). |
| URL | https://github.com/CADDE-CENTRE/MetagenomicWorkshop |
| Title | Code and Data: A scoping literature review of global dengue age-stratified seroprevalence data: estimating dengue force of infection in endemic countries |
| Description | A github repository contains age-stratified seroprevalence data for dengue, obtained through a comprehensive literature review described in our paper entitled "A scoping literature review of global dengue age-stratified seroprevalence: estimating dengue force of infection in endemic countries". This literature review identified all dengue seroprevalence studies conducted within the identified search period and we provided force of infection estimates for each identified study. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2024 |
| Provided To Others? | Yes |
| Impact | N/A |
| URL | https://github.com/AVicco/Dengue_FOI_review_code |
| Title | Code and Data: Efficacy, public health impact and optimal use of the Takeda dengue vaccine |
| Description | Github repository containing the code needed to reproduce the main results presented in the manuscript: Efficacy, public health impact and optimal use of the Takeda dengue vaccine. Repository also contains all data used for model calibration. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2025 |
| Provided To Others? | Yes |
| Impact | Unknown impact. |
| URL | https://github.com/mrc-ide/qdenga_impact |
| Title | Code and data: A systematic review and meta-analysis of Zika virus epidemiology |
| Description | Data are publicly available from https://github.com/mrc-ide/epireview/. Code and a vignette to reproduce the analysis are available from https://github.com/mrc-ide/priority-pathogens and https://mrc-ide.github.io/priority-pathogens/articles/pathogen_zika.html. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2026 |
| Provided To Others? | Yes |
| Impact | The data published in this paper summarise the current understanding of Zika epidemiology, seroprevalence and parameter estimates relevant for outbreak response |
| URL | https://www.nature.com/articles/s44360-025-00051-4 |
| Title | Cross-Sectional Seroprevalence Dengue Data from Angola |
| Description | This repository contains the code used to implement the analyses presented in "Dengue transmission dynamics and spread in Angola: a phylogenetic and cross-sectional seroprevalence study." |
| Type Of Material | Database/Collection of data |
| Year Produced | 2024 |
| Provided To Others? | Yes |
| Impact | This dataset was used to investigate transmission dynamics of dengue in Angola. |
| URL | https://github.com/mrc-ide/dengue_dynamics_angola |
| Title | Data from: Costs of crowding for the transmission potential in malaria parasites |
| Description | The utility of using evolutionary and ecological frameworks to understand the dynamics of infectious diseases is gaining increasing recognition. However, integrating evolutionary ecology and infectious disease epidemiology is challenging because within-host dynamics can have counterintuitive consequences for between-host transmission, especially for vector-borne parasites. A major obstacle to linking within- and between-host processes is that the drivers of the relationships between the density, virulence, and fitness of parasites are poorly understood. By experimentally manipulating the intensity of rodent malaria (Plasmodium berghei) infections in Anopheles stephensi mosquitoes under different environmental conditions, we show that parasites experience substantial density-dependent fitness costs because crowding reduces both parasite proliferation and vector survival. We then use our data to predict how interactions between parasite density and vector environmental conditions shape within-vector processes and onward disease transmission. Our model predicts that density-dependent processes can have substantial and unexpected effects on the transmission potential of vector-borne disease, which should be considered in the development and evaluation of transmission-blocking interventions. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2013 |
| Provided To Others? | Yes |
| Impact | Evidence on parasite density-dependent success of Plasmodium infection establishment in mosquitoes. |
| URL | https://datadryad.org/dataset/doi:10.5061/dryad.44jf2 |
| Title | Data from: Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection |
| Description | Transmission reduction is a key component of global efforts to control and eliminate malaria; yet, it is unclear how the density of transmission stages (gametocytes) influences infection (proportion of mosquitoes infected). Human to mosquito transmission was assessed using 171 direct mosquito feeding assays conducted in Burkina Faso and Kenya. Plasmodium falciparum infects Anopheles gambiae efficiently at low densities (4% mosquitoes at 1/µl blood), although substantially more (>200/µl) are required to increase infection further. In a site in Burkina Faso, children harbour more gametocytes than adults though the non-linear relationship between gametocyte density and mosquito infection means that (per person) they only contribute slightly more to transmission. This method can be used to determine the reservoir of infection in different endemic settings. Interventions reducing gametocyte density need to be highly effective in order to halt human-mosquito transmission, although their use can be optimised by targeting those contributing the most to transmission. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2013 |
| Provided To Others? | Yes |
| Impact | Value for the modelling of transmission-blocking vaccines n malaria. |
| URL | https://datadryad.org/dataset/doi:10.5061/dryad.0k402 |
| Title | Dataset for study on persistence of onchocerciasis and associated dermatologic and ophthalmic pathologies after 27 years of ivermectin mass drug administration in the middle-belt of Ghana |
| Description | This is the dataset used for analysis in the study on persistence of onchocerciasis and associated dermatologic and ophthalmic pathologies after 27 years of ivermectin mass drug administration in the middle-belt of Ghana. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2023 |
| Provided To Others? | Yes |
| Impact | Data on the persistence of infection and morbidity due to onchocerciasis in a mesoendemic area at baseline. |
| URL | https://zenodo.org/record/7655117 |
| Title | Dataset of the performance of Ov16 RDTs versus skin snip microscopy and Ov16 ELISA, Gabon, 2015 |
| Description | Skin snip biopsies remain the gold standard for the diagnosis of active infection with Onchocerca volvulus. However, in low-prevalence settings, such as after several rounds of mass drug administration of ivermectin, the sensitivity of skin snipping is low, and the procedure is poorly tolerated. Detection of Ov16 IgG4 antibodies from whole blood or dried blood spots (DBS) via rapid diagnostic test (RDT) or enzyme linked immunosorbent assay (ELISA), respectively, may therefore provide a more sensitive tool for the assessment of elimination (interruption) of transmission (EoT). RDTs require little training and resources to deploy and are therefore favoured by policy makers in Lower-Middle Income Countries (LMICs). This dataset was compiled from individual-based surveys conducted across 67 villages in Gabon in 2015, aiming to compare the performance of skin snipping versus that of Ov16 RDTs and ELISAs. Gabon had not received MDA but features many implementation units (IU) with hypoendemic (<35% microfilarial prevalence) transmission. Local healthcare centres conducted the surveys. The initial participant pool totaled 5,829 individuals, with a median age of 30 years (Interquartile Range (IQR): 11-55 years). Skin snips were obtained from 4,350 individuals (sheet 1), and RDTs were performed on blood samples collected from 4,257 individuals. 337 individuals (8%) gave a positive skin snip, with 383 individuals (9%) recording a positive Ov16 RDT. Of these, 174 individuals tested positive in both tests, giving the RDT an overall sensitivity of 52% and specificity of 95%. Sheet 2 shows the data aggregated at the village level. Sheet 3 shows the Ov16 ELISA data. Horse radish peroxidase (HRP) Ov16 ELISAs were conducted on DBS in 58 (87%) of the 67 villages. A total of 3,012 individuals underwent ELISA testing, producing 348 (12%) Ov16 positive results. These data highlight, that whilst broadly efficacious, there is a need for caution on the reliance of RDTs in determination of EoT and furthers calls for the development of a novel RDT, with a diagnostic profile providing higher sensitivity and specificity values. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2024 |
| Provided To Others? | Yes |
| Impact | These data have reuse potential for policy makers, test manufacturers and country programmes when making determinations at community level of the suitability of using Ov16 RDT for conducting delineation mapping or evaluating the current stage of a community or, more generally, an evaluation unit along the elimination of transmission path. Further, these data are of use to transmission dynamics modellers who can fit models to these data to better understand the stage(s) in the Onchocerca volvulus lifecycle likely responsible for IgG4 antibody seroconversion in the presence of Ov16 antigen. This is crucial for incorporation of antibody prevalence as an output of onchocerciasis transmission models to permit evaluation of currently proposed serological thresholds to inform decisions about Startor Stop-MDA in the context of onchocerciasis elimination mapping (OEM) and verification of elimination of transmission, respectively. |
| URL | https://data.mendeley.com/datasets/vtvmrzs9ch/2 |
| Title | Dataset on household survey on the prevalence of epilepsy in onchocerciasis endemic communities in the Bono Region of Ghana |
| Description | Household survey on prevalence of epilepsy in onchocerciasis endemic communities in the Bono Region of Ghana |
| Type Of Material | Database/Collection of data |
| Year Produced | 2023 |
| Provided To Others? | Yes |
| Impact | Data on epilepsy in onchocerciasis-endemic communities in Ghana. |
| URL | https://zenodo.org/record/7650291 |
| Title | Dataset on non-compliance to ivermectin intake in the Bono Region of Ghana |
| Description | Dataset on survey on non-compliance to ivermectin intake in onchocerciasis-endemic communities in the Bono Region of Ghana |
| Type Of Material | Database/Collection of data |
| Year Produced | 2023 |
| Provided To Others? | Yes |
| Impact | Better understanding of the impact of systematic non-adherence to mass drug administration (MDA) ivermectin programmes in endemic areas of sub-Saharan Africa. |
| URL | https://zenodo.org/record/7654986 |
| Title | Fatal outcome of chikungunya virus infection in Brazil |
| Description | Abstract Background Chikungunya virus (CHIKV) emerged in the Americas in 2013 and has caused ~2.1 million cases and over 600 deaths. A retrospective investigation was undertaken to describe clinical, epidemiological and virus genomic features associated with deaths caused by CHIKV in Ceará state, northeast Brazil. Methods Sera, cerebrospinal fluid (CSF) and tissue samples from 100 fatal cases with suspected arbovirus infection were tested for CHIKV, dengue (DENV) and Zika virus (ZIKV). Clinical, epidemiological and death reports were obtained for patients with confirmed CHIKV infection. Logistic regression analysis was undertaken to identify independent factors associated with risk of death during CHIKV infection. Phylogenetic analysis was conducted using whole genomes from a subset of cases. Results 68 fatal cases had CHIKV infection confirmed by RT-qPCR (52.9%), viral antigen (41.1%), and/or specific-IgM (63.2%). Co-detection of CHIKV with DENV were found in 22% of fatal cases, ZIKV in 2.9%, and DENV and ZIKV in 1.5%. A total of 39 CHIKV-deaths presented with neurological signs and symptoms, and CHIKV-RNA was found in the CSF of 92.3% of these patients. Fatal outcomes were associated with irreversible multiple organ dysfunction syndrome. Patients with diabetes appear to die at a higher frequency during the sub-acute phase. Genetic analysis showed circulation of two CHIKV-East Central South African (ECSA) lineages in Ceará and revealed no unique virus genomic mutation associated with fatal outcome. Conclusion The investigation of the largest cross-sectional cohort of CHIKV-deaths to date reveals that CHIKV-ECSA strains can cause death in individuals from both risk and non-risk groups, including young adults. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | This dataset formed the basis for subsequent studies investigating the pathophysiology of chikungunya virus infection with fatal outcomes. |
| URL | https://datadryad.org/dataset/doi:10.5061/dryad.7d7wm37sm |
| Title | HISTONCHO |
| Description | HISTONCHO: A dataset of intervention histories for onchocerciasis control & elimination in sub-Saharan Africa |
| Type Of Material | Database/Collection of data |
| Year Produced | 2026 |
| Provided To Others? | Yes |
| Impact | HISTONCHO is a dataset collating detailed information on interventions for the control and elimination of onchocerciasis in sub-Saharan Africa, including vector control, from 1975 through to 2022, using the ESPEN portal (2013-2022), regional and country reports, implementation partners' records, and published literature. Reconstructing such intervention histories is crucial for an understanding of their evolution, modelling their impact, and tailoring future interventions. |
| URL | https://zenodo.org/records/15390119 |
| Title | Model of HIV prevention cascade in East Zimbabwe |
| Description | Individual based model of the transmission dynamics of HIV infection in East Zimbabwe incorporating an HIV prevention cascade framework |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2021 |
| Provided To Others? | No |
| Impact | Not yet recognised |
| URL | http://www.manicalandhivproject.org/resources.html |
| Title | Modelling analysis for Onchocerciasis-Associated Epilepsy |
| Description | This sub-model of the stochastic. individual-based model EPIONCHO-IBM permits modelling of the incidence and prevalence of onchocerciasis-associated epilepsy (OAE) in a given setting characterised by a vector annual biting rate, and the impact of ivermectin MDA on OAE prevalence and incidence. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2024 |
| Provided To Others? | Yes |
| Impact | Scenario-based simulations highlight the urgency of strengthening MDA-based programmes by increasing treatment frequency and coverage and minimising non-adherence to effect maximal reductions in OAE prevalence and incidence, whose benefits may continue after treatment cessation. In holoendemic settings, alternative and/or complementary strategies will likely be required to markedly reduce transmission and protect gains against OAE. |
| URL | https://zenodo.org/records/12570421 |
| Title | Mortality, morbidity & healthseeking behaviours in PLHIV in east Zimbabwe |
| Description | General population survey data on mortality, morbidity & healthseeking behaviours by HIV infection status in the post-ART scale-up period in adults in east Zimbabwe |
| Type Of Material | Database/Collection of data |
| Year Produced | 2025 |
| Provided To Others? | No |
| Impact | Data analysis is currently in progress. Results will be shared with policymakers and participating communities later in 2026 |
| URL | http://www.manicalandhivproject.org/resources.html |
| Title | Naomi model |
| Description | The Naomi model is a methodology and software for estimating district-level HIV prevalence, treatment coverage and new infections. It has been adopted by UNAIDS for use by countries across sub-Saharan Africa. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | The model is used annually by national HIV programmes in sub-Saharan Africa to produce official estimates used for national policy and planning purposes. Results are collected from countries and published by UNAIDS: http://naomi-spectrum.unaids.org/ Results of are routinely used for national budget allocation and monitoring, Global Fund proposals, and US Government PEPFAR budget allocation and target setting. |
| URL | https://github.com/mrc-ide/naomi |
| Title | Phylotype consensus sequences for paper: Evidence for circulation of high-virulence HIV-1 subtype B variants in the United Kingdom |
| Description | These data files contain consensus sequences of phylotypes/clusters with putative differences in transmission patterns, identified using the treestructure package on genomic data from the UK Drug Resistance Database-a central repository for routine resistance testing in the UK. These phylotypes were then used in statistical analyses of clinical markers (viral load and CD4 counts) to identify HIV-1 variants associated with increased virulence. Files and variables File: phylotype_consensus.fastaDescription: Unaligned FASTA file of phylotype consensus sequences for subtypes A1, B, C, and CRF02AG. File: phylotype_consensus.csvVariables: Sequence_ID: the phylotype consensus identifier. Collection_date: the range of dates (in years) of the individual sequences for which a phylotype was called. Country: the country of all the sequences within each phylotype. Host: the organism from which the viruses, used to generate the consensus, were isolated. Organism: the virus species. Genomic_region: the genomic region used to generate the consensus sequences. Methods These sequences were derived from a cluster/phylotype analysis performed on the UK Drug Resistace Database dataset for subtypes A1, B, C, and CRF02AG. Therefore, collection dates represent the range of dates of the individual sequences for which a phylotype was called. Phylotypes were identified using subtype-specific time-scaled trees estimated using treedater v0.5.3. Samples sizes of those trees were, respectively, 2714, 24100, 11331, and 2743. Phylotypes were estimated using treestructure v0.3.1 with a minimum clade size of 30 and a bootstrap support threshold of 80%. The consensus phylotype sequences were obtained using seqinr v4.2.8 with the site majority method (i.e. high-frequency character is returned as consensus) and a minimum relative frequency threshold of 80%. Initially, some phylotypes were paraphyletic (n=30 of the submitted consensuses, listed IDs in paper Table S5; preprint available at https://doi.org/10.2139/ssrn.4929798). We resolved this by tracing the most recent common ancestor (MRCA) of all sequences in the phylotype until a monophyletic group was formed. Then called the consensus as mentioned above. There is no consensus sequence uploaded for the backbone phylotype (paraphyletic) of each subtype, which represents the large (~50% of samples) and diverse ancestral type from which all of the other phylotypes were descended. Individual-level HIV genetic, demographic, and clinical data from the UKRDB can be accessed for collaborative projects, subject to the approval of a research proposal by the UKRDB Steering Committee. The code used for all the analyses is freely accessible at GitHub (https://github.com/vinibfranc/HIV_UKRDB_phylotypes). |
| Type Of Material | Database/Collection of data |
| Year Produced | 2025 |
| Provided To Others? | Yes |
| Impact | Consensus sequences can be used to identify high-path phylotypes in new datasets including data from outside the United Kingdom. |
| URL | https://zenodo.org/doi/10.5281/zenodo.14792962 |
| Title | Population size, HIV prevalence, and antiretroviral therapy coverage among key populations in sub-Saharan Africa: collation and synthesis of survey data 2010-2023 |
| Description | This dataset contains surveillance study estimates for population size, HIV prevalence, and ART coverage among female sex workers (FSW), men who have sex with men (MSM), people who inject drugs (PWID), and transgender men and women (TGM/W) from 2010-2023. It was created to support the UNAIDS Estimates Key Population Workbook for use by HIV estimates teams in sub-Saharan Africa. Key population surveillance reports, including Ministry of Health-led biobehavioural surveys, mapping studies, and academic studies were used to populate the database. The dataset was populated using existing key population size estimate databases including: UNAIDS Key Population Atlas US Centers for Disease Control and Prevention surveillance database Global Fund against HIV/AIDS, TB, and Malaria surveillance database Global.HIV database Systematic review databases among MSM (Stannah et al, 2019 and Stannah et al., 2023) and PWID (Degenhardt et al., 2023) and was additionally supplemented by a literature review of peer-reviewed and grey literature sources. The data can be explored in this web application and the accompanying manuscript can be found here |
| Type Of Material | Database/Collection of data |
| Year Produced | 2024 |
| Provided To Others? | Yes |
| Impact | This dataset forms the basis for UNAIDS Key Population Workbooks completed by countries during annual UNAIDS HIV Estimates processes. Results are used as inputs to national and global estimates of HIV among key populations published by UNAIDS (https://aidsinfo.unaids.org) |
| URL | https://zenodo.org/doi/10.5281/zenodo.13144705 |
| Title | Reinforcement learning/model predictive control algorithm for optimising epidemic interventions |
| Description | Team developed a novel approach to optimising interventions in real time by using techniques from reinforcement learning, model predictive control and Markov decision processes. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2024 |
| Provided To Others? | Yes |
| Impact | Two papers https://www.medrxiv.org/content/10.1101/2025.11.17.25340271v1 and https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1013426 We have built a new package called EpiControl that we think will have future impact as it allows anyone to access optimal control algorithms to improve epidemic scenario analysis under control actions. |
| URL | https://sandorberegi.github.io/EpiControl/ |
| Title | SARS-CoV-2 sequencing data for the eight cities |
| Description | This repository contains fasta and metadata files for sequences obtained from samples from PCR+ patients. Samples were collected between March 2020 and December 2022 in the eight Brazilian capitals participating of the COVID-IgG project (Belo Horizonte, Curitiba, Fortaleza, Manaus, Recife, Rio de Janeiro, Salvador, São Paulo). |
| Type Of Material | Database/Collection of data |
| Year Produced | 2023 |
| Provided To Others? | Yes |
| Impact | This dataset contributed to SARS-CoV-2 genomic surveillance efforts in Brazil. A publication is currently being prepared addressing the importance of representativity in pathogen sequencing strategies. |
| URL | https://github.com/CADDE-CENTRE/genomics_eight_cities |
| Title | Source data for combined Maela panproteome and population genomics analysis |
| Description | Source data for figures and supplementary figures describing the combined analysis of pneumococcal panproteome array and population genomic data from the Maela camp. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2023 |
| Provided To Others? | Yes |
| Impact | The development of the vaccine design concepts described in https://doi.org/10.1111/1751-7915.14446. |
| URL | https://figshare.com/articles/dataset/Source_data_for_combined_Maela_panproteome_and_population_geno... |
| Title | The Thazni La Onse Model |
| Description | This is a model for investigating health, healthcare systems and resource use in settings in Eastern, Central and Southern Africa. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2023 |
| Provided To Others? | Yes |
| Impact | Publications by our group. Use by groups in Zambia, Kenya, Switzerland and Malawi. It has formed the basis of at least five other independent grant applications and new projects (there may be others we do not know about, as the model is available under the CC-BY license). |
| URL | https://zenodo.org/records/10144016 |
| Title | Translating genotype to phenotype for malaria preventive treatment |
| Description | An online tool was developed which allows policy makers and health professionals to input information on malaria parasite genotypes in a particular area, and estimate the efficacy of preventive treatment for children using sulphadoxine-pyrimethamine. https://andriamousa.shinyapps.io/SP_PE_prediction_tool/ Described in this preprint (also recently accepted in nature communications journal): https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4856036 |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2024 |
| Provided To Others? | Yes |
| Impact | Input into preventive treatment implementation in Cameroon, Benin, Zambia. |
| URL | https://andriamousa.shinyapps.io/SP_PE_prediction_tool/ |
| Title | World Health Organisation pfhrp2/3 Deletion Risk Explorer |
| Description | Malaria rapid diagnostic tests (RDTs) commonly deployed for the diagnosis of Plasmodium falciparum malaria detect the P. falciparum histidine-rich protein 2 (PfHRP2) and its paralog P. falciparum histidine-rich protein 3 (PfHRP3). However, progress against malaria is now threatened by an increase in pfhrp2/3 gene deletions. The timeline for countries to transition away from HRP2-based RDTs to alternative diagnostic methods is dependent upon several factors, which include: malaria transmission intensity, treatment-seeking, testing patterns, and RDT usage. The objective of this pfhrp2/3 Deletion Risk Explorer is to allow users to explore how changes in the underlying modelling assumptions impact the risk of pfhrp2/3 continuing to spread. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2025 |
| Provided To Others? | Yes |
| Impact | Contribution to WHO 2024 updated policy guidance on pfhrp2/3 deletions. |
| URL | https://worldhealthorg.shinyapps.io/DeletionRiskExplorer/ |
| Title | Zimbabwe Social Contact Data |
| Description | Social contact data for Zimbabwe |
| Type Of Material | Database/Collection of data |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | These data were widely used in mathematical models of Covid-19 transmission and impact for countries in sub-Saharan Africa during the Covid-19 pandemic |
| URL | https://zenodo.org/record/1251944 |
| Description | ANC surveillance in Tanzania - National Malaria Control Programme of Tanzania and University of Dar es Salaam |
| Organisation | National Malaria Control Programme, Tanzania |
| Country | Tanzania, United Republic of |
| Sector | Public |
| PI Contribution | Our team has provided technical expertise and analytical support to integrate MAMASANTE, an ANC-based malaria surveillance tool, into Tanzania's NMCP. We are developing an analytical framework for assessing malaria intervention impact, designed to support future programmatic decision-making. We have showcased this work to the Permanent Secretary for Health and are organising a three-day workshop in Dar es Salaam to further engage stakeholders. Additionally, we are in advanced stages of securing three years of funding from BMGF, based on a co-created scope of work in direct partnership with NMCP and researchers based at University of Dar es Salaam to . I also serve as an advisor for the PhD research of our key collaborators within the programme and my team are working with senior academics at UDSM with the aim strengthening local research capacity to develop an use such modelling tools. |
| Collaborator Contribution | The Tanzanian NMCP has provided policy leadership and implementation expertise, ensuring alignment with national malaria strategies and routine health system workflows. They have facilitated access to routine surveillance data, supported integration within DHIS2, and actively contributed to the co-development of research priorities. Their engagement has been critical in shaping an evidence-based approach to malaria surveillance, ensuring findings directly inform policy and practice. Our partnership with UDSM is more recent and the subject of an ongoing skill-sharing project between myself and Dr. Wilfred Senyoni, the architect of the health information system dashboards used by NMCP. This has involved working with the NMCP over the last three months to develop a formal plan to integrate our ANC surveillance tool directly within the existing decision-making framework of the NMCP. Both partners have also played a key role in the development of the BMGF funding proposal, strengthening long-term collaboration and research impact. |
| Impact | Integration of ANC surveillance platform into NMCP Decision making- we have provided the NMCP with an analysis of priority districts for Seasonal Malaria Chemoprevention Presentation at Roll Back Malaria meeting into Alternative Surveillance tools for malaria - presentations from both ICL and NMCP arising directly from this work Recently accepted co-authored first publication for main collaborator's PhD (Frank Chacky) Dissemination meeting in Dar es Salaam to be conducted March 18-20th 2025 Modelling training workshop at UDSM to be conducted March 28th-April 2nd. |
| Start Year | 2016 |
| Description | Acting as Faculty Observer for the MMED2025 Modelling short course |
| Organisation | University of Stellenbosch |
| Department | South African Centre for Epidemiological Modelling and Analysis |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | In June 2025 I acted as a Faculty Observer on the MMED modelling short course, held in Muizenberg, Cape Town, South Africa. This involved participating in all the course activities. Following the course, I delivered a written report, summarising my assessment of the course, and some areas for improvement. |
| Collaborator Contribution | N/A |
| Impact | n/a |
| Start Year | 2025 |
| Description | Analysing nosocomial COVID-19 outbreaks in Switzerland |
| Organisation | University of Geneva |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Design of methodology Statistical support |
| Collaborator Contribution | Providing data Contextual knowledge |
| Impact | Papers published - Explosive nosocomial outbreak of SARS-CoV-2 in a rehabilitation clinic: the limits of genomics for outbreak reconstruction Journal of Hospital Infection Occupational versus community risk of SARS-CoV-2 infection among employees of a long-term care facility: an observational study Antimicrobial resistance and infection control Reconstruction of transmission chains of SARS-CoV-2 amidst multiple outbreaks in a geriatric acute-care hospital: a combined retrospective epidemiological and genomic study life + Papers in preparation + a recent successful grant by the Swiss National Foundation due to start in 2026 |
| Start Year | 2020 |
| Description | Andean-Brazil-Mexico-Imperial emerging pandemic modelling training partnership |
| Organisation | Central University of Venezuela |
| Country | Venezuela, Bolivarian Republic of |
| Sector | Academic/University |
| PI Contribution | The WHO's Pandemic and Resilience for Emerging Threats (PRET) initiative calls for formulation of preparedness plans and priority actions underpinned by learnings from the COVID-19 pandemic. Robust epidemiological analytics to assess the impact of emerging pandemics and efficacy of mitigation strategies are needed from across low- and middleincome settings. |
| Collaborator Contribution | Judicious use of mathematical modelling and deeply understanding the local context are essential to yield robust emerging pandemic analytics. A collaborative workshop was carried out to expand the School of Public Health's collaborating network in Latin America by delivering epidemic modelling training and setting a pandemic research priority agenda together with key regional academic institutions and stakeholders. |
| Impact | ongoing. |
| Start Year | 2025 |
| Description | Andean-Brazil-Mexico-Imperial emerging pandemic modelling training partnership |
| Organisation | National School of Public Health - FIOCRUZ |
| Country | Brazil |
| Sector | Academic/University |
| PI Contribution | The WHO's Pandemic and Resilience for Emerging Threats (PRET) initiative calls for formulation of preparedness plans and priority actions underpinned by learnings from the COVID-19 pandemic. Robust epidemiological analytics to assess the impact of emerging pandemics and efficacy of mitigation strategies are needed from across low- and middleincome settings. |
| Collaborator Contribution | Judicious use of mathematical modelling and deeply understanding the local context are essential to yield robust emerging pandemic analytics. A collaborative workshop was carried out to expand the School of Public Health's collaborating network in Latin America by delivering epidemic modelling training and setting a pandemic research priority agenda together with key regional academic institutions and stakeholders. |
| Impact | ongoing. |
| Start Year | 2025 |
| Description | Andean-Brazil-Mexico-Imperial emerging pandemic modelling training partnership |
| Organisation | Pan American Health Organization |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | The WHO's Pandemic and Resilience for Emerging Threats (PRET) initiative calls for formulation of preparedness plans and priority actions underpinned by learnings from the COVID-19 pandemic. Robust epidemiological analytics to assess the impact of emerging pandemics and efficacy of mitigation strategies are needed from across low- and middleincome settings. |
| Collaborator Contribution | Judicious use of mathematical modelling and deeply understanding the local context are essential to yield robust emerging pandemic analytics. A collaborative workshop was carried out to expand the School of Public Health's collaborating network in Latin America by delivering epidemic modelling training and setting a pandemic research priority agenda together with key regional academic institutions and stakeholders. |
| Impact | ongoing. |
| Start Year | 2025 |
| Description | Andean-Brazil-Mexico-Imperial emerging pandemic modelling training partnership |
| Organisation | Pontifical Xavierian University |
| Country | Colombia |
| Sector | Academic/University |
| PI Contribution | The WHO's Pandemic and Resilience for Emerging Threats (PRET) initiative calls for formulation of preparedness plans and priority actions underpinned by learnings from the COVID-19 pandemic. Robust epidemiological analytics to assess the impact of emerging pandemics and efficacy of mitigation strategies are needed from across low- and middleincome settings. |
| Collaborator Contribution | Judicious use of mathematical modelling and deeply understanding the local context are essential to yield robust emerging pandemic analytics. A collaborative workshop was carried out to expand the School of Public Health's collaborating network in Latin America by delivering epidemic modelling training and setting a pandemic research priority agenda together with key regional academic institutions and stakeholders. |
| Impact | ongoing. |
| Start Year | 2025 |
| Description | Andean-Brazil-Mexico-Imperial emerging pandemic modelling training partnership |
| Organisation | The National Institute of Public Health of Mexico (INSP) |
| Country | Mexico |
| Sector | Academic/University |
| PI Contribution | The WHO's Pandemic and Resilience for Emerging Threats (PRET) initiative calls for formulation of preparedness plans and priority actions underpinned by learnings from the COVID-19 pandemic. Robust epidemiological analytics to assess the impact of emerging pandemics and efficacy of mitigation strategies are needed from across low- and middleincome settings. |
| Collaborator Contribution | Judicious use of mathematical modelling and deeply understanding the local context are essential to yield robust emerging pandemic analytics. A collaborative workshop was carried out to expand the School of Public Health's collaborating network in Latin America by delivering epidemic modelling training and setting a pandemic research priority agenda together with key regional academic institutions and stakeholders. |
| Impact | ongoing. |
| Start Year | 2025 |
| Description | Andean-Brazil-Mexico-Imperial emerging pandemic modelling training partnership |
| Organisation | University of San Francisco Quito |
| Country | Ecuador |
| Sector | Academic/University |
| PI Contribution | The WHO's Pandemic and Resilience for Emerging Threats (PRET) initiative calls for formulation of preparedness plans and priority actions underpinned by learnings from the COVID-19 pandemic. Robust epidemiological analytics to assess the impact of emerging pandemics and efficacy of mitigation strategies are needed from across low- and middleincome settings. |
| Collaborator Contribution | Judicious use of mathematical modelling and deeply understanding the local context are essential to yield robust emerging pandemic analytics. A collaborative workshop was carried out to expand the School of Public Health's collaborating network in Latin America by delivering epidemic modelling training and setting a pandemic research priority agenda together with key regional academic institutions and stakeholders. |
| Impact | ongoing. |
| Start Year | 2025 |
| Description | Andean-Brazil-Mexico-Imperial emerging pandemic modelling training partnership |
| Organisation | World Health Organization (WHO) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | The WHO's Pandemic and Resilience for Emerging Threats (PRET) initiative calls for formulation of preparedness plans and priority actions underpinned by learnings from the COVID-19 pandemic. Robust epidemiological analytics to assess the impact of emerging pandemics and efficacy of mitigation strategies are needed from across low- and middleincome settings. |
| Collaborator Contribution | Judicious use of mathematical modelling and deeply understanding the local context are essential to yield robust emerging pandemic analytics. A collaborative workshop was carried out to expand the School of Public Health's collaborating network in Latin America by delivering epidemic modelling training and setting a pandemic research priority agenda together with key regional academic institutions and stakeholders. |
| Impact | ongoing. |
| Start Year | 2025 |
| Description | Assessing dengue seroprevalence in Ghana, DRC and Senegal |
| Organisation | Drugs for Neglected Diseases initiative (DNDi) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | We developed the study design, implemented the analytical and modelling framework and prepared manuscripts for publication, and posters and talks for conference presentations. |
| Collaborator Contribution | DNDi managed the project. KNUST, the Univeristy of Kinshasa and Institut Pasteur du Dakar tested the blood samples. |
| Impact | We published two papers, one in Plos Comp Biol and one in eBioMed. We are currently drafting the main paper describing the projects results. We have also delivered several conference presentations. We have also shared informal training sessions (i.e., self-organised, as 1:1 meetings) in modelling to our partners. We found evidence of dengue and other arboviruses circulation across all 19 locations tested - once that these estimates become publicly available, we expected that they will catalyse new research on the topic as well as initiate discussions on interventions. |
| Start Year | 2022 |
| Description | Assessing dengue seroprevalence in Ghana, DRC and Senegal |
| Organisation | Kwame Nkrumah University of Science and Technology (KNUST) |
| Country | Ghana |
| Sector | Academic/University |
| PI Contribution | We developed the study design, implemented the analytical and modelling framework and prepared manuscripts for publication, and posters and talks for conference presentations. |
| Collaborator Contribution | DNDi managed the project. KNUST, the Univeristy of Kinshasa and Institut Pasteur du Dakar tested the blood samples. |
| Impact | We published two papers, one in Plos Comp Biol and one in eBioMed. We are currently drafting the main paper describing the projects results. We have also delivered several conference presentations. We have also shared informal training sessions (i.e., self-organised, as 1:1 meetings) in modelling to our partners. We found evidence of dengue and other arboviruses circulation across all 19 locations tested - once that these estimates become publicly available, we expected that they will catalyse new research on the topic as well as initiate discussions on interventions. |
| Start Year | 2022 |
| Description | Assessing dengue seroprevalence in Ghana, DRC and Senegal |
| Organisation | Pasteur Institute Dakar |
| Country | Senegal |
| Sector | Charity/Non Profit |
| PI Contribution | We developed the study design, implemented the analytical and modelling framework and prepared manuscripts for publication, and posters and talks for conference presentations. |
| Collaborator Contribution | DNDi managed the project. KNUST, the Univeristy of Kinshasa and Institut Pasteur du Dakar tested the blood samples. |
| Impact | We published two papers, one in Plos Comp Biol and one in eBioMed. We are currently drafting the main paper describing the projects results. We have also delivered several conference presentations. We have also shared informal training sessions (i.e., self-organised, as 1:1 meetings) in modelling to our partners. We found evidence of dengue and other arboviruses circulation across all 19 locations tested - once that these estimates become publicly available, we expected that they will catalyse new research on the topic as well as initiate discussions on interventions. |
| Start Year | 2022 |
| Description | Assessing dengue seroprevalence in Ghana, DRC and Senegal |
| Organisation | University of Kinshasa |
| Country | Congo, the Democratic Republic of the |
| Sector | Academic/University |
| PI Contribution | We developed the study design, implemented the analytical and modelling framework and prepared manuscripts for publication, and posters and talks for conference presentations. |
| Collaborator Contribution | DNDi managed the project. KNUST, the Univeristy of Kinshasa and Institut Pasteur du Dakar tested the blood samples. |
| Impact | We published two papers, one in Plos Comp Biol and one in eBioMed. We are currently drafting the main paper describing the projects results. We have also delivered several conference presentations. We have also shared informal training sessions (i.e., self-organised, as 1:1 meetings) in modelling to our partners. We found evidence of dengue and other arboviruses circulation across all 19 locations tested - once that these estimates become publicly available, we expected that they will catalyse new research on the topic as well as initiate discussions on interventions. |
| Start Year | 2022 |
| Description | CEPI - Disease X |
| Organisation | Coalition for Epidemic Preparedness Innovations |
| Country | Norway |
| Sector | Learned Society |
| PI Contribution | Joint research to evaluate the potential value of investment in vaccines against SARS-X to support CEPI's investment strategy |
| Collaborator Contribution | Provided intellectual input and supporting data for model-based assumptions |
| Impact | PMID: 39424569; PMID: 41006237; PMID: 39424569 |
| Start Year | 2023 |
| Description | Center for Epidemiological Modelling and Analysis (CEMA) at the University of Nairobi |
| Organisation | University of Nairobi |
| Country | Kenya |
| Sector | Academic/University |
| PI Contribution | Experiences during the COVID-19 pandemic highlighted the challenges decision makers face in interpreting and using analytics for public health policy. To respond to these challenges, researchers at the MRC Centre for Global Infectious Disease Analysis (MRC-GIDA) at Imperial College London and the Center for Epidemiological Modelling and Analysis (CEMA) at the University of Nairobi conducted mixed-methods research study to explore how the gap between quantitative scientists and policymakers, especially in resource-constrained settings can be bridged. This research was supplemented by The "Bridging the Gap Hackathon", which was a 5-day event to bring together public health decision-makers, developers, technical experts, and academics and researchers to create free, open-source resources to support and facilitate evidence-informed decision making and address health policy needs in Kenya. |
| Collaborator Contribution | The team at CEMA worked with the ministry of health in Kenya to identify specific health policy challenges, which were the focus of the hackathon. CEMA also advertised the vent and co-organised its creation and delivery with researchers from MRC-GIDA |
| Impact | Two publications both under peer-review. |
| Start Year | 2024 |
| Description | Centre for Infectious Disease Research Zambia |
| Organisation | Centre for Infectious Disease Research in Zambia |
| Country | Zambia |
| Sector | Charity/Non Profit |
| PI Contribution | Study design and lab support for a rotavirus study Liaising with funders Grant writing |
| Collaborator Contribution | Running a clinical trial of rotavirus vaccine in Zambia Performance of lab assays Project Management |
| Impact | Successful application for "Human infection challenge vaccine (HIC-vac) network" with Roma Chilengi |
| Start Year | 2018 |
| Description | Clinton Heath Access Initiative support of Antimalarial Resistance Containment |
| Organisation | Clinton Health Access Initiative |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Ongoing modelling support to quantify the risk, spread and costs to combat malaria drug resistance in Africa. |
| Collaborator Contribution | Technical and data-analytics support as well as project shaping. |
| Impact | Modelling results (https://doi.org/10.1101/2024.08.28.24312699) that underpin the Roll Back Malaria Multiple First-line Therapies (MFT) Tool (https://dashboards.endmalaria.org/en/mft-scenario-tool) and WHO Implementation Guides on MFT (https://www.who.int/publications/i/item/9789240103603) |
| Start Year | 2023 |
| Description | Clinton Heath Access Initiative support of Novel RDT Rollout |
| Organisation | Clinton Health Access Initiative |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Ongoing modelling support to quantify the impact of switching to alternative malaria rapid diagnostic tests in Africa. |
| Collaborator Contribution | Technical and data-analytics support as well as project shaping. |
| Impact | None to date as the project is at early stage. |
| Start Year | 2025 |
| Description | Clinton Heath Access Initiative support of Presidents Malaria Initiative modelling |
| Organisation | Clinton Health Access Initiative |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Ongoing modelling support to quantify the past and future impaft of Presidents Malaria Initiative investments on reducing the burden of malaria |
| Collaborator Contribution | Technical and data-analytics support as well as project shaping |
| Impact | None to date as the project is at early stage. |
| Start Year | 2024 |
| Description | Collaboration with AFRIMS |
| Organisation | Armed Forces Research Institute of Medical Sciences |
| Country | Thailand |
| Sector | Public |
| PI Contribution | In collaboration with AFRIMS and Imperial colleagues based in the Faculty of Medicine, we have developed a machine learning prognostic tool to predict the onset of severe dengue that can be utilised during the first 72 hours since illness onset. |
| Collaborator Contribution | In collaboration with AFRIMS and Imperial colleagues based in the Faculty of Medicine, we have developed a machine learning prognostic tool to predict the onset of severe dengue that can be utilised during the first 72 hours since illness onset. |
| Impact | Article available here: https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001171 |
| Start Year | 2024 |
| Description | Collaboration with AFRIMS and SUNY Medical School |
| Organisation | Armed Forces Research Institute of Medical Sciences |
| Country | Thailand |
| Sector | Public |
| PI Contribution | In collaboration with AFRIMS and SUNY, we have developed a machine learning algorithm to predict the serotype of infection from pre- and post-infection antibody titres. |
| Collaborator Contribution | In collaboration with AFRIMS and SUNY, we have developed a machine learning algorithm to predict the serotype of infection from pre- and post-infection antibody titres. |
| Impact | Article: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1012188 |
| Start Year | 2025 |
| Description | Collaboration with AFRIMS and SUNY Medical School |
| Organisation | State University of New York |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | In collaboration with AFRIMS and SUNY, we have developed a machine learning algorithm to predict the serotype of infection from pre- and post-infection antibody titres. |
| Collaborator Contribution | In collaboration with AFRIMS and SUNY, we have developed a machine learning algorithm to predict the serotype of infection from pre- and post-infection antibody titres. |
| Impact | Article: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1012188 |
| Start Year | 2025 |
| Description | Collaboration with IZSLER (Italy) |
| Organisation | Lombardy and Emilia Romagna Experimental Zootechnic Institute (IZSLER) |
| Country | Italy |
| Sector | Public |
| PI Contribution | Collaboration with Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER) for the analysis of the meteorological drivers of WNV transmission and its association with avian biodiversity. |
| Collaborator Contribution | Collaboration with Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER) for the analysis of the meteorological drivers of WNV transmission and its association with avian biodiversity. |
| Impact | Journal article: https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013753 |
| Start Year | 2024 |
| Description | Collaboration with Regione Emilia Romagna - Chikungunya outbreak |
| Organisation | Regional Health Authority of Emilia-Romagna |
| Country | Italy |
| Sector | Public |
| PI Contribution | Collaboration with Regione Emilia Romagna on the analysis of the Chikungunya outbreak that occurred in Carpi (Italy) in the summer of 2025; Data analysis Modelling expertise Paper writing. |
| Collaborator Contribution | Collaboration with Regione Emilia Romagna on the analysis of the Chikungunya outbreak that occurred in Carpi (Italy) in the summer of 2025; Data analysis Modelling expertise Paper writing. |
| Impact | Outputs in progress |
| Start Year | 2025 |
| Description | Collaboration with The International Federation of Red Cross and Red Crescent Societies |
| Organisation | International Federation of Red Cross and Crescents |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Working with the malaria team to understand how the cost-effectiveness of malaria control can be improved |
| Collaborator Contribution | Technical expertise |
| Impact | Reports and Grant Applications |
| Start Year | 2025 |
| Description | Collaboration with WHO SEARO and Bangladesh Offices |
| Organisation | World Health Organization (WHO) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | Collaboration with WHO SEARO (South East Asia Regional Office), the WHO Bangladeshi Office, and the Institute of Epidemiology, Disease Control and Research in Dhaka for the development and operationalisation of a neural networks based dengue forecasting tool. Following the Sri Lanka experience, we plan to deliver training in modelling and forecasting to the Bangladeshi team in the spring of 2026. |
| Collaborator Contribution | Collaboration with WHO SEARO (South East Asia Regional Office), the WHO Bangladeshi Office, and the Institute of Epidemiology, Disease Control and Research in Dhaka for the development and operationalisation of a neural networks based dengue forecasting tool. Following the Sri Lanka experience, we plan to deliver training in modelling and forecasting to the Bangladeshi team in the spring of 2026. |
| Impact | Model development co-designed with public health officials and co-production of papers (not yet published). |
| Start Year | 2024 |
| Description | Collaboration with the Tropical Insect Science Institute (ICIPE) |
| Organisation | International Centre of Insect Physiology and Ecology (ICIPE) |
| Country | Kenya |
| Sector | Academic/University |
| PI Contribution | We have provided statistical and modelling support to a project looking at the impact of microsymbiont bacteria on malaria transmission to mosquitoes. Together we have developed SYMBIOVECTOR research programme, which aims to advance symbiont based strategies for malaria control. |
| Collaborator Contribution | Provided a sub-contract to fund the work and raw data to parameterise the statistical and mathematical models. |
| Impact | Multidisciplinary project, bringing together entomology, parasitology, statistical epidemiology and transmission dynamics modelling. |
| Start Year | 2025 |
| Description | Collaborations with WHO Global Hepatitis Unit on viral hepatitis elimination strategies |
| Organisation | World Health Organization (WHO) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | We have been collaborating with the WHO, both at headquarter level and at regional WPRO level on viral hepatitis strategies. Our primary work has focus on the use of applied modelling in guiding public health policy, modelling global targets for elimination, country level work in China and elimination of mother-to-child transmission of HBV. |
| Collaborator Contribution | The WHO provided the contacts and the context of the priority policy questions to be addressed. |
| Impact | Our work has been referenced in the Global Health Sector Strategy on Viral Hepatitis and other policy documents (see other sections of form for further details). We have been invited to national consultations in China and Malaysia on the elimination of mother to child transmission of HBV. Participants of this consultative process included academics, representatives of the health ministries and other key policy makers. |
| Start Year | 2014 |
| Description | Community Health Systems & Outbreak Response |
| Organisation | Makerere University |
| Department | School of Public Health |
| Country | Uganda |
| Sector | Academic/University |
| PI Contribution | The NIHR award has consolidated bi-lateral partnerships with Makerere University and the Uganda Ministry of Health, embedding modelling and economic evaluation within national outbreak-response planning. This collaboration extends prior academic links into a funded, multi-institution programme with shared work packages, joint supervision and co-authorship pipelines. The partnership is active and currently in implementation. |
| Collaborator Contribution | Makerere University School of Public Health Leads in-country research coordination, field engagement, and stakeholder interface with the Ministry of Health. Provides contextual expertise in community health systems, qualitative implementation research, and policy translation pathways. Uganda Ministry of Health Supplies programme data, operational insights into health-system functioning, and defines priority policy questions. Ensures alignment with national planning processes and uptake into strategy discussions. Interdisciplinary academic collaborators (epidemiology, economics, implementation science) Provide complementary methodological expertise enabling integration of epidemiological modelling with health economics and health-systems evaluation. |
| Impact | Project has just started |
| Start Year | 2026 |
| Description | Cost-effectiveness of the Ebola response in Eastern DRC |
| Organisation | Ministry of Public Health |
| Country | Congo, the Democratic Republic of the |
| Sector | Public |
| PI Contribution | Leading infectious disease modelling study to assess of the cost-effectiveness of the Ebola response in North Kivu / Ituri, 2018-2020. |
| Collaborator Contribution | WBG has provided costing data for the study. Ministry of Public Health of the DRC has contributed epidemiological data. WHO has provided insights into the handling of the response. |
| Impact | Publications: 1. Jombart T, Zeng W, Yao M, Cori A, Samaha H, Wilkinson T, et al. Estimating the impact and cost-effectiveness of the response to Ebola in the Democratic Republic of the Congo, 2018-2020. Aaccepted in BMJ Glob Health. 2. Zeng W, Samaha H, Yao M, Ahuka-Mundeke S, Wilkinson T, Jombart T, et al. The cost of public health interventions to respond to the 10th Ebola outbreak in the Democratic Republic of the Congo. BMJ Glob Health. 2023;8. doi:10.1136/bmjgh-2023-012660 Other outcome: the findings are being translated into a software tools for estimating the cost effectiveness of outbreak responses for different disease with several African partner countries. |
| Start Year | 2023 |
| Description | Cost-effectiveness of the Ebola response in Eastern DRC |
| Organisation | World Bank Group |
| Country | United States |
| Sector | Public |
| PI Contribution | Leading infectious disease modelling study to assess of the cost-effectiveness of the Ebola response in North Kivu / Ituri, 2018-2020. |
| Collaborator Contribution | WBG has provided costing data for the study. Ministry of Public Health of the DRC has contributed epidemiological data. WHO has provided insights into the handling of the response. |
| Impact | Publications: 1. Jombart T, Zeng W, Yao M, Cori A, Samaha H, Wilkinson T, et al. Estimating the impact and cost-effectiveness of the response to Ebola in the Democratic Republic of the Congo, 2018-2020. Aaccepted in BMJ Glob Health. 2. Zeng W, Samaha H, Yao M, Ahuka-Mundeke S, Wilkinson T, Jombart T, et al. The cost of public health interventions to respond to the 10th Ebola outbreak in the Democratic Republic of the Congo. BMJ Glob Health. 2023;8. doi:10.1136/bmjgh-2023-012660 Other outcome: the findings are being translated into a software tools for estimating the cost effectiveness of outbreak responses for different disease with several African partner countries. |
| Start Year | 2023 |
| Description | Cost-effectiveness of the Ebola response in Eastern DRC |
| Organisation | World Health Organization (WHO) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | Leading infectious disease modelling study to assess of the cost-effectiveness of the Ebola response in North Kivu / Ituri, 2018-2020. |
| Collaborator Contribution | WBG has provided costing data for the study. Ministry of Public Health of the DRC has contributed epidemiological data. WHO has provided insights into the handling of the response. |
| Impact | Publications: 1. Jombart T, Zeng W, Yao M, Cori A, Samaha H, Wilkinson T, et al. Estimating the impact and cost-effectiveness of the response to Ebola in the Democratic Republic of the Congo, 2018-2020. Aaccepted in BMJ Glob Health. 2. Zeng W, Samaha H, Yao M, Ahuka-Mundeke S, Wilkinson T, Jombart T, et al. The cost of public health interventions to respond to the 10th Ebola outbreak in the Democratic Republic of the Congo. BMJ Glob Health. 2023;8. doi:10.1136/bmjgh-2023-012660 Other outcome: the findings are being translated into a software tools for estimating the cost effectiveness of outbreak responses for different disease with several African partner countries. |
| Start Year | 2023 |
| Description | DelftiaTC1 for vector borne disease control |
| Organisation | GlaxoSmithKline (GSK) |
| Country | Global |
| Sector | Private |
| PI Contribution | Transmission dynamics modelling to support the development of DelftiaTC1 for blocking transmission of different vector borne diseases (malaria, dengue, leishmania). |
| Collaborator Contribution | Primary entomological data. |
| Impact | Report and Grants Award from EU Horizon and Wellcome Trust. |
| Start Year | 2024 |
| Description | District-level HIV estimation and HIV resource allocation in South Africa |
| Organisation | Government of South Africa |
| Department | Department of Health |
| Country | South Africa |
| Sector | Public |
| PI Contribution | - Statistical modelling of HIV surveillance and program data |
| Collaborator Contribution | - Curation of survey and programme data. - Interpretation and implementation of estimates. |
| Impact | - Official HIV estimates and targets for South Africa HIV programme Further funding from Gates to continue work https://www.hivdata.org.za |
| Start Year | 2019 |
| Description | District-level HIV estimation and HIV resource allocation in South Africa |
| Organisation | Human Sciences Research Council (HSRC) |
| Country | South Africa |
| Sector | Charity/Non Profit |
| PI Contribution | - Statistical modelling of HIV surveillance and program data |
| Collaborator Contribution | - Curation of survey and programme data. - Interpretation and implementation of estimates. |
| Impact | - Official HIV estimates and targets for South Africa HIV programme Further funding from Gates to continue work https://www.hivdata.org.za |
| Start Year | 2019 |
| Description | District-level HIV estimation and HIV resource allocation in South Africa |
| Organisation | University of Cape Town |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | - Statistical modelling of HIV surveillance and program data |
| Collaborator Contribution | - Curation of survey and programme data. - Interpretation and implementation of estimates. |
| Impact | - Official HIV estimates and targets for South Africa HIV programme Further funding from Gates to continue work https://www.hivdata.org.za |
| Start Year | 2019 |
| Description | District-level HIV estimation and HIV resource allocation in South Africa |
| Organisation | Wits Health Consortium |
| Country | South Africa |
| Sector | Private |
| PI Contribution | - Statistical modelling of HIV surveillance and program data |
| Collaborator Contribution | - Curation of survey and programme data. - Interpretation and implementation of estimates. |
| Impact | - Official HIV estimates and targets for South Africa HIV programme Further funding from Gates to continue work https://www.hivdata.org.za |
| Start Year | 2019 |
| Description | EU4Health Joint Action |
| Organisation | European Centre for Disease Prevention and Control (ECDC) |
| Country | Sweden |
| Sector | Public |
| PI Contribution | As Imperial lead and modelling Work Package lead within the €20m Joint Action coordinated by Rigshospitalet (CHIP), the award has established structured collaboration across 13 EU Member States and with European Centre for Disease Prevention and Control. This represents a new Europe-facing policy and modelling partnership, distinct from earlier Africa-centred work. The programme includes formalised governance arrangements, data-sharing protocols and joint analytic frameworks across national public health institutes and academic groups. This partnership is active and expanding, with recruitment and delivery underway (2025-2028). |
| Collaborator Contribution | CHIP / Rigshospitalet (Coordinating centre) Provides overall programme governance, coordination across Member States, regulatory alignment, and integration with EU policy frameworks. Leads central data infrastructure and harmonisation of surveillance datasets. National public health institutes and academic partners across 13 EU Member States Contribute country-specific epidemiological data, clinical and registry linkages (particularly infection-related cancers), and contextual policy expertise. Provide local implementation insight required for model parameterisation and scenario interpretation. ECDC and associated EU stakeholders Supply surveillance standards, policy guidance, and facilitate translation of outputs into EU-level decision-support processes. |
| Impact | Project started end-2025. no outputs as yet. |
| Start Year | 2025 |
| Description | EU4Health Joint Action |
| Organisation | Rigshospitalet |
| Country | Denmark |
| Sector | Hospitals |
| PI Contribution | As Imperial lead and modelling Work Package lead within the €20m Joint Action coordinated by Rigshospitalet (CHIP), the award has established structured collaboration across 13 EU Member States and with European Centre for Disease Prevention and Control. This represents a new Europe-facing policy and modelling partnership, distinct from earlier Africa-centred work. The programme includes formalised governance arrangements, data-sharing protocols and joint analytic frameworks across national public health institutes and academic groups. This partnership is active and expanding, with recruitment and delivery underway (2025-2028). |
| Collaborator Contribution | CHIP / Rigshospitalet (Coordinating centre) Provides overall programme governance, coordination across Member States, regulatory alignment, and integration with EU policy frameworks. Leads central data infrastructure and harmonisation of surveillance datasets. National public health institutes and academic partners across 13 EU Member States Contribute country-specific epidemiological data, clinical and registry linkages (particularly infection-related cancers), and contextual policy expertise. Provide local implementation insight required for model parameterisation and scenario interpretation. ECDC and associated EU stakeholders Supply surveillance standards, policy guidance, and facilitate translation of outputs into EU-level decision-support processes. |
| Impact | Project started end-2025. no outputs as yet. |
| Start Year | 2025 |
| Description | Fellow of the Academy of Medical Sciences UK |
| Organisation | Academy of Medical Sciences (AMS) |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | As a fellow I am responsible for guiding medical policy globally, and in particular with a focus to European policy |
| Collaborator Contribution | The academy provides me with meeting space that can be used for conferences etc, but more broadly is a marker of prestige. |
| Impact | none |
| Start Year | 2023 |
| Description | Foundation of Tropical Medicine Dr Heitor Vieira Dourado, Manaus, Amazonas |
| Organisation | Tropical Medicine Foundation Doctor Heitor Vieira Dourado |
| Country | Brazil |
| Sector | Hospitals |
| PI Contribution | Co-organised a workshop for 30 early career researchers (15 UK, 15 Brazil/Amazon) entitled "Bridging Communities and Research for a Healthier Amazon: A Workshop on Infectious Diseases, Climate, and Development" at the Tropical Medicine Foundation Doctor Heitor Vieira Dourado. |
| Collaborator Contribution | Provided local expertise and contributed discussions on community engagement around One Health in the Brazilian Amazon. |
| Impact | The Brazilian Amazon PI, Prof. Wuelton Monteiro, is now involved as a collaborator in a MRC/FAPESP grant application. New collaborative links with One Project Vivera led by Brazilian Amazon PI, Prof. Wuelton Monteiro. Policy document on One Health surveillance in the Amazon (under preparation). |
| Start Year | 2024 |
| Description | Gavi - COVID-19 |
| Organisation | Gavi |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Estimates of the public health impact of COVID-19 vaccination - both retrospective and future scenarios to inform Gavi PPC and Board decisions. |
| Collaborator Contribution | Provided estimates of vaccine demand and discussion and interpretation of results. |
| Impact | PMID: 35753318 |
| Start Year | 2021 |
| Description | Gavi - malaria |
| Organisation | Gavi |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Provided public health and cost-effectiveness estimates of introduction of the RTS,S and R21 malaria vaccined to support Gavi PPC and Board decisions. |
| Collaborator Contribution | Provided estimates of vaccine demand and discussed outputs to support communication. |
| Impact | PMID: 36400084; PMID: 38342107 |
| Start Year | 2021 |
| Description | GenMoz |
| Organisation | Centro de Investigação em Saúde de Manhiça |
| Country | Mozambique |
| Sector | Charity/Non Profit |
| PI Contribution | Our team has provided expertise in modelling ANC-based malaria surveillance data, helping with co-creation of the original grant application funding GenMoz2 and supporting the application of our surveillance framework to the project. We facilitated capacity building by hosting a PhD candidate from ISGlobal/CISM, training them in modelling approaches and application of ANC surveillance data. This work is contributing to improving analytical capacity and integrating ANC surveillance tools into malaria burden estimation in Mozambique. |
| Collaborator Contribution | ISGlobal and CISM have played a key role in data collection and implementation, ensuring the integration of ANC-based malaria surveillance within Mozambique's health system. They have provided local expertise and contextual knowledge, facilitating access to relevant datasets and ensuring alignment with national malaria control priorities. Their support in coordinating research activities has been essential in applying ANC data for malaria surveillance and improving health information systems. |
| Impact | Capacity Building Through PhD Training - A PhD candidate from ISGlobal/CISM completed a research visit to develop modelling skills, focusing on the application of ANC data for malaria surveillance. Presentation at RBM Workshop (October 2024) - The findings from this work were showcased at the RBM workshop, engaging stakeholders in discussions on the role of ANC data in malaria surveillance and control. Integration of ANC Surveillance Approaches - The collaboration is strengthening the use of ANC-based malaria surveillance in Mozambique, contributing to ongoing analyses of malaria burden. |
| Start Year | 2021 |
| Description | GenMoz |
| Organisation | Instituto de Salud Global de Barcelona |
| Country | Spain |
| Sector | Charity/Non Profit |
| PI Contribution | Our team has provided expertise in modelling ANC-based malaria surveillance data, helping with co-creation of the original grant application funding GenMoz2 and supporting the application of our surveillance framework to the project. We facilitated capacity building by hosting a PhD candidate from ISGlobal/CISM, training them in modelling approaches and application of ANC surveillance data. This work is contributing to improving analytical capacity and integrating ANC surveillance tools into malaria burden estimation in Mozambique. |
| Collaborator Contribution | ISGlobal and CISM have played a key role in data collection and implementation, ensuring the integration of ANC-based malaria surveillance within Mozambique's health system. They have provided local expertise and contextual knowledge, facilitating access to relevant datasets and ensuring alignment with national malaria control priorities. Their support in coordinating research activities has been essential in applying ANC data for malaria surveillance and improving health information systems. |
| Impact | Capacity Building Through PhD Training - A PhD candidate from ISGlobal/CISM completed a research visit to develop modelling skills, focusing on the application of ANC data for malaria surveillance. Presentation at RBM Workshop (October 2024) - The findings from this work were showcased at the RBM workshop, engaging stakeholders in discussions on the role of ANC data in malaria surveillance and control. Integration of ANC Surveillance Approaches - The collaboration is strengthening the use of ANC-based malaria surveillance in Mozambique, contributing to ongoing analyses of malaria burden. |
| Start Year | 2021 |
| Description | Global Burden of Disease study |
| Organisation | Institute for Health Metrics and Evaluation (IHME) |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Modelling expertise Development of tools |
| Collaborator Contribution | Production of GBD study |
| Impact | Publication of GBD 2019 study Local burden of disease HIV estimates in SSA |
| Start Year | 2018 |
| Description | Global HITAP |
| Organisation | Government of Thailand |
| Country | Thailand |
| Sector | Public |
| PI Contribution | Working with Health Intervention and Technology Assessment Program within the Ministry of Health in Thailand. Producing methodological papers that provide a comprehensive explanation of fundamental topics relating to how to conduct or interpret economic evaluations. Provide mentorship to their staff. |
| Collaborator Contribution | Co-author on papers |
| Impact | 5 papers |
| Start Year | 2021 |
| Description | HIV mortality & healthcare seeking behaviours study |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Drafting the funding proposal for the project. Joint management of all aspects of implementation of the project. |
| Collaborator Contribution | BRTI: Employment of field staff to assist with obtaining the local ethical and regulatory approvals required to implement the research in Zimbabwe, to conduct all data collection and data management activities, to assist with data analysis and interpretation and write-up of research results, and to lead on local dissemination of the study findings. Copenhagen: Design and management of qualitative research activities for the study. Heidelberg: Assistance with statistical data analysis for the study. |
| Impact | Study still in progress |
| Start Year | 2023 |
| Description | HIV mortality & healthcare seeking behaviours study |
| Organisation | Heidelberg University |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Drafting the funding proposal for the project. Joint management of all aspects of implementation of the project. |
| Collaborator Contribution | BRTI: Employment of field staff to assist with obtaining the local ethical and regulatory approvals required to implement the research in Zimbabwe, to conduct all data collection and data management activities, to assist with data analysis and interpretation and write-up of research results, and to lead on local dissemination of the study findings. Copenhagen: Design and management of qualitative research activities for the study. Heidelberg: Assistance with statistical data analysis for the study. |
| Impact | Study still in progress |
| Start Year | 2023 |
| Description | HIV mortality & healthcare seeking behaviours study |
| Organisation | University of Copenhagen |
| Department | Department of Public Health |
| Country | Denmark |
| Sector | Academic/University |
| PI Contribution | Drafting the funding proposal for the project. Joint management of all aspects of implementation of the project. |
| Collaborator Contribution | BRTI: Employment of field staff to assist with obtaining the local ethical and regulatory approvals required to implement the research in Zimbabwe, to conduct all data collection and data management activities, to assist with data analysis and interpretation and write-up of research results, and to lead on local dissemination of the study findings. Copenhagen: Design and management of qualitative research activities for the study. Heidelberg: Assistance with statistical data analysis for the study. |
| Impact | Study still in progress |
| Start Year | 2023 |
| Description | Health economic support to Oxford University Clinical Research Unit |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Health economic expertise Supervision of two PhD students and mentorship to various staff Academic mentor within the MORU-OUCRU Discovery Research Academy (MODRA): supporting the development of local postdoctoral researchers across the South Asia region (2024-ongoing). |
| Collaborator Contribution | Management of clinical trials Provision of data |
| Impact | 11 peer reviewed papers and other papers currently being drafted/under submission |
| Start Year | 2020 |
| Description | Hosting visiting Global Development Hub Fellows |
| Organisation | Institut de Recherche en Sciences de la Santé |
| Country | Burkina Faso |
| Sector | Academic/University |
| PI Contribution | I provided supervision and guidance to African PhD students, during short-term (3-4 months) placements at Imperial. |
| Collaborator Contribution | The students provided data generated as part of their PhD work, for us to analyse together |
| Impact | This partnership resulted in two publications |
| Start Year | 2024 |
| Description | Hosting visiting Global Development Hub Fellows |
| Organisation | National Centre for Research and Training on Malaria |
| Country | Burkina Faso |
| Sector | Public |
| PI Contribution | I provided supervision and guidance to African PhD students, during short-term (3-4 months) placements at Imperial. |
| Collaborator Contribution | The students provided data generated as part of their PhD work, for us to analyse together |
| Impact | This partnership resulted in two publications |
| Start Year | 2024 |
| Description | Hosting visiting global development hub fellows |
| Organisation | Ifakara Health Institute |
| Country | Tanzania, United Republic of |
| Sector | Charity/Non Profit |
| PI Contribution | Hosting 4 PhD/Masters students from Tanzania, Kenya and Senegal for 3 month visits, training in malaria modelling and developing their PhD work with them. |
| Collaborator Contribution | Co-supervision. |
| Impact | Ongoing collaboration. Multi disciplinary - epidemiologists, molecular biologists, mathematicians. |
| Start Year | 2024 |
| Description | Hosting visiting global development hub fellows |
| Organisation | Mount Kenya University |
| Country | Kenya |
| Sector | Academic/University |
| PI Contribution | Hosting 4 PhD/Masters students from Tanzania, Kenya and Senegal for 3 month visits, training in malaria modelling and developing their PhD work with them. |
| Collaborator Contribution | Co-supervision. |
| Impact | Ongoing collaboration. Multi disciplinary - epidemiologists, molecular biologists, mathematicians. |
| Start Year | 2024 |
| Description | Hosting visiting global development hub fellows |
| Organisation | University of Dar es Salaam |
| Country | Tanzania, United Republic of |
| Sector | Academic/University |
| PI Contribution | Hosting 4 PhD/Masters students from Tanzania, Kenya and Senegal for 3 month visits, training in malaria modelling and developing their PhD work with them. |
| Collaborator Contribution | Co-supervision. |
| Impact | Ongoing collaboration. Multi disciplinary - epidemiologists, molecular biologists, mathematicians. |
| Start Year | 2024 |
| Description | Hosting visiting global development hub fellows |
| Organisation | University of Thiès |
| Country | Senegal |
| Sector | Academic/University |
| PI Contribution | Hosting 4 PhD/Masters students from Tanzania, Kenya and Senegal for 3 month visits, training in malaria modelling and developing their PhD work with them. |
| Collaborator Contribution | Co-supervision. |
| Impact | Ongoing collaboration. Multi disciplinary - epidemiologists, molecular biologists, mathematicians. |
| Start Year | 2024 |
| Description | Human Resources for Health Collaboration |
| Organisation | Institute for Disease Modeling |
| Country | United States |
| Sector | Public |
| PI Contribution | This is a collaborative that writes paper and seeks funding on the topic of Human Resources for Health. It includes partners from philanthropy, business, government and academia. |
| Collaborator Contribution | We have contributed to the group and are leading the development of a collaborative paper setting out the mission of the group. |
| Impact | None yet |
| Start Year | 2024 |
| Description | Identifying strategies for long-term control of HIV in different epidemic settings: Mathematical model comparison analysis |
| Organisation | Avenir Health |
| Country | United States |
| Sector | Private |
| PI Contribution | Co-developing scenarios of feasible HIV interventions for countries to implement, and producing the corresponding mathematical model projections. |
| Collaborator Contribution | Co-developing scenarios and producing model projections for each scenario. |
| Impact | No outputs yet, manuscript in development |
| Start Year | 2025 |
| Description | Identifying strategies for long-term control of HIV in different epidemic settings: Mathematical model comparison analysis |
| Organisation | Burnet Institute |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Co-developing scenarios of feasible HIV interventions for countries to implement, and producing the corresponding mathematical model projections. |
| Collaborator Contribution | Co-developing scenarios and producing model projections for each scenario. |
| Impact | No outputs yet, manuscript in development |
| Start Year | 2025 |
| Description | Identifying strategies for long-term control of HIV in different epidemic settings: Mathematical model comparison analysis |
| Organisation | UNISA |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | Co-developing scenarios of feasible HIV interventions for countries to implement, and producing the corresponding mathematical model projections. |
| Collaborator Contribution | Co-developing scenarios and producing model projections for each scenario. |
| Impact | No outputs yet, manuscript in development |
| Start Year | 2025 |
| Description | Identifying strategies for long-term control of HIV in different epidemic settings: Mathematical model comparison analysis |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Co-developing scenarios of feasible HIV interventions for countries to implement, and producing the corresponding mathematical model projections. |
| Collaborator Contribution | Co-developing scenarios and producing model projections for each scenario. |
| Impact | No outputs yet, manuscript in development |
| Start Year | 2025 |
| Description | Impact of seasonal malaria chemoprevention in eastern and southern Africa - Malaria Consortium |
| Organisation | Malaria Consortium |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Since 2023 we have worked with the Malaria Consortium charity on data and model-based analysis to inform whether seasonal malaria chemoprevention should be implemented in countries in eastern and southern Africa: specifically Uganda, Mozambique and Malawi. We liaised with national control programme staff in Uganda and Mozambique and presented results regularly. |
| Collaborator Contribution | Overarching research question, data, regular guidance and feedback on specific questions to address. |
| Impact | Informing decision to continue SMC in Uganda and Mozambique. Conference presentations at ASTMH and MIM 2023-2025. |
| Start Year | 2023 |
| Description | Innovations to improve the speed and sensitivity of polio surveillance |
| Organisation | Congo National Institute of Biomedical Research |
| Country | Congo, the Democratic Republic of the |
| Sector | Academic/University |
| PI Contribution | Project Management Coordination of lab equipment and reagents Development of lab methods Analysis of samples and laboratory performance Updating of protocols Website management |
| Collaborator Contribution | Bioinformatic expertise Software development Sample provision Testing of Environmental and stool samples Methods development |
| Impact | Publication in Journal of Clinical Microbiology Training of 3 labs - NICD in South Africa, INRB in DRC and NIH in Pakistan Detection of new poliovirus outbreaks that are programmatically significant to the polio eradication programmes Update 2023: Additional funding awarded (2023 - 2024) for methods development and training of Global polio labs in direct detection methods Publication in Lancet Update 2025: Additional funding awarded until 2027 for method development of ES testing, training of global polio labs and expansion of sequencing capacity Multiple publications Update 2026: 11 labs globally across 4 WHO regions using DDNS method in parallel testing of stool samples. Development ongoing for protocol for environmental samples |
| Start Year | 2020 |
| Description | Innovations to improve the speed and sensitivity of polio surveillance |
| Organisation | National Institute for Biological Standards and Control (NIBSC) |
| Country | United Kingdom |
| PI Contribution | Project Management Coordination of lab equipment and reagents Development of lab methods Analysis of samples and laboratory performance Updating of protocols Website management |
| Collaborator Contribution | Bioinformatic expertise Software development Sample provision Testing of Environmental and stool samples Methods development |
| Impact | Publication in Journal of Clinical Microbiology Training of 3 labs - NICD in South Africa, INRB in DRC and NIH in Pakistan Detection of new poliovirus outbreaks that are programmatically significant to the polio eradication programmes Update 2023: Additional funding awarded (2023 - 2024) for methods development and training of Global polio labs in direct detection methods Publication in Lancet Update 2025: Additional funding awarded until 2027 for method development of ES testing, training of global polio labs and expansion of sequencing capacity Multiple publications Update 2026: 11 labs globally across 4 WHO regions using DDNS method in parallel testing of stool samples. Development ongoing for protocol for environmental samples |
| Start Year | 2020 |
| Description | Innovations to improve the speed and sensitivity of polio surveillance |
| Organisation | National Institute of Health, Pakistan |
| Country | Pakistan |
| Sector | Public |
| PI Contribution | Project Management Coordination of lab equipment and reagents Development of lab methods Analysis of samples and laboratory performance Updating of protocols Website management |
| Collaborator Contribution | Bioinformatic expertise Software development Sample provision Testing of Environmental and stool samples Methods development |
| Impact | Publication in Journal of Clinical Microbiology Training of 3 labs - NICD in South Africa, INRB in DRC and NIH in Pakistan Detection of new poliovirus outbreaks that are programmatically significant to the polio eradication programmes Update 2023: Additional funding awarded (2023 - 2024) for methods development and training of Global polio labs in direct detection methods Publication in Lancet Update 2025: Additional funding awarded until 2027 for method development of ES testing, training of global polio labs and expansion of sequencing capacity Multiple publications Update 2026: 11 labs globally across 4 WHO regions using DDNS method in parallel testing of stool samples. Development ongoing for protocol for environmental samples |
| Start Year | 2020 |
| Description | Innovations to improve the speed and sensitivity of polio surveillance |
| Organisation | University of Edinburgh |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project Management Coordination of lab equipment and reagents Development of lab methods Analysis of samples and laboratory performance Updating of protocols Website management |
| Collaborator Contribution | Bioinformatic expertise Software development Sample provision Testing of Environmental and stool samples Methods development |
| Impact | Publication in Journal of Clinical Microbiology Training of 3 labs - NICD in South Africa, INRB in DRC and NIH in Pakistan Detection of new poliovirus outbreaks that are programmatically significant to the polio eradication programmes Update 2023: Additional funding awarded (2023 - 2024) for methods development and training of Global polio labs in direct detection methods Publication in Lancet Update 2025: Additional funding awarded until 2027 for method development of ES testing, training of global polio labs and expansion of sequencing capacity Multiple publications Update 2026: 11 labs globally across 4 WHO regions using DDNS method in parallel testing of stool samples. Development ongoing for protocol for environmental samples |
| Start Year | 2020 |
| Description | Innovations to improve the speed and sensitivity of polio surveillance |
| Organisation | World Health Organization (WHO) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | Project Management Coordination of lab equipment and reagents Development of lab methods Analysis of samples and laboratory performance Updating of protocols Website management |
| Collaborator Contribution | Bioinformatic expertise Software development Sample provision Testing of Environmental and stool samples Methods development |
| Impact | Publication in Journal of Clinical Microbiology Training of 3 labs - NICD in South Africa, INRB in DRC and NIH in Pakistan Detection of new poliovirus outbreaks that are programmatically significant to the polio eradication programmes Update 2023: Additional funding awarded (2023 - 2024) for methods development and training of Global polio labs in direct detection methods Publication in Lancet Update 2025: Additional funding awarded until 2027 for method development of ES testing, training of global polio labs and expansion of sequencing capacity Multiple publications Update 2026: 11 labs globally across 4 WHO regions using DDNS method in parallel testing of stool samples. Development ongoing for protocol for environmental samples |
| Start Year | 2020 |
| Description | Instituto Nacional de Investigação em Saúde - Ministry of Health Angola |
| Organisation | Ministry of Health |
| Department | Health Research Centre of Angola |
| Country | Angola |
| Sector | Public |
| PI Contribution | Expertise in epidemiology, genomics, and capacity building. |
| Collaborator Contribution | Country and regional expertise on arbovirus and Pathogen X surveillance. |
| Impact | Pilot grant on arbovirus genomics attributed by the Research England Institutional Support Grant (ISPF) Global Development Hub ODA Project Accelerator, Imperial College London. Outputs include: - Policy workshop at the Ministry of Health Angola for 50 Angolan public health officials (Feb 2025) - 2-week hands-on laboratory training workshop for 15 early career researchers at MoH Angola (Feb 2025) - First detection of dengue virus serotype 3 in the country (manuscript in preparation) - Generation of the first mpox genome sequences from Angola (manuscript in preparation) - Generation of the first measles genome sequences in Angola (manuscript in preparation) - Preparation of new applications for research funding |
| Start Year | 2024 |
| Description | Integrated Disease surveillance in Ghana |
| Organisation | Ghana Health Service |
| Country | Ghana |
| Sector | Public |
| PI Contribution | VERG are contributing to assay design and validation, providing analytical software and will be contributing to data analysis. |
| Collaborator Contribution | Collaborative partners in Ghana will: Develop a strategic framework for implementation and integration of wastewater-based surveillance for multiple pathogens Identify and map out potential sites for environmental surveillance of priority pathogens of public health importance Conduct wastewater-based surveillance for detection of multiple priority pathogens of public health relevance. Perform training of laboratory staff to perform molecular methods |
| Impact | This collaboration is multi-disciplinary, spanning molecular laboratory work, bioinformatics, analytics and health economics. |
| Start Year | 2024 |
| Description | Integrated Disease surveillance in Ghana |
| Organisation | Kwame Nkrumah University of Science and Technology (KNUST) |
| Country | Ghana |
| Sector | Academic/University |
| PI Contribution | VERG are contributing to assay design and validation, providing analytical software and will be contributing to data analysis. |
| Collaborator Contribution | Collaborative partners in Ghana will: Develop a strategic framework for implementation and integration of wastewater-based surveillance for multiple pathogens Identify and map out potential sites for environmental surveillance of priority pathogens of public health importance Conduct wastewater-based surveillance for detection of multiple priority pathogens of public health relevance. Perform training of laboratory staff to perform molecular methods |
| Impact | This collaboration is multi-disciplinary, spanning molecular laboratory work, bioinformatics, analytics and health economics. |
| Start Year | 2024 |
| Description | Integrated Disease surveillance in Ghana |
| Organisation | Noguchi Memorial Institute for Medical Research (NMRR) |
| Country | Ghana |
| Sector | Academic/University |
| PI Contribution | VERG are contributing to assay design and validation, providing analytical software and will be contributing to data analysis. |
| Collaborator Contribution | Collaborative partners in Ghana will: Develop a strategic framework for implementation and integration of wastewater-based surveillance for multiple pathogens Identify and map out potential sites for environmental surveillance of priority pathogens of public health importance Conduct wastewater-based surveillance for detection of multiple priority pathogens of public health relevance. Perform training of laboratory staff to perform molecular methods |
| Impact | This collaboration is multi-disciplinary, spanning molecular laboratory work, bioinformatics, analytics and health economics. |
| Start Year | 2024 |
| Description | Intrepid trial |
| Organisation | Duke University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Imperial College London has co-created the analysis plan for the INTREPiD study and will lead the mathematical modeling component once trial data become available. We will integrate trial data to parameterize the relationships between parasite detectability, gestational age, and pregnancy-specific immunity. This modeling will assess the potential incremental benefits of first-trimester screening with high-sensitivity diagnostics and alternative treatment regimens on adverse pregnancy outcomes. By extending existing models of malaria in pregnancy, ICL will provide a framework to project the impact of INTREPiD's findings across different transmission settings, informing future malaria prevention strategies. |
| Collaborator Contribution | Duke University (Coordinating Centre): Leads the overall study design, trial implementation, and data analysis, with Dr. Steve Taylor as principal investigator. Duke oversees clinical monitoring, regulatory compliance, and safety assessments through the Duke Clinical Research Institute (DCRI). Moi University (Kenya) & Kinshasa School of Public Health (DRC): Conduct trial implementation, including participant recruitment, randomization, and follow-up. These institutions provide essential operational infrastructure, leveraging established ANC networks and prior experience in antenatal research. |
| Impact | his interdisciplinary collaboration combines clinical research, pharmacokinetics, and epidemiological modeling to generate actionable evidence on malaria prevention in early pregnancy. To date the main outcome is the successful grant application. |
| Start Year | 2018 |
| Description | Intrepid trial |
| Organisation | Moi University |
| Country | Kenya |
| Sector | Academic/University |
| PI Contribution | Imperial College London has co-created the analysis plan for the INTREPiD study and will lead the mathematical modeling component once trial data become available. We will integrate trial data to parameterize the relationships between parasite detectability, gestational age, and pregnancy-specific immunity. This modeling will assess the potential incremental benefits of first-trimester screening with high-sensitivity diagnostics and alternative treatment regimens on adverse pregnancy outcomes. By extending existing models of malaria in pregnancy, ICL will provide a framework to project the impact of INTREPiD's findings across different transmission settings, informing future malaria prevention strategies. |
| Collaborator Contribution | Duke University (Coordinating Centre): Leads the overall study design, trial implementation, and data analysis, with Dr. Steve Taylor as principal investigator. Duke oversees clinical monitoring, regulatory compliance, and safety assessments through the Duke Clinical Research Institute (DCRI). Moi University (Kenya) & Kinshasa School of Public Health (DRC): Conduct trial implementation, including participant recruitment, randomization, and follow-up. These institutions provide essential operational infrastructure, leveraging established ANC networks and prior experience in antenatal research. |
| Impact | his interdisciplinary collaboration combines clinical research, pharmacokinetics, and epidemiological modeling to generate actionable evidence on malaria prevention in early pregnancy. To date the main outcome is the successful grant application. |
| Start Year | 2018 |
| Description | Intrepid trial |
| Organisation | University of Kinshasa |
| Country | Congo, the Democratic Republic of the |
| Sector | Academic/University |
| PI Contribution | Imperial College London has co-created the analysis plan for the INTREPiD study and will lead the mathematical modeling component once trial data become available. We will integrate trial data to parameterize the relationships between parasite detectability, gestational age, and pregnancy-specific immunity. This modeling will assess the potential incremental benefits of first-trimester screening with high-sensitivity diagnostics and alternative treatment regimens on adverse pregnancy outcomes. By extending existing models of malaria in pregnancy, ICL will provide a framework to project the impact of INTREPiD's findings across different transmission settings, informing future malaria prevention strategies. |
| Collaborator Contribution | Duke University (Coordinating Centre): Leads the overall study design, trial implementation, and data analysis, with Dr. Steve Taylor as principal investigator. Duke oversees clinical monitoring, regulatory compliance, and safety assessments through the Duke Clinical Research Institute (DCRI). Moi University (Kenya) & Kinshasa School of Public Health (DRC): Conduct trial implementation, including participant recruitment, randomization, and follow-up. These institutions provide essential operational infrastructure, leveraging established ANC networks and prior experience in antenatal research. |
| Impact | his interdisciplinary collaboration combines clinical research, pharmacokinetics, and epidemiological modeling to generate actionable evidence on malaria prevention in early pregnancy. To date the main outcome is the successful grant application. |
| Start Year | 2018 |
| Description | Javier Martin (Dr) -NIBSC |
| Organisation | National Institute for Biological Standards and Control (NIBSC) |
| Country | United Kingdom |
| PI Contribution | Sequencing and analysis of polio virus in stool and environmental samples |
| Collaborator Contribution | Virus isolation and sequencing |
| Impact | A supplement to the existing grant and a new grant |
| Start Year | 2017 |
| Description | Kuzama pa Kalondo: 'Getting Smart' on HIV Surveillance |
| Organisation | Harvard University |
| Department | Harvard T.H. Chan School of Public Health |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Imperial College London contributes software engineering and dissemination and support of use of software tools by project team. |
| Collaborator Contribution | Partners conduct mathematical modelling, data analysis, and field epidemiology studies. |
| Impact | This project has resulted in new methodological approaches to estimating HIV treatment coverage in countries with high programme coverage and effective progress against HIV. |
| Start Year | 2023 |
| Description | Kuzama pa Kalondo: 'Getting Smart' on HIV Surveillance |
| Organisation | Kamuzu University of Health Sciences |
| Country | Malawi |
| Sector | Academic/University |
| PI Contribution | Imperial College London contributes software engineering and dissemination and support of use of software tools by project team. |
| Collaborator Contribution | Partners conduct mathematical modelling, data analysis, and field epidemiology studies. |
| Impact | This project has resulted in new methodological approaches to estimating HIV treatment coverage in countries with high programme coverage and effective progress against HIV. |
| Start Year | 2023 |
| Description | Kuzama pa Kalondo: 'Getting Smart' on HIV Surveillance |
| Organisation | University of Cape Town |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | Imperial College London contributes software engineering and dissemination and support of use of software tools by project team. |
| Collaborator Contribution | Partners conduct mathematical modelling, data analysis, and field epidemiology studies. |
| Impact | This project has resulted in new methodological approaches to estimating HIV treatment coverage in countries with high programme coverage and effective progress against HIV. |
| Start Year | 2023 |
| Description | LSHTM collaboration on forecasting |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We have provided feedback and guidance on the design of an R package developed by LSHTM colleagues to evaluate and compare epidemic forecasts. I was a co-supervisor of a PhD student and we have multiple papers submitted or accepted together. |
| Collaborator Contribution | They led the development and implementation of models and packages. |
| Impact | Multiple paper published/submitted, one R package developed, one PhD student co-supervised to completion |
| Start Year | 2020 |
| Description | MESA - A global knowledge hub to coordinate research, discussions, and learning needed to advance malaria eradication efforts |
| Organisation | Instituto de Salud Global de Barcelona |
| Country | Spain |
| Sector | Charity/Non Profit |
| PI Contribution | MESA (Malaria Eradication Scientific Alliance) was established in 2011 from the Malaria Eradication Research Agenda (malERA) to identify research gaps and guide efforts toward malaria elimination and eradication. MESA serves as a global knowledge hub to coordinate research, discussions, and learning needed to advance malaria eradication efforts. We partnered with MESA to host materials pertaining to responding to the threat of Plasmodium pfhrp2/3 gene deletions, including our pfhrp2/3 Planner app (https://mesamalaria.org/resource-hub/pfhrp23-planner/) that is now the WHO recommended approach. |
| Collaborator Contribution | MESA host a wide range of research and project materials. In addition to hosting our materials, they assisted with the delivery and popularization of a workshop on using the pfhrp2/3 Planner in Kigali, Rwanda in 2024. |
| Impact | Hosting the updated WHO master protocol, which I was involved in shaping (https://iris.who.int/bitstream/handle/10665/379471/9789240101814-eng.pdf?sequence=1) Hosting the Imperial College London developed pfhrp2/3 Planner (https://mesamalaria.org/resource-hub/pfhrp23-planner/) |
| Start Year | 2024 |
| Description | Machine learning for blue line tracing and wastewater surveillance |
| Organisation | University of Virginia (UVa) |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Epidemiological analyses Contribution to study design and provide statistical analysis of the wastewater surveillance data collected from Dhaka which has either been mapped by the icddr,b implementation team or mapped through AI. |
| Collaborator Contribution | Project Management Lead on the study design, coordinates the projects across partners, designs the diagnostic assays, and oversees the mapping and field teams |
| Impact | No ouputs yet |
| Start Year | 2025 |
| Description | Malaria multi-model comparison of prioritized interventions (M3CPI) project |
| Organisation | Swiss Tropical & Public Health Institute |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | One of two malaria modelling teams contributing to this WHO-led project |
| Collaborator Contribution | WHO are leading this project, SwissTPH are the other malaria modelling group involved |
| Impact | Project ongoing with the aim of updating WHO high-level guidance on malaria intervention prioritisation |
| Start Year | 2024 |
| Description | Malaria multi-model comparison of prioritized interventions (M3CPI) project |
| Organisation | World Health Organization (WHO) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | One of two malaria modelling teams contributing to this WHO-led project |
| Collaborator Contribution | WHO are leading this project, SwissTPH are the other malaria modelling group involved |
| Impact | Project ongoing with the aim of updating WHO high-level guidance on malaria intervention prioritisation |
| Start Year | 2024 |
| Description | Malaria programme country-support modelling for Sierra Leone |
| Organisation | National Malaria Control Programme |
| Country | Swaziland |
| Sector | Public |
| PI Contribution | Malaria modelling support for the malaria control programme in Sierra Leone to aid grant applications and strategic planning. |
| Collaborator Contribution | Country expertise in implementation and data. |
| Impact | Ongoing work to feed into and inform the next national strategic plan for malaria in Sierra Leone |
| Start Year | 2024 |
| Description | Meade Epidemiology Travel grant host |
| Organisation | University of Thiès |
| Country | Senegal |
| Sector | Academic/University |
| PI Contribution | Supported application by Dr Mouhamad Allaya who successfully obtained a Meade Epidemiology travel grant to visit our team for 3 months in 2025. We worked on climate and malaria predictions in Senegal. |
| Collaborator Contribution | Dr Allaya designed and led the research, and brought data on malaria burden in Senegal. |
| Impact | Continuing collaboration. |
| Start Year | 2025 |
| Description | Medicines Development for Global Health - Moxidectin |
| Organisation | Medicines Development for Global Health |
| Country | Australia |
| Sector | Private |
| PI Contribution | Led an updated economic assessment of Moxidectin for Medicines Development for Global Health |
| Collaborator Contribution | Inputted on model scenarios |
| Impact | One paper |
| Start Year | 2023 |
| Description | Ministry of Health (Malawi) |
| Organisation | Ministry of Health Malawi |
| Country | Malawi |
| Sector | Public |
| PI Contribution | Contribution of scientific analysis to inform planning decision in the Ministry of Health (Malawi), specifically the Department of Planning. |
| Collaborator Contribution | Multiple scientific analyses requested by, and delivered to, the Ministry including on: health system strengthening, the impact of service integration, sustainability of HIV programs, cadre reviews. |
| Impact | * Contributions to the Health Sector Strategic Plan III (published by Malawi Ministry of Health), and subsequent bulletins. * Scientific work has been published containing most of the work. * Selected pieces have also been published in reports by the Global Fund (Results Report, 2024, and the 2025 Investment Case). |
| Start Year | 2023 |
| Description | Modeling the potential impact of PEPFAR funding withdrawal on HIV outcomes in Western Africa |
| Organisation | Institute of Development Research (IRD) |
| Country | France |
| Sector | Academic/University |
| PI Contribution | We are producing estimates of the epidemiological impact of the recent cuts in HIV funding in Côte d'Ivoire, Mali, and Senegal |
| Collaborator Contribution | This institution coordinates the efforts from our modelling teams and collaborators in the affected countries |
| Impact | No output yet |
| Start Year | 2025 |
| Description | Modeling the potential impact of PEPFAR funding withdrawal on HIV outcomes in Western Africa |
| Organisation | McGill University |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | We are producing estimates of the epidemiological impact of the recent cuts in HIV funding in Côte d'Ivoire, Mali, and Senegal |
| Collaborator Contribution | This institution coordinates the efforts from our modelling teams and collaborators in the affected countries |
| Impact | No output yet |
| Start Year | 2025 |
| Description | Modeling the potential impact of PEPFAR funding withdrawal on HIV outcomes in Western Africa |
| Organisation | PACCI |
| Country | Cote d'Ivoire |
| Sector | Public |
| PI Contribution | We are producing estimates of the epidemiological impact of the recent cuts in HIV funding in Côte d'Ivoire, Mali, and Senegal |
| Collaborator Contribution | This institution coordinates the efforts from our modelling teams and collaborators in the affected countries |
| Impact | No output yet |
| Start Year | 2025 |
| Description | Modelling a new antimalarial drug candidate: cabamiquine, with Merck |
| Organisation | Merck |
| Country | Germany |
| Sector | Private |
| PI Contribution | Modelling the potential impact of the drug cabamiquine as a preventive treatment against malaria in children in different settings in sub Saharan Africa. Drafting a manuscript, presenting at conferences (American Society of Tropical Medicine and Hygiene 2025 and Multilateral Initiative for Malaria). |
| Collaborator Contribution | Grant funding. Output of a pharmacokinetic pharmacodynamic model to inform our model inputs. Guidance and advice. |
| Impact | Conference presentation at MIM 2024. |
| Start Year | 2023 |
| Description | Modelling the dynamics of hand, foot and mouth disease in Malaysia |
| Organisation | University of Malaya |
| Country | Malaysia |
| Sector | Academic/University |
| PI Contribution | Data analysis and modelling |
| Collaborator Contribution | Provision of data, interpretation of the results. |
| Impact | Cox VM, Jahis R, Abu Bakar RS, Yusof NM, Pilay KPV, Chem YK, Selvanesan S, Shamsudin N, Hinsley W, Blake IM, Hasran NZ, Rusli N, Sam IC, Chan YF, Pons-Salort M. Spatio-temporal dynamics of hand, foot and mouth disease in Malaysia, 2009-2019. PLoS Negl Trop Dis. 2025 Jun 9;19(6):e0013174. doi: 10.1371/journal.pntd.0013174. PMID: 40489559; PMCID: PMC12180618. |
| Start Year | 2019 |
| Description | Modelling the effects of cuts in US development assistance for health |
| Organisation | Avenir Health |
| Country | United States |
| Sector | Private |
| PI Contribution | Producing estimates of epidemiological impact, measured through new HIV infections and AIDS-related deaths, of the the effects of recent cuts in US development assistance for health in Zimbabwe, using the PopART-IBM individual-based model, as part of a multi-model collaboration. |
| Collaborator Contribution | Modelling efforts across teams are coordinated by Avenir Health (John Stover). |
| Impact | No impact yet |
| Start Year | 2025 |
| Description | Modelling the impact of Anopheles stephensi malaria transmission in the Horn of Africa |
| Organisation | PATH |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Developing and calibrating malaria transmission models to malaria data from across the Horn of Africa, to estimate the potential burden of urban Anopheles stephensi driven transmission across the region. |
| Collaborator Contribution | The PATH team have contributed expertise and insight into existing malaria control efforts and programmes in the region, as well as highlighting the most relevant locations for us to focus our modelling efforts on. They have also provided insight into how to process required data sources in order to carry out the modelling effectively. |
| Impact | Manuscript in preparation |
| Start Year | 2024 |
| Description | Modelling the impact of mass malaria vaccination |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We designed and ran a modelling analysis of mass malaria vaccination in collaboration with MRC Unit The Gambia, Centre National de la Recherche Scientifique et Technologique (CNRST), Burkina Faso, and London School of Hygiene & Tropical Medicine, UK calibrating to a trial conducted in Burkina Faso and The Gambia. |
| Collaborator Contribution | The partners ran the cluster randomised trial, shared data, and collaborated on the design of the modelling analysis. |
| Impact | Conference presentations American Society of Tropical Medicine & Hygiene 2024 and 2025. |
| Start Year | 2023 |
| Description | Modelling the impact of mass malaria vaccination |
| Organisation | Medical Research Council (MRC) |
| Department | MRC Unit, The Gambia |
| Country | Gambia |
| Sector | Public |
| PI Contribution | We designed and ran a modelling analysis of mass malaria vaccination in collaboration with MRC Unit The Gambia, Centre National de la Recherche Scientifique et Technologique (CNRST), Burkina Faso, and London School of Hygiene & Tropical Medicine, UK calibrating to a trial conducted in Burkina Faso and The Gambia. |
| Collaborator Contribution | The partners ran the cluster randomised trial, shared data, and collaborated on the design of the modelling analysis. |
| Impact | Conference presentations American Society of Tropical Medicine & Hygiene 2024 and 2025. |
| Start Year | 2023 |
| Description | Modelling the impact of mass malaria vaccination |
| Organisation | National Center for Scientific and Technological Research (CNRST) |
| Country | Burkina Faso |
| Sector | Public |
| PI Contribution | We designed and ran a modelling analysis of mass malaria vaccination in collaboration with MRC Unit The Gambia, Centre National de la Recherche Scientifique et Technologique (CNRST), Burkina Faso, and London School of Hygiene & Tropical Medicine, UK calibrating to a trial conducted in Burkina Faso and The Gambia. |
| Collaborator Contribution | The partners ran the cluster randomised trial, shared data, and collaborated on the design of the modelling analysis. |
| Impact | Conference presentations American Society of Tropical Medicine & Hygiene 2024 and 2025. |
| Start Year | 2023 |
| Description | Modelling to Inform HIV Programmes in Sub-Saharan Africa (MIHPSA) Collaboration |
| Organisation | UNISA |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | Lead contributor with the the Ministry of Health, National AIDS Commission and the HIV Modelling Consortium to generate modelling outputs to inform the future design of country HIV programmes in African countries |
| Collaborator Contribution | In Malawi, the project is co-led by the Ministry of Health, National AIDS Commission and the HIV Modelling Consortium. It is co-ordinated on the modelling side by Debra ten Brink and Rowan Martin-Hughes (Optima model, Burnet Institute) and Robert Glaubius (Goals model, Avenir Health). |
| Impact | In development |
| Start Year | 2021 |
| Description | Modelling to understand STI transmission patterns in Uganda |
| Organisation | Johns Hopkins University |
| Department | Johns Hopkins Bloomberg School of Public Health |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Modelling and data analysis. Study design. |
| Collaborator Contribution | Data collection, curation, and provision, study administration |
| Impact | One paper in JID: Lilith K Whittles, Ronald M Galiwango, Josephine Mpagazi, Aaron A R Tobian, Robert Ssekubugu, Jade Jackson, Austin D Peer, Caitlin Kennedy, Margaret Nakalanzi, Anthony Ndyanabo, Godfrey Kigozi, Larry W Chang, David Serwadda, Yukari C Manabe, Charlotte A Gaydos, Oliver Laeyendecker, Thomas C Quinn, Steven J Reynolds, Joseph Kagaayi, Jeffrey W Eaton, M Kate Grabowski, on behalf of the Rakai Health Sciences Program, Age Patterns of HSV-2 Incidence and Prevalence in Two Ugandan Communities: A Catalytic Incidence Model Applied to Population-Based Seroprevalence Data, The Journal of Infectious Diseases, Volume 228, Issue 9, 1 November 2023, Pages 1198-1207, https://doi.org/10.1093/infdis/jiad113 Successful grant application: R01AI177132 - Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control through PrEP: The IN-STEP study |
| Start Year | 2022 |
| Description | Modelling to understand STI transmission patterns in Uganda |
| Organisation | Rakai Health Sciences Program |
| Country | Uganda |
| Sector | Public |
| PI Contribution | Modelling and data analysis. Study design. |
| Collaborator Contribution | Data collection, curation, and provision, study administration |
| Impact | One paper in JID: Lilith K Whittles, Ronald M Galiwango, Josephine Mpagazi, Aaron A R Tobian, Robert Ssekubugu, Jade Jackson, Austin D Peer, Caitlin Kennedy, Margaret Nakalanzi, Anthony Ndyanabo, Godfrey Kigozi, Larry W Chang, David Serwadda, Yukari C Manabe, Charlotte A Gaydos, Oliver Laeyendecker, Thomas C Quinn, Steven J Reynolds, Joseph Kagaayi, Jeffrey W Eaton, M Kate Grabowski, on behalf of the Rakai Health Sciences Program, Age Patterns of HSV-2 Incidence and Prevalence in Two Ugandan Communities: A Catalytic Incidence Model Applied to Population-Based Seroprevalence Data, The Journal of Infectious Diseases, Volume 228, Issue 9, 1 November 2023, Pages 1198-1207, https://doi.org/10.1093/infdis/jiad113 Successful grant application: R01AI177132 - Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control through PrEP: The IN-STEP study |
| Start Year | 2022 |
| Description | Modelling to undertand streptococcus pyogenes transmission and health economic impact in the US |
| Organisation | Harvard University |
| Department | Harvard T.H. Chan School of Public Health |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Technical and modelling support as well as project shaping |
| Collaborator Contribution | Data provision, technical, and modelling work as well as project design |
| Impact | Three publications in Clinical Infectious Diseases: 1. Lewnard JA, Whittles LK, Rick AM, Martin JM. Naturally Acquired Protection Against Upper Respiratory Symptoms Involving Group A Streptococcus in a Longitudinal Cohort Study. Clin Infect Dis. 2020 Nov 5;71(8):e244-e254. doi: 10.1093/cid/ciaa044. PMID: 31955205; PMCID: PMC7750950. 2. Andrejko K, Whittles LK, Lewnard JA. Health-Economic Value of Vaccination Against Group A Streptococcus in the United States. Clin Infect Dis. 2022 Mar 23;74(6):983-992. doi: 10.1093/cid/ciab597. PMID: 34192307. 3. Madeleine C Kline, Stephen M Kissler, Lilith K Whittles, Michael L Barnett, Yonatan H Grad, Spatiotemporal Trends in Group A Streptococcal Pharyngitis in the United States, Clinical Infectious Diseases, Volume 78, Issue 5, 15 May 2024, Pages 1345-1351, https://doi.org/10.1093/cid/ciae083 |
| Start Year | 2020 |
| Description | Modelling to undertand streptococcus pyogenes transmission and health economic impact in the US |
| Organisation | University of California, Berkeley |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Technical and modelling support as well as project shaping |
| Collaborator Contribution | Data provision, technical, and modelling work as well as project design |
| Impact | Three publications in Clinical Infectious Diseases: 1. Lewnard JA, Whittles LK, Rick AM, Martin JM. Naturally Acquired Protection Against Upper Respiratory Symptoms Involving Group A Streptococcus in a Longitudinal Cohort Study. Clin Infect Dis. 2020 Nov 5;71(8):e244-e254. doi: 10.1093/cid/ciaa044. PMID: 31955205; PMCID: PMC7750950. 2. Andrejko K, Whittles LK, Lewnard JA. Health-Economic Value of Vaccination Against Group A Streptococcus in the United States. Clin Infect Dis. 2022 Mar 23;74(6):983-992. doi: 10.1093/cid/ciab597. PMID: 34192307. 3. Madeleine C Kline, Stephen M Kissler, Lilith K Whittles, Michael L Barnett, Yonatan H Grad, Spatiotemporal Trends in Group A Streptococcal Pharyngitis in the United States, Clinical Infectious Diseases, Volume 78, Issue 5, 15 May 2024, Pages 1345-1351, https://doi.org/10.1093/cid/ciae083 |
| Start Year | 2020 |
| Description | Multi-pathogen wastewater surveillance in Dhaka Bnagladesh |
| Organisation | International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) |
| Country | Bangladesh |
| Sector | Public |
| PI Contribution | Epidemiological analysis of clinical surveillance and wastewater surveillance of SARS-CoV-2, cholera and other enteric pathogens |
| Collaborator Contribution | Mapping of sewage network, collection of sewage samples and laboratory testing of sewage samples |
| Impact | Quantification of wastewater early warning for SARS-CoV-2 and identification of virus circulation in populations where access to clinical testing was limited. Assessment of TaqMan array cards to detect poliovirus in sewage in an integrated framework alongside testing for other enteric pathogens. Update 2026: publication https://dx.doi.org/10.1016/j.ijid.2024.107383 |
| Start Year | 2018 |
| Description | Multi-pathogen wastewater surveillance in Dhaka Bnagladesh |
| Organisation | University of Virginia (UVa) |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Epidemiological analysis of clinical surveillance and wastewater surveillance of SARS-CoV-2, cholera and other enteric pathogens |
| Collaborator Contribution | Mapping of sewage network, collection of sewage samples and laboratory testing of sewage samples |
| Impact | Quantification of wastewater early warning for SARS-CoV-2 and identification of virus circulation in populations where access to clinical testing was limited. Assessment of TaqMan array cards to detect poliovirus in sewage in an integrated framework alongside testing for other enteric pathogens. Update 2026: publication https://dx.doi.org/10.1016/j.ijid.2024.107383 |
| Start Year | 2018 |
| Description | NIH Pakistan |
| Organisation | National Institute of Health, Pakistan |
| Country | Pakistan |
| Sector | Public |
| PI Contribution | Analyse data |
| Collaborator Contribution | Work together on sequencing poliovirus circulating in Pakistan and Afghanistan |
| Impact | Published paper: https://doi.org/10.21203/rs.3.rs-5331855/v1 https://www.sciencedirect.com/science/article/pii/S0264410X21012287?via%3Dihub https://www.dx.doi.org/10.1186/s12879-018-3070-4 https://www.webofscience.com/wos/woscc/full-record/WOS:000447732600030 |
| Start Year | 2016 |
| Description | Naomi model for district-level HIV estimates in sub-Saharan Africa |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Country | United States |
| Sector | Public |
| PI Contribution | - Developed new model for district-level estimates of HIV prevalence, antiretroviral treatment coverage, and new HIV infections in sub-Saharan Africa. - Developed web-based software interface for district HIV estimates used by national governments in 25 sub-Saharan African countries. |
| Collaborator Contribution | - Provided technical expertise on surveillance data and statistical modelling. - Provided data inputs to modelling. - Supported implementation of software tool with national governments. |
| Impact | - District HIV estimates used for US Government PEPFAR 2020 budget allocations. - Manuscript in preparation. - District level HIV estimates to be publicly released by UNAIDS in June 2020. Update 2021: Used again in 2021 by Global Fund to support work |
| Start Year | 2019 |
| Description | Naomi model for district-level HIV estimates in sub-Saharan Africa |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Country | Global |
| Sector | Public |
| PI Contribution | - Developed new model for district-level estimates of HIV prevalence, antiretroviral treatment coverage, and new HIV infections in sub-Saharan Africa. - Developed web-based software interface for district HIV estimates used by national governments in 25 sub-Saharan African countries. |
| Collaborator Contribution | - Provided technical expertise on surveillance data and statistical modelling. - Provided data inputs to modelling. - Supported implementation of software tool with national governments. |
| Impact | - District HIV estimates used for US Government PEPFAR 2020 budget allocations. - Manuscript in preparation. - District level HIV estimates to be publicly released by UNAIDS in June 2020. Update 2021: Used again in 2021 by Global Fund to support work |
| Start Year | 2019 |
| Description | Naomi model for district-level HIV estimates in sub-Saharan Africa |
| Organisation | United States President's Emergency Plan for AIDS Relief |
| Country | United States |
| Sector | Public |
| PI Contribution | - Developed new model for district-level estimates of HIV prevalence, antiretroviral treatment coverage, and new HIV infections in sub-Saharan Africa. - Developed web-based software interface for district HIV estimates used by national governments in 25 sub-Saharan African countries. |
| Collaborator Contribution | - Provided technical expertise on surveillance data and statistical modelling. - Provided data inputs to modelling. - Supported implementation of software tool with national governments. |
| Impact | - District HIV estimates used for US Government PEPFAR 2020 budget allocations. - Manuscript in preparation. - District level HIV estimates to be publicly released by UNAIDS in June 2020. Update 2021: Used again in 2021 by Global Fund to support work |
| Start Year | 2019 |
| Description | Naomi model for district-level HIV estimates in sub-Saharan Africa |
| Organisation | University of Washington |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | - Developed new model for district-level estimates of HIV prevalence, antiretroviral treatment coverage, and new HIV infections in sub-Saharan Africa. - Developed web-based software interface for district HIV estimates used by national governments in 25 sub-Saharan African countries. |
| Collaborator Contribution | - Provided technical expertise on surveillance data and statistical modelling. - Provided data inputs to modelling. - Supported implementation of software tool with national governments. |
| Impact | - District HIV estimates used for US Government PEPFAR 2020 budget allocations. - Manuscript in preparation. - District level HIV estimates to be publicly released by UNAIDS in June 2020. Update 2021: Used again in 2021 by Global Fund to support work |
| Start Year | 2019 |
| Description | Optimization of integrated molecular detection of pathogens in wastewater |
| Organisation | Christian Medical College, Vellore |
| Country | India |
| Sector | Academic/University |
| PI Contribution | My team at Imperial have developed and validated integrated wastewater surveillance methods, using amplicon sequencing targeted at enteric pathogens whose detection could inform public health interventions. We researched, developed, tested and validated the methods using spiked wastewater samples at Imperial. The methods are documented on our website at https://www.protocols.io/file-manager/22D3304DB69911ED9EF70A58A9FEAC02. We provided training in these methods for our collaborative partners and will iteratively improve them in line with results from a field trials of the methods. |
| Collaborator Contribution | Teams at KNUST (Ghana) and CMC Vellore (India) are employing the methods over 6 months to validate their efficacy for pathogen detection. The teams are also employing two different sample collection methods, grab sampling (a bucket collection) and Moore swabs (a passive sampler of absorbent material left to dangle in flowing sewage for 24+ hours) to allow comparison of the best methods to sample for both viruses and bacteria. |
| Impact | Data has been presented at: Africa CDC Environmental Workshop 2023 (South Africa) London Calling 2024 (United Kingdom) The 20th International Congress on Infectious Diseases (South Africa) Publications underway: Experimental validation of methods to support integrated detection of viruses and bacteria in wastewater Paper(s) presenting the field trial data from KNUST and CMC Vellore Wastewater environmental surveillance for rotavirus: performance and impact Wastewater environmental surveillance for Influenza, measles and RSV Protocols Twelve protocols describing WES-focused methods with costing and validation data are being shared in the workspace. Further funding Validation of multi-pathogen methods in Ghana has been noted by the Ministry of Health who have received a Gates Foundation grant to support a national rollout Further collaborations Nucleic acids from the method development work have been shared with Josh' Quicks research team (University of Birmingham) to contribute to his work on primer design for WES. |
| Start Year | 2023 |
| Description | Optimization of integrated molecular detection of pathogens in wastewater |
| Organisation | Kwame Nkrumah University of Science and Technology (KNUST) |
| Country | Ghana |
| Sector | Academic/University |
| PI Contribution | My team at Imperial have developed and validated integrated wastewater surveillance methods, using amplicon sequencing targeted at enteric pathogens whose detection could inform public health interventions. We researched, developed, tested and validated the methods using spiked wastewater samples at Imperial. The methods are documented on our website at https://www.protocols.io/file-manager/22D3304DB69911ED9EF70A58A9FEAC02. We provided training in these methods for our collaborative partners and will iteratively improve them in line with results from a field trials of the methods. |
| Collaborator Contribution | Teams at KNUST (Ghana) and CMC Vellore (India) are employing the methods over 6 months to validate their efficacy for pathogen detection. The teams are also employing two different sample collection methods, grab sampling (a bucket collection) and Moore swabs (a passive sampler of absorbent material left to dangle in flowing sewage for 24+ hours) to allow comparison of the best methods to sample for both viruses and bacteria. |
| Impact | Data has been presented at: Africa CDC Environmental Workshop 2023 (South Africa) London Calling 2024 (United Kingdom) The 20th International Congress on Infectious Diseases (South Africa) Publications underway: Experimental validation of methods to support integrated detection of viruses and bacteria in wastewater Paper(s) presenting the field trial data from KNUST and CMC Vellore Wastewater environmental surveillance for rotavirus: performance and impact Wastewater environmental surveillance for Influenza, measles and RSV Protocols Twelve protocols describing WES-focused methods with costing and validation data are being shared in the workspace. Further funding Validation of multi-pathogen methods in Ghana has been noted by the Ministry of Health who have received a Gates Foundation grant to support a national rollout Further collaborations Nucleic acids from the method development work have been shared with Josh' Quicks research team (University of Birmingham) to contribute to his work on primer design for WES. |
| Start Year | 2023 |
| Description | PERG - Pathogen epidemiology review group |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The Pathogen Epidemiology Review Group (PERG) under the leadership of Dr Anne Cori, are undertaking an ambitious project to make key epidemiological information widely accessible in a standardised and easy-to-access way. This will help the global research and policy community to rapidly access the latest and best available evidence during future epidemics, so that they can act as quickly and effectively as possible. PERG are undertaking a series of systematic literature reviews for nine pathogens identified by the World Health Organization (WHO) as most likely to cause a future epidemic or pandemic. The aim is to create a central standardised database of epidemiological parameters to aid in the design and implementation of modelling, initially focusing on these nine WHO priority pathogens, but with a possibility to later further expand. PERG is a key collaborator of the WHO Global Repository of Epidemic Parameter project of the recently formed WHO Hub for Pandemic and Epidemic Intelligence. PERG is designing an interface that presents the data in a clear, user-friendly and synthetic way. In addition, an accompanying R package, epireview, is developed as a key component of this work. By maximising the usability and dissemination of the information that is being collected, we aim for all outputs to be 1) easy for policy-makers and the broader scientific community to access; and 2) always kept up to date with new information added when available. |
| Collaborator Contribution | WHO is coordinating a broader initiative LSHTM develops software to easily use our parameters in analytic pipelines PHAC is investigating whether AI can facilitate parameter extraction from the literature |
| Impact | Multiple hackathons Multiple publications Presentations at conferences Mpox parameter resources to support the response to the ongoing mpox response |
| Start Year | 2022 |
| Description | PERG - Pathogen epidemiology review group |
| Organisation | Public Health Agency of Canada |
| Country | Canada |
| Sector | Public |
| PI Contribution | The Pathogen Epidemiology Review Group (PERG) under the leadership of Dr Anne Cori, are undertaking an ambitious project to make key epidemiological information widely accessible in a standardised and easy-to-access way. This will help the global research and policy community to rapidly access the latest and best available evidence during future epidemics, so that they can act as quickly and effectively as possible. PERG are undertaking a series of systematic literature reviews for nine pathogens identified by the World Health Organization (WHO) as most likely to cause a future epidemic or pandemic. The aim is to create a central standardised database of epidemiological parameters to aid in the design and implementation of modelling, initially focusing on these nine WHO priority pathogens, but with a possibility to later further expand. PERG is a key collaborator of the WHO Global Repository of Epidemic Parameter project of the recently formed WHO Hub for Pandemic and Epidemic Intelligence. PERG is designing an interface that presents the data in a clear, user-friendly and synthetic way. In addition, an accompanying R package, epireview, is developed as a key component of this work. By maximising the usability and dissemination of the information that is being collected, we aim for all outputs to be 1) easy for policy-makers and the broader scientific community to access; and 2) always kept up to date with new information added when available. |
| Collaborator Contribution | WHO is coordinating a broader initiative LSHTM develops software to easily use our parameters in analytic pipelines PHAC is investigating whether AI can facilitate parameter extraction from the literature |
| Impact | Multiple hackathons Multiple publications Presentations at conferences Mpox parameter resources to support the response to the ongoing mpox response |
| Start Year | 2022 |
| Description | PERG - Pathogen epidemiology review group |
| Organisation | World Health Organization (WHO) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | The Pathogen Epidemiology Review Group (PERG) under the leadership of Dr Anne Cori, are undertaking an ambitious project to make key epidemiological information widely accessible in a standardised and easy-to-access way. This will help the global research and policy community to rapidly access the latest and best available evidence during future epidemics, so that they can act as quickly and effectively as possible. PERG are undertaking a series of systematic literature reviews for nine pathogens identified by the World Health Organization (WHO) as most likely to cause a future epidemic or pandemic. The aim is to create a central standardised database of epidemiological parameters to aid in the design and implementation of modelling, initially focusing on these nine WHO priority pathogens, but with a possibility to later further expand. PERG is a key collaborator of the WHO Global Repository of Epidemic Parameter project of the recently formed WHO Hub for Pandemic and Epidemic Intelligence. PERG is designing an interface that presents the data in a clear, user-friendly and synthetic way. In addition, an accompanying R package, epireview, is developed as a key component of this work. By maximising the usability and dissemination of the information that is being collected, we aim for all outputs to be 1) easy for policy-makers and the broader scientific community to access; and 2) always kept up to date with new information added when available. |
| Collaborator Contribution | WHO is coordinating a broader initiative LSHTM develops software to easily use our parameters in analytic pipelines PHAC is investigating whether AI can facilitate parameter extraction from the literature |
| Impact | Multiple hackathons Multiple publications Presentations at conferences Mpox parameter resources to support the response to the ongoing mpox response |
| Start Year | 2022 |
| Description | Phylo2Vec: Accelerating Phylogenetic Research - eScience partnership |
| Organisation | University of Washington |
| Department | eScience Institute |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | In a publication developed under this grant, we invented a new algorithm to represent phylogenetic trees - an object to summarise genetic data and time. We applied to the eScience institute and were awarded with developer time to write our code professionally and perform unit testing. |
| Collaborator Contribution | eScience has provided 3 professional programmers time to developing our software in the language RUST |
| Impact | The output is a GitHub repository and a paper in progress |
| Start Year | 2024 |
| Description | Potential public health impacts of STI intervention programmes in Singapore |
| Organisation | Nanyang Technological University |
| Department | Lee Kong Chian School of Medicine |
| Country | Singapore |
| Sector | Academic/University |
| PI Contribution | We collaborated with researchers in Singapore (NTU / NUS) to adapt our models of gonorrhoea spread among MSM in the UK, to a local context to inform vaccine decisions. I supervised the research assistant based at NTU throughout this process, and provided general training |
| Collaborator Contribution | A postgraduate researcher adapted the model and conducted the analysis under my supervision in collaboration with partners at NTU, partners at NUS provided data from local sexual health surveys. |
| Impact | Outputs: Geng L, Whittles LK, Dickens BL, Chio MTW, Chen Y, Tan RKJ, et al. (2025) Potential public health impacts of gonorrhea vaccination programmes under declining incidences: A modeling study. PLoS Med 22(2): e1004521. https://doi.org/10.1371/journal.pmed.1004521 |
| Start Year | 2023 |
| Description | Potential public health impacts of STI intervention programmes in Singapore |
| Organisation | National University of Singapore |
| Country | Singapore |
| Sector | Academic/University |
| PI Contribution | We collaborated with researchers in Singapore (NTU / NUS) to adapt our models of gonorrhoea spread among MSM in the UK, to a local context to inform vaccine decisions. I supervised the research assistant based at NTU throughout this process, and provided general training |
| Collaborator Contribution | A postgraduate researcher adapted the model and conducted the analysis under my supervision in collaboration with partners at NTU, partners at NUS provided data from local sexual health surveys. |
| Impact | Outputs: Geng L, Whittles LK, Dickens BL, Chio MTW, Chen Y, Tan RKJ, et al. (2025) Potential public health impacts of gonorrhea vaccination programmes under declining incidences: A modeling study. PLoS Med 22(2): e1004521. https://doi.org/10.1371/journal.pmed.1004521 |
| Start Year | 2023 |
| Description | Preparation of a business case for the deployment of moxidectin mass drug administration (MDA) to accelerate elimination of onchocerciasis in sub-Saharan Africa |
| Organisation | Bill and Melinda Gates Foundation |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | We have performed the simulations of the epidemiological impact of moxidectin MDA strategies (in comparison with ivermectin MDA) in various endemicity and coverage scenarios, and have commenced investigation of economic analyses (the latter with Dr Hugo Turner, at DIDE). |
| Collaborator Contribution | Preparation of a concept note to be discussed among all partners. |
| Impact | A paper has been submitted to the Neglected Tropical Disease Collection of the Philosophical Transactions of the Royal Society, Series B. This paper is under review. |
| Start Year | 2023 |
| Description | Preparation of a business case for the deployment of moxidectin mass drug administration (MDA) to accelerate elimination of onchocerciasis in sub-Saharan Africa |
| Organisation | Medicines Development for Global Health |
| Country | Australia |
| Sector | Private |
| PI Contribution | We have performed the simulations of the epidemiological impact of moxidectin MDA strategies (in comparison with ivermectin MDA) in various endemicity and coverage scenarios, and have commenced investigation of economic analyses (the latter with Dr Hugo Turner, at DIDE). |
| Collaborator Contribution | Preparation of a concept note to be discussed among all partners. |
| Impact | A paper has been submitted to the Neglected Tropical Disease Collection of the Philosophical Transactions of the Royal Society, Series B. This paper is under review. |
| Start Year | 2023 |
| Description | Preparation of a business case for the deployment of moxidectin mass drug administration (MDA) to accelerate elimination of onchocerciasis in sub-Saharan Africa |
| Organisation | Neglected Tropical Diseases Modelling Consortium |
| Sector | Charity/Non Profit |
| PI Contribution | We have performed the simulations of the epidemiological impact of moxidectin MDA strategies (in comparison with ivermectin MDA) in various endemicity and coverage scenarios, and have commenced investigation of economic analyses (the latter with Dr Hugo Turner, at DIDE). |
| Collaborator Contribution | Preparation of a concept note to be discussed among all partners. |
| Impact | A paper has been submitted to the Neglected Tropical Disease Collection of the Philosophical Transactions of the Royal Society, Series B. This paper is under review. |
| Start Year | 2023 |
| Description | Preparation of a business case for the deployment of moxidectin mass drug administration (MDA) to accelerate elimination of onchocerciasis in sub-Saharan Africa |
| Organisation | Oriole Global Health |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | We have performed the simulations of the epidemiological impact of moxidectin MDA strategies (in comparison with ivermectin MDA) in various endemicity and coverage scenarios, and have commenced investigation of economic analyses (the latter with Dr Hugo Turner, at DIDE). |
| Collaborator Contribution | Preparation of a concept note to be discussed among all partners. |
| Impact | A paper has been submitted to the Neglected Tropical Disease Collection of the Philosophical Transactions of the Royal Society, Series B. This paper is under review. |
| Start Year | 2023 |
| Description | R21 Malaria vaccine collaboration with the Jenner Institute, Oxford |
| Organisation | University of Oxford |
| Department | Jenner Institute |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Working with lab and field teams to fit models of antibody titre and efficacy for the newly approved R21 malaria vaccine |
| Collaborator Contribution | Trial and immunological expertise to complement the data-sharing from the trial. |
| Impact | A fitted and validated model of the R21 vaccine involving experts from field trials, immunologists, statisticians and modellers. |
| Start Year | 2024 |
| Description | Rapid Assessment Framework for the impact of Seasonal Malaria Chemoprevention in East Africa |
| Organisation | Malaria Consortium |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | We work with malaria consortium to provide modelling support as part of rapid assessment toolkit aimed towards assessing the likely impact of expanding Seasonal Malaria Chemoprevention to East African geographies where it has yet to be deployed. This will involve providing estimates of the suitability of target areas and simulations of difference chemoprevention scenarios. |
| Collaborator Contribution | Malaria consortium provide us with funding for this work as well as helping us to access relevant datasets. Their wealth of experience working with national malaria control programmes also ensures that our work can have maximum policy-relevance and impact. |
| Impact | As the collaboration has just begun no impact has yet to be effected. |
| Start Year | 2023 |
| Description | Research collaboration on the analysis of EV-D68 genetic data |
| Organisation | ETH Zurich |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Designed the study, performed the analysis. |
| Collaborator Contribution | Contributed to methods. |
| Impact | No outputs yet. |
| Start Year | 2023 |
| Description | Research collaboration on the development of an R package for the analysis of data from micro-neutralisation assays |
| Organisation | University of Oxford |
| Department | Department of Statistics |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Designing research study, co-supervision of student. |
| Collaborator Contribution | Methods development and code implementation. |
| Impact | No outputs yet |
| Start Year | 2021 |
| Description | Research collaboration on the development of analytical frameworks for seroepidemiologic data |
| Organisation | National Institute of Health and Medical Research (INSERM) |
| Country | France |
| Sector | Public |
| PI Contribution | Contributed to methods. |
| Collaborator Contribution | Designed research, model implementation. |
| Impact | Hozé N, Pons-Salort M, Metcalf CJE, White M, Salje H, Cauchemez S. RSero: A user-friendly R package to reconstruct pathogen circulation history from seroprevalence studies. PLoS Comput Biol. 2025 Feb 3;21(2):e1012777. doi: 10.1371/journal.pcbi.1012777. PMID: 39899643; PMCID: PMC11809794. |
| Start Year | 2023 |
| Description | Research collaboration on the development of analytical frameworks for seroepidemiologic data |
| Organisation | Pasteur Institute, Paris |
| Country | France |
| Sector | Charity/Non Profit |
| PI Contribution | Contributed to methods. |
| Collaborator Contribution | Designed research, model implementation. |
| Impact | Hozé N, Pons-Salort M, Metcalf CJE, White M, Salje H, Cauchemez S. RSero: A user-friendly R package to reconstruct pathogen circulation history from seroprevalence studies. PLoS Comput Biol. 2025 Feb 3;21(2):e1012777. doi: 10.1371/journal.pcbi.1012777. PMID: 39899643; PMCID: PMC11809794. |
| Start Year | 2023 |
| Description | Research collaboration with Oxford University |
| Organisation | University of Oxford |
| Department | Oxford Hub |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We performed data analysis and modelling of seroprevalence data. |
| Collaborator Contribution | Generated serology data from archived blood samples. |
| Impact | Pons-Salort M, Lambert B, Kamau E, Pebody R, Harvala H, Simmonds P, Grassly NC. Changes in transmission of Enterovirus D68 (EV-D68) in England inferred from seroprevalence data. Elife. 2023 Jun 9;12:e76609. doi: 10.7554/eLife.76609. PMID: 37294299; PMCID: PMC10259368. Kamau E, Lambert B, Allen DJ, Celma C, Beard S, Harvala H, Simmonds P, Grassly NC, Pons-Salort M. Enterovirus A71 and coxsackievirus A6 circulation in England, UK, 2006-2017: A mathematical modelling study using cross-sectional seroprevalence data. PLoS Pathog. 2024 Nov 20;20(11):e1012703. doi: 10.1371/journal.ppat.1012703. PMID: 39565769; PMCID: PMC11578500. |
| Start Year | 2018 |
| Description | Return-on-Investment on Programs Supporting Healthcare Systems |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Lead investigator on project analysing return on investment for health systems strengthening and vertical programs. Research team conducted the analysis and presented findings through presentations to Global Fund and input into the Global Fund Investment Case 2025. |
| Collaborator Contribution | Partners in The Global Fund contributed their expertise to aligning research priorities with funding priorities in the coming years. |
| Impact | Results from Analysis of HTM Service Scale-Up and RSSH Investments - presentation to The Global Fund Input of these research outcomes into The Global Fund Investment Case |
| Start Year | 2024 |
| Description | Secondment as Director General to United Kingdom Health Security Agency |
| Organisation | UK Health Security Agency |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | As a direct result of work inspired by and supported by this award I was seconded 90% as a founding member of the Executive Committee of UKHSA. My initial appointment was Director General of Data, Analytics and Surveillance (DAS) in October 2021. In my role I have helped shape the new agency from legacy organisations and temporary pandemic activity. My role has now transitioned into Director General and Chief Data Officer. |
| Collaborator Contribution | The UK Government |
| Impact | I have contributed to or reviewed all papers passing through the agency ExCo since it started. These all either affect the running of the health security agency in the UK or they contribute to policy. |
| Start Year | 2021 |
| Description | Seq&Treat Consortium |
| Organisation | Foundation for Innovative New Diagnostics (FIND) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Overseeing methodology for identifying mutations associated with drug resistance in TB Method development Contribution to writing the WHO report |
| Collaborator Contribution | Overseeing methodology for identifying mutations associated with drug resistance in TB Method development Contribution to writing the WHO report |
| Impact | Contributed to WHO report - expected March 2021 Collation of largest existing dataset of whole genome sequence data and drug resistance profiles for TB Update 2022 - WHO report was published in July 2021 - multiple countries adopting the catalogue as a basis for their surveillance and diagnosis programmes in TB https://www.who.int/publications/i/item/9789240028173 |
| Start Year | 2020 |
| Description | Sierra Leone National Malaria Control Programme: SNT modelling support |
| Organisation | National Malaria Control Programme |
| Country | Swaziland |
| Sector | Public |
| PI Contribution | Provided malaria transmission modelling support to inform updates to the National Stragetic Plan for malaria control |
| Collaborator Contribution | The malaria control programme led this project |
| Impact | Modelling inputs have contributed to the Malaria Programme's National Strategic Plan |
| Start Year | 2024 |
| Description | Spatio-temporal dynamics of Enterovirus D68 in the US |
| Organisation | BioFire Diagnostics, LLC |
| Country | United States |
| Sector | Private |
| PI Contribution | Provision of data analysis and modelling expertise |
| Collaborator Contribution | Provision of data and modelling expertise |
| Impact | Park SW, Pons-Salort M, Messacar K, Cook C, Meyers L, Farrar J, Grenfell BT. Epidemiological dynamics of enterovirus D68 in the US and implications for acute flaccid myelitis. Sci Transl Med 2021;13(584):eabd2400. |
| Start Year | 2019 |
| Description | Spatio-temporal dynamics of Enterovirus D68 in the US |
| Organisation | Princeton University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Provision of data analysis and modelling expertise |
| Collaborator Contribution | Provision of data and modelling expertise |
| Impact | Park SW, Pons-Salort M, Messacar K, Cook C, Meyers L, Farrar J, Grenfell BT. Epidemiological dynamics of enterovirus D68 in the US and implications for acute flaccid myelitis. Sci Transl Med 2021;13(584):eabd2400. |
| Start Year | 2019 |
| Description | Spatio-temporal dynamics of Enterovirus D68 in the US |
| Organisation | University of Colorado |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Provision of data analysis and modelling expertise |
| Collaborator Contribution | Provision of data and modelling expertise |
| Impact | Park SW, Pons-Salort M, Messacar K, Cook C, Meyers L, Farrar J, Grenfell BT. Epidemiological dynamics of enterovirus D68 in the US and implications for acute flaccid myelitis. Sci Transl Med 2021;13(584):eabd2400. |
| Start Year | 2019 |
| Description | Strengthening public health in modelling network - Wellcome Trust |
| Organisation | Kampala International University |
| Country | Tanzania, United Republic of |
| Sector | Academic/University |
| PI Contribution | We are providing supervision and training to a cohort of junior mathematical disease modellers and data scientists in Tanzania and Kenya, working on malaria vaccines and treatment to prevent malaria. I am co-supervising a PhD student from Tanzania on modelling the impact of malaria prevention among those recovering from severe malaria. We have 2 students from the programme from Mount Kenya University visiting in April - July 2026 and will work on projects related to malaria vaccine modelling. I have co-organised an internal seminar series for our network, and attended the inaugural meeting in Nairobi in October 2025. |
| Collaborator Contribution | Partners liaise closely with National Control Programmes, and the scientific planning is done jointly across institutions. They will host and train junior mathematical modellers from our team, and also provide visiting fellowships to national malaria control programme staff. |
| Impact | Dr Winnie Kulei from Mount Kenya University successfully obtained an Imperial Global Development Hub Fellowship to visit our team at Imperial in 2026. Rachael Wachuka, a Masters student from Mount Kenya, successfully won a Vaccine Impact Modelling Consortium travel fellowship to visit our team in 2026 for analysing malaria vaccine impact data. |
| Start Year | 2024 |
| Description | Strengthening public health in modelling network - Wellcome Trust |
| Organisation | University of Nairobi |
| Country | Kenya |
| Sector | Academic/University |
| PI Contribution | We are providing supervision and training to a cohort of junior mathematical disease modellers and data scientists in Tanzania and Kenya, working on malaria vaccines and treatment to prevent malaria. I am co-supervising a PhD student from Tanzania on modelling the impact of malaria prevention among those recovering from severe malaria. We have 2 students from the programme from Mount Kenya University visiting in April - July 2026 and will work on projects related to malaria vaccine modelling. I have co-organised an internal seminar series for our network, and attended the inaugural meeting in Nairobi in October 2025. |
| Collaborator Contribution | Partners liaise closely with National Control Programmes, and the scientific planning is done jointly across institutions. They will host and train junior mathematical modellers from our team, and also provide visiting fellowships to national malaria control programme staff. |
| Impact | Dr Winnie Kulei from Mount Kenya University successfully obtained an Imperial Global Development Hub Fellowship to visit our team at Imperial in 2026. Rachael Wachuka, a Masters student from Mount Kenya, successfully won a Vaccine Impact Modelling Consortium travel fellowship to visit our team in 2026 for analysing malaria vaccine impact data. |
| Start Year | 2024 |
| Description | Supporting and strengthening infectious disease modelling: A global peer support network |
| Organisation | Indian Institute of Technology Bombay |
| Country | India |
| Sector | Academic/University |
| PI Contribution | I have been leading the establishment of a network connecting infectious disease modellers across the globe that can act as a platform to provide more sustainable and far-reaching training opportunities in this area. An overarching theme will be providing mentorship and peer support to junior staff. The network will be co-hosted by seven partner institutions which are leading centres of excellence in modelling across the world: 1. MRC Centre for Global Infectious Disease Analysis (MRC-GIDA), Imperial College London. 2. Center for Epidemiological Modelling and Analysis (CEMA), University of Nairobi, Kenya. 3. Public Health Institute, Pontificia Universidad Javeriana, Colombia. 4. National Disease Modelling Consortium (NDMC), Indian Institute of Technology Bombay, India. 5. South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, South Africa. 6. MRC Unit The Gambia, London School of Hygiene & Tropical Medicine, The Gambia. 7. Modelling Infectious Diseases in South East Asia Network (MIDSEA). The seven institutions will collectively act as implementation partners who will offer training and mentorship activities to GS LEARN participating organisations. |
| Collaborator Contribution | All of the partners contributed to a grant application to CEPI's GS-LEARN funding call. This is currently undergoing due diligence. |
| Impact | A US$5 million grant for supporting the network is currently undergoing due diligence. |
| Start Year | 2026 |
| Description | Supporting and strengthening infectious disease modelling: A global peer support network |
| Organisation | Medical Research Council (MRC) |
| Department | MRC Unit, The Gambia |
| Country | Gambia |
| Sector | Public |
| PI Contribution | I have been leading the establishment of a network connecting infectious disease modellers across the globe that can act as a platform to provide more sustainable and far-reaching training opportunities in this area. An overarching theme will be providing mentorship and peer support to junior staff. The network will be co-hosted by seven partner institutions which are leading centres of excellence in modelling across the world: 1. MRC Centre for Global Infectious Disease Analysis (MRC-GIDA), Imperial College London. 2. Center for Epidemiological Modelling and Analysis (CEMA), University of Nairobi, Kenya. 3. Public Health Institute, Pontificia Universidad Javeriana, Colombia. 4. National Disease Modelling Consortium (NDMC), Indian Institute of Technology Bombay, India. 5. South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, South Africa. 6. MRC Unit The Gambia, London School of Hygiene & Tropical Medicine, The Gambia. 7. Modelling Infectious Diseases in South East Asia Network (MIDSEA). The seven institutions will collectively act as implementation partners who will offer training and mentorship activities to GS LEARN participating organisations. |
| Collaborator Contribution | All of the partners contributed to a grant application to CEPI's GS-LEARN funding call. This is currently undergoing due diligence. |
| Impact | A US$5 million grant for supporting the network is currently undergoing due diligence. |
| Start Year | 2026 |
| Description | Supporting and strengthening infectious disease modelling: A global peer support network |
| Organisation | National University of Singapore |
| Country | Singapore |
| Sector | Academic/University |
| PI Contribution | I have been leading the establishment of a network connecting infectious disease modellers across the globe that can act as a platform to provide more sustainable and far-reaching training opportunities in this area. An overarching theme will be providing mentorship and peer support to junior staff. The network will be co-hosted by seven partner institutions which are leading centres of excellence in modelling across the world: 1. MRC Centre for Global Infectious Disease Analysis (MRC-GIDA), Imperial College London. 2. Center for Epidemiological Modelling and Analysis (CEMA), University of Nairobi, Kenya. 3. Public Health Institute, Pontificia Universidad Javeriana, Colombia. 4. National Disease Modelling Consortium (NDMC), Indian Institute of Technology Bombay, India. 5. South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, South Africa. 6. MRC Unit The Gambia, London School of Hygiene & Tropical Medicine, The Gambia. 7. Modelling Infectious Diseases in South East Asia Network (MIDSEA). The seven institutions will collectively act as implementation partners who will offer training and mentorship activities to GS LEARN participating organisations. |
| Collaborator Contribution | All of the partners contributed to a grant application to CEPI's GS-LEARN funding call. This is currently undergoing due diligence. |
| Impact | A US$5 million grant for supporting the network is currently undergoing due diligence. |
| Start Year | 2026 |
| Description | Supporting and strengthening infectious disease modelling: A global peer support network |
| Organisation | Pontifical Xavierian University |
| Country | Colombia |
| Sector | Academic/University |
| PI Contribution | I have been leading the establishment of a network connecting infectious disease modellers across the globe that can act as a platform to provide more sustainable and far-reaching training opportunities in this area. An overarching theme will be providing mentorship and peer support to junior staff. The network will be co-hosted by seven partner institutions which are leading centres of excellence in modelling across the world: 1. MRC Centre for Global Infectious Disease Analysis (MRC-GIDA), Imperial College London. 2. Center for Epidemiological Modelling and Analysis (CEMA), University of Nairobi, Kenya. 3. Public Health Institute, Pontificia Universidad Javeriana, Colombia. 4. National Disease Modelling Consortium (NDMC), Indian Institute of Technology Bombay, India. 5. South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, South Africa. 6. MRC Unit The Gambia, London School of Hygiene & Tropical Medicine, The Gambia. 7. Modelling Infectious Diseases in South East Asia Network (MIDSEA). The seven institutions will collectively act as implementation partners who will offer training and mentorship activities to GS LEARN participating organisations. |
| Collaborator Contribution | All of the partners contributed to a grant application to CEPI's GS-LEARN funding call. This is currently undergoing due diligence. |
| Impact | A US$5 million grant for supporting the network is currently undergoing due diligence. |
| Start Year | 2026 |
| Description | Supporting and strengthening infectious disease modelling: A global peer support network |
| Organisation | University of Nairobi |
| Country | Kenya |
| Sector | Academic/University |
| PI Contribution | I have been leading the establishment of a network connecting infectious disease modellers across the globe that can act as a platform to provide more sustainable and far-reaching training opportunities in this area. An overarching theme will be providing mentorship and peer support to junior staff. The network will be co-hosted by seven partner institutions which are leading centres of excellence in modelling across the world: 1. MRC Centre for Global Infectious Disease Analysis (MRC-GIDA), Imperial College London. 2. Center for Epidemiological Modelling and Analysis (CEMA), University of Nairobi, Kenya. 3. Public Health Institute, Pontificia Universidad Javeriana, Colombia. 4. National Disease Modelling Consortium (NDMC), Indian Institute of Technology Bombay, India. 5. South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, South Africa. 6. MRC Unit The Gambia, London School of Hygiene & Tropical Medicine, The Gambia. 7. Modelling Infectious Diseases in South East Asia Network (MIDSEA). The seven institutions will collectively act as implementation partners who will offer training and mentorship activities to GS LEARN participating organisations. |
| Collaborator Contribution | All of the partners contributed to a grant application to CEPI's GS-LEARN funding call. This is currently undergoing due diligence. |
| Impact | A US$5 million grant for supporting the network is currently undergoing due diligence. |
| Start Year | 2026 |
| Description | Supporting and strengthening infectious disease modelling: A global peer support network |
| Organisation | University of Stellenbosch |
| Department | South African Centre for Epidemiological Modelling and Analysis |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | I have been leading the establishment of a network connecting infectious disease modellers across the globe that can act as a platform to provide more sustainable and far-reaching training opportunities in this area. An overarching theme will be providing mentorship and peer support to junior staff. The network will be co-hosted by seven partner institutions which are leading centres of excellence in modelling across the world: 1. MRC Centre for Global Infectious Disease Analysis (MRC-GIDA), Imperial College London. 2. Center for Epidemiological Modelling and Analysis (CEMA), University of Nairobi, Kenya. 3. Public Health Institute, Pontificia Universidad Javeriana, Colombia. 4. National Disease Modelling Consortium (NDMC), Indian Institute of Technology Bombay, India. 5. South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, South Africa. 6. MRC Unit The Gambia, London School of Hygiene & Tropical Medicine, The Gambia. 7. Modelling Infectious Diseases in South East Asia Network (MIDSEA). The seven institutions will collectively act as implementation partners who will offer training and mentorship activities to GS LEARN participating organisations. |
| Collaborator Contribution | All of the partners contributed to a grant application to CEPI's GS-LEARN funding call. This is currently undergoing due diligence. |
| Impact | A US$5 million grant for supporting the network is currently undergoing due diligence. |
| Start Year | 2026 |
| Description | The Global Fund |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Explore the epidemiological benefit of different insecticide treated net distribution strategies. |
| Collaborator Contribution | Technical expertise. |
| Impact | Presentation at Global Fund Headquarters, Geneva, Switzerland and at expert meetings organised by The Global Fund in Uganda (2026), Kenya (2026 and 2025) and Rwanda (2024). Manuscript published https://elifesciences.org/reviewed-preprints/108745. |
| Start Year | 2022 |
| Description | The Global Fund - Malaria |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Modelling of malaria scenarios to support multiple Investment Cases and subsequent strategy development targets |
| Collaborator Contribution | Provided scenarios and input data |
| Impact | Global Fund Investment Cases: https://www.theglobalfund.org/en/news/2019-02-08-global-partners-commit-to-step-up-the-fight-against-aids-tb-and-malaria/ https://www.theglobalfund.org/media/15381/core_2025-investment-case_summary_en.pdf |
| Start Year | 2018 |
| Description | The Health Impact of Investments in Vertical Programs and Healthcare System Strengthening |
| Organisation | Foreign Commonwealth and Development Office (FCDO) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Led the comparative analyses of horizontal versus vertical investments |
| Collaborator Contribution | Partners provided expert input into direction of analysis and refined the final policy brief |
| Impact | Policy brief, manuscript in preparation |
| Start Year | 2024 |
| Description | Tools for the detection of AMR Pathogens |
| Organisation | Christian Medical College, Vellore |
| Country | India |
| Sector | Academic/University |
| PI Contribution | Project Management Assistance with procurement Grant writing Primer design Laboratory testing of samples Provision of training on laboratory sequencing methods Technical assistance (site selection) Provision of training on site selection methods |
| Collaborator Contribution | LSHTM - Bioinformatics expertise KNUST - Provision of data and samples CMC Vellore - Provision of data and samples |
| Impact | Manuscript published: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0013211 |
| Start Year | 2022 |
| Description | Tools for the detection of AMR Pathogens |
| Organisation | Gadjah Mada University |
| Country | Indonesia |
| Sector | Academic/University |
| PI Contribution | Project Management Assistance with procurement Grant writing Primer design Laboratory testing of samples Provision of training on laboratory sequencing methods Technical assistance (site selection) Provision of training on site selection methods |
| Collaborator Contribution | LSHTM - Bioinformatics expertise KNUST - Provision of data and samples CMC Vellore - Provision of data and samples |
| Impact | Manuscript published: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0013211 |
| Start Year | 2022 |
| Description | Tools for the detection of AMR Pathogens |
| Organisation | Kwame Nkrumah University of Science and Technology (KNUST) |
| Country | Ghana |
| Sector | Academic/University |
| PI Contribution | Project Management Assistance with procurement Grant writing Primer design Laboratory testing of samples Provision of training on laboratory sequencing methods Technical assistance (site selection) Provision of training on site selection methods |
| Collaborator Contribution | LSHTM - Bioinformatics expertise KNUST - Provision of data and samples CMC Vellore - Provision of data and samples |
| Impact | Manuscript published: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0013211 |
| Start Year | 2022 |
| Description | Tools for the detection of AMR Pathogens |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project Management Assistance with procurement Grant writing Primer design Laboratory testing of samples Provision of training on laboratory sequencing methods Technical assistance (site selection) Provision of training on site selection methods |
| Collaborator Contribution | LSHTM - Bioinformatics expertise KNUST - Provision of data and samples CMC Vellore - Provision of data and samples |
| Impact | Manuscript published: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0013211 |
| Start Year | 2022 |
| Description | Tools for the detection of AMR Pathogens |
| Organisation | National Institute of Health, Mozambique |
| Country | Mozambique |
| Sector | Public |
| PI Contribution | Project Management Assistance with procurement Grant writing Primer design Laboratory testing of samples Provision of training on laboratory sequencing methods Technical assistance (site selection) Provision of training on site selection methods |
| Collaborator Contribution | LSHTM - Bioinformatics expertise KNUST - Provision of data and samples CMC Vellore - Provision of data and samples |
| Impact | Manuscript published: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0013211 |
| Start Year | 2022 |
| Description | Tools for the detection of AMR Pathogens |
| Organisation | Pasteur Institute Dakar |
| Country | Senegal |
| Sector | Charity/Non Profit |
| PI Contribution | Project Management Assistance with procurement Grant writing Primer design Laboratory testing of samples Provision of training on laboratory sequencing methods Technical assistance (site selection) Provision of training on site selection methods |
| Collaborator Contribution | LSHTM - Bioinformatics expertise KNUST - Provision of data and samples CMC Vellore - Provision of data and samples |
| Impact | Manuscript published: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0013211 |
| Start Year | 2022 |
| Description | TransformHIV project - Transforming the response to the HIV epidemics amongst key populations: Addressing structural factors for achieving HIV elimination - multi county collaboration |
| Organisation | Johns Hopkins University |
| Department | Johns Hopkins Bloomberg School of Public Health |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Project co lead. Provide research direction and results , co supervision, capacity building |
| Collaborator Contribution | Partners in the UK, Canada, India, Cote d'Ivoire et Ukraine - each contribute to the research agenda, research , PPI, : |
| Impact | Multidisciplinary collaboration: epidemiology, mathematical modelling, economics, biostatistics, HIV programming, PPI Capacity building workshop in Cote d'Ivoire (https://hptnmodelling.org/resources/workshop-de-modelisation-mathematique-2025/) + several publications including: Stannah J, Knight J, Sandfort T, Laurent C, Otieno FO, Larmarange J, Coulaud PJ, Mudhune V, Hamilton E, Cummings V, Spire B, Reynolds D, Dadabhai S, Okall D, Keita BD, Sagaon-Teyssier L, Panchia R, Boily MC, Maheu-Giroux M. The Effect of Sexual and Gender Minority Violence on Depression, Hazardous Drinking, Condom Use, and HIV Acquisition: An Individual Participant Data Meta-Analysis of the CohMSM, HPTN 075, and Anza Mapema Cohort Studies in Africa. AIDS Behav. 2025 Nov;29(11):3557-3572. doi: 10.1007/s10461-025-04799-4. Epub 2025 Jun 11. PMID: 40498238; PMCID: PMC12237430. Pickles M, Mountain E, Bhattacharjee P, Kioko J, Musimbi J, Musyoki H, Gichangi P, Stannah J, Maheu-Giroux M, Becker M, Boily MC. Exploratory analysis of the potential impact of violence on HIV among female sex workers in Mombasa, Kenya: a mathematical modelling study. BMC Med. 2024 Oct 15;22(1):468. doi: 10.1186/s12916-024-03670-y. PMID: 39407271; PMCID: PMC11475892. Stannah J, Flores Anato JL, Pickles M, Larmarange J, Mitchell KM, Artenie A, Dumchev K, Niangoran S, Platt L, Terris-Prestholt F, Singh A, Stone J, Vickerman P, Phillips A, Johnson L, Maheu-Giroux M, Boily MC. From conceptualising to modelling structural determinants and interventions in HIV transmission dynamics models: a scoping review and methodological framework for evidence-based analyses. BMC Med. 2024 Sep 19;22(1):404. doi: 10.1186/s12916-024-03580-z. PMID: 39300441; PMCID: PMC11414142. |
| Start Year | 2023 |
| Description | TransformHIV project - Transforming the response to the HIV epidemics amongst key populations: Addressing structural factors for achieving HIV elimination - multi county collaboration |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project co lead. Provide research direction and results , co supervision, capacity building |
| Collaborator Contribution | Partners in the UK, Canada, India, Cote d'Ivoire et Ukraine - each contribute to the research agenda, research , PPI, : |
| Impact | Multidisciplinary collaboration: epidemiology, mathematical modelling, economics, biostatistics, HIV programming, PPI Capacity building workshop in Cote d'Ivoire (https://hptnmodelling.org/resources/workshop-de-modelisation-mathematique-2025/) + several publications including: Stannah J, Knight J, Sandfort T, Laurent C, Otieno FO, Larmarange J, Coulaud PJ, Mudhune V, Hamilton E, Cummings V, Spire B, Reynolds D, Dadabhai S, Okall D, Keita BD, Sagaon-Teyssier L, Panchia R, Boily MC, Maheu-Giroux M. The Effect of Sexual and Gender Minority Violence on Depression, Hazardous Drinking, Condom Use, and HIV Acquisition: An Individual Participant Data Meta-Analysis of the CohMSM, HPTN 075, and Anza Mapema Cohort Studies in Africa. AIDS Behav. 2025 Nov;29(11):3557-3572. doi: 10.1007/s10461-025-04799-4. Epub 2025 Jun 11. PMID: 40498238; PMCID: PMC12237430. Pickles M, Mountain E, Bhattacharjee P, Kioko J, Musimbi J, Musyoki H, Gichangi P, Stannah J, Maheu-Giroux M, Becker M, Boily MC. Exploratory analysis of the potential impact of violence on HIV among female sex workers in Mombasa, Kenya: a mathematical modelling study. BMC Med. 2024 Oct 15;22(1):468. doi: 10.1186/s12916-024-03670-y. PMID: 39407271; PMCID: PMC11475892. Stannah J, Flores Anato JL, Pickles M, Larmarange J, Mitchell KM, Artenie A, Dumchev K, Niangoran S, Platt L, Terris-Prestholt F, Singh A, Stone J, Vickerman P, Phillips A, Johnson L, Maheu-Giroux M, Boily MC. From conceptualising to modelling structural determinants and interventions in HIV transmission dynamics models: a scoping review and methodological framework for evidence-based analyses. BMC Med. 2024 Sep 19;22(1):404. doi: 10.1186/s12916-024-03580-z. PMID: 39300441; PMCID: PMC11414142. |
| Start Year | 2023 |
| Description | TransformHIV project - Transforming the response to the HIV epidemics amongst key populations: Addressing structural factors for achieving HIV elimination - multi county collaboration |
| Organisation | McGill University |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Project co lead. Provide research direction and results , co supervision, capacity building |
| Collaborator Contribution | Partners in the UK, Canada, India, Cote d'Ivoire et Ukraine - each contribute to the research agenda, research , PPI, : |
| Impact | Multidisciplinary collaboration: epidemiology, mathematical modelling, economics, biostatistics, HIV programming, PPI Capacity building workshop in Cote d'Ivoire (https://hptnmodelling.org/resources/workshop-de-modelisation-mathematique-2025/) + several publications including: Stannah J, Knight J, Sandfort T, Laurent C, Otieno FO, Larmarange J, Coulaud PJ, Mudhune V, Hamilton E, Cummings V, Spire B, Reynolds D, Dadabhai S, Okall D, Keita BD, Sagaon-Teyssier L, Panchia R, Boily MC, Maheu-Giroux M. The Effect of Sexual and Gender Minority Violence on Depression, Hazardous Drinking, Condom Use, and HIV Acquisition: An Individual Participant Data Meta-Analysis of the CohMSM, HPTN 075, and Anza Mapema Cohort Studies in Africa. AIDS Behav. 2025 Nov;29(11):3557-3572. doi: 10.1007/s10461-025-04799-4. Epub 2025 Jun 11. PMID: 40498238; PMCID: PMC12237430. Pickles M, Mountain E, Bhattacharjee P, Kioko J, Musimbi J, Musyoki H, Gichangi P, Stannah J, Maheu-Giroux M, Becker M, Boily MC. Exploratory analysis of the potential impact of violence on HIV among female sex workers in Mombasa, Kenya: a mathematical modelling study. BMC Med. 2024 Oct 15;22(1):468. doi: 10.1186/s12916-024-03670-y. PMID: 39407271; PMCID: PMC11475892. Stannah J, Flores Anato JL, Pickles M, Larmarange J, Mitchell KM, Artenie A, Dumchev K, Niangoran S, Platt L, Terris-Prestholt F, Singh A, Stone J, Vickerman P, Phillips A, Johnson L, Maheu-Giroux M, Boily MC. From conceptualising to modelling structural determinants and interventions in HIV transmission dynamics models: a scoping review and methodological framework for evidence-based analyses. BMC Med. 2024 Sep 19;22(1):404. doi: 10.1186/s12916-024-03580-z. PMID: 39300441; PMCID: PMC11414142. |
| Start Year | 2023 |
| Description | TransformHIV project - Transforming the response to the HIV epidemics amongst key populations: Addressing structural factors for achieving HIV elimination - multi county collaboration |
| Organisation | Programme PAC-CI |
| Country | Cote d'Ivoire |
| Sector | Charity/Non Profit |
| PI Contribution | Project co lead. Provide research direction and results , co supervision, capacity building |
| Collaborator Contribution | Partners in the UK, Canada, India, Cote d'Ivoire et Ukraine - each contribute to the research agenda, research , PPI, : |
| Impact | Multidisciplinary collaboration: epidemiology, mathematical modelling, economics, biostatistics, HIV programming, PPI Capacity building workshop in Cote d'Ivoire (https://hptnmodelling.org/resources/workshop-de-modelisation-mathematique-2025/) + several publications including: Stannah J, Knight J, Sandfort T, Laurent C, Otieno FO, Larmarange J, Coulaud PJ, Mudhune V, Hamilton E, Cummings V, Spire B, Reynolds D, Dadabhai S, Okall D, Keita BD, Sagaon-Teyssier L, Panchia R, Boily MC, Maheu-Giroux M. The Effect of Sexual and Gender Minority Violence on Depression, Hazardous Drinking, Condom Use, and HIV Acquisition: An Individual Participant Data Meta-Analysis of the CohMSM, HPTN 075, and Anza Mapema Cohort Studies in Africa. AIDS Behav. 2025 Nov;29(11):3557-3572. doi: 10.1007/s10461-025-04799-4. Epub 2025 Jun 11. PMID: 40498238; PMCID: PMC12237430. Pickles M, Mountain E, Bhattacharjee P, Kioko J, Musimbi J, Musyoki H, Gichangi P, Stannah J, Maheu-Giroux M, Becker M, Boily MC. Exploratory analysis of the potential impact of violence on HIV among female sex workers in Mombasa, Kenya: a mathematical modelling study. BMC Med. 2024 Oct 15;22(1):468. doi: 10.1186/s12916-024-03670-y. PMID: 39407271; PMCID: PMC11475892. Stannah J, Flores Anato JL, Pickles M, Larmarange J, Mitchell KM, Artenie A, Dumchev K, Niangoran S, Platt L, Terris-Prestholt F, Singh A, Stone J, Vickerman P, Phillips A, Johnson L, Maheu-Giroux M, Boily MC. From conceptualising to modelling structural determinants and interventions in HIV transmission dynamics models: a scoping review and methodological framework for evidence-based analyses. BMC Med. 2024 Sep 19;22(1):404. doi: 10.1186/s12916-024-03580-z. PMID: 39300441; PMCID: PMC11414142. |
| Start Year | 2023 |
| Description | TransformHIV project - Transforming the response to the HIV epidemics amongst key populations: Addressing structural factors for achieving HIV elimination - multi county collaboration |
| Organisation | University of Bristol |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project co lead. Provide research direction and results , co supervision, capacity building |
| Collaborator Contribution | Partners in the UK, Canada, India, Cote d'Ivoire et Ukraine - each contribute to the research agenda, research , PPI, : |
| Impact | Multidisciplinary collaboration: epidemiology, mathematical modelling, economics, biostatistics, HIV programming, PPI Capacity building workshop in Cote d'Ivoire (https://hptnmodelling.org/resources/workshop-de-modelisation-mathematique-2025/) + several publications including: Stannah J, Knight J, Sandfort T, Laurent C, Otieno FO, Larmarange J, Coulaud PJ, Mudhune V, Hamilton E, Cummings V, Spire B, Reynolds D, Dadabhai S, Okall D, Keita BD, Sagaon-Teyssier L, Panchia R, Boily MC, Maheu-Giroux M. The Effect of Sexual and Gender Minority Violence on Depression, Hazardous Drinking, Condom Use, and HIV Acquisition: An Individual Participant Data Meta-Analysis of the CohMSM, HPTN 075, and Anza Mapema Cohort Studies in Africa. AIDS Behav. 2025 Nov;29(11):3557-3572. doi: 10.1007/s10461-025-04799-4. Epub 2025 Jun 11. PMID: 40498238; PMCID: PMC12237430. Pickles M, Mountain E, Bhattacharjee P, Kioko J, Musimbi J, Musyoki H, Gichangi P, Stannah J, Maheu-Giroux M, Becker M, Boily MC. Exploratory analysis of the potential impact of violence on HIV among female sex workers in Mombasa, Kenya: a mathematical modelling study. BMC Med. 2024 Oct 15;22(1):468. doi: 10.1186/s12916-024-03670-y. PMID: 39407271; PMCID: PMC11475892. Stannah J, Flores Anato JL, Pickles M, Larmarange J, Mitchell KM, Artenie A, Dumchev K, Niangoran S, Platt L, Terris-Prestholt F, Singh A, Stone J, Vickerman P, Phillips A, Johnson L, Maheu-Giroux M, Boily MC. From conceptualising to modelling structural determinants and interventions in HIV transmission dynamics models: a scoping review and methodological framework for evidence-based analyses. BMC Med. 2024 Sep 19;22(1):404. doi: 10.1186/s12916-024-03580-z. PMID: 39300441; PMCID: PMC11414142. |
| Start Year | 2023 |
| Description | Translating Data to Policy: Modelling Techniques for Malaria Surveillance Data in Tanzania |
| Organisation | National Malaria Control Programme, Tanzania |
| Country | Tanzania, United Republic of |
| Sector | Public |
| PI Contribution | The purpose of the workshop was to enhance data analytic and visualisation skills among Tanzania-based malaria researchers and Ministry of Health staff. Participants were selected based on their experience, skills, proposed research questions, and alignment with National Malaria Control Programme (NMCP) priorities. Participants attended from Ifakara Health Institute, University of Dar es Salaam, National Institute for Medical Research Tanzania, Catholic University of Health and Allied Sciences, Kilimanjaro Christian Medical Centre, NMCP, Swiss TPH, the University of Nairobi, and the Zanzibar Malaria Elimination Program. |
| Collaborator Contribution | To ensure that workshop activities aligned with NMCP priorities, the first day of the workshop was framed as a Priority Setting Symposium, opened by Dr Samwel Lazaro, Programme Manager for the National Malaria Control Programme. We were also joined by Dr Billy Ngasala (Muhimbili University of Health and Allied Sciences) and Dr Vito Baraka (National Institute for Medical Research Tanzania), who participated in a panel discussion on successes and barriers in malaria research in Tanzania. During the workshop participants took part in a series of activities including formal lectures, facilitator-guided practicals, and collaborative group work. Lecture topics covered research development (research questions, data cleaning, exploratory analysis), data communication (data visualisation and scientific writing), and modelling and analytics (weather and climate modelling, mechanistic modelling, geospatial modelling). Concepts introduced in lectures were then practised through group work, in which participants formed groups of three to six to develop a research question and begin conducting analyses. This work culminated in a presentation by each group on the final day. The group work used malaria surveillance data from antenatal care-based surveillance and biennial school-based surveys provided by the NMCP, with a particular focus on investigating the impact of weather and climate on malaria burden. |
| Impact | Ongoing collaboration. |
| Start Year | 2025 |
| Description | Typhoid Environmental Surveillance in Nigeria |
| Organisation | University of Ibadan |
| Country | Nigeria |
| Sector | Academic/University |
| PI Contribution | Assistance with procurement Project Management Liaising with funders GIS data expertise Data analysis Provision of training in laboratory sequencing methods |
| Collaborator Contribution | Fieldwork activities GIS data expertise Provision of data |
| Impact | No outputs yet |
| Start Year | 2022 |
| Description | Typhoid environmental surveillance |
| Organisation | Christian Medical College, Vellore |
| Country | India |
| Sector | Academic/University |
| PI Contribution | environmental site selection and GIS data analysis Development of protocol Writing of paper Training of laboratories Data analysis |
| Collaborator Contribution | Sample collection and testing and analysis Data analysis Methods development |
| Impact | Paper on medrXiv Methodology shared with other groups in Fiji, Nigeria and Indonesia and will be used to support environmental surveillance for disease burden https://doi.org/10.1371/journal.pntd.0012373 https://doi.org/10.1371/journal.pone.0318840 https://doi.org/10.1371/journal.pntd.0012518 https://doi.org/10.1093/infdis/jiad427 https://verixiv.org/articles/1-26/v1 https://doi.org/10.1101/2024.07.25.24310996 |
| Start Year | 2019 |
| Description | Typhoid environmental surveillance |
| Organisation | Kwame Nkrumah University of Science and Technology (KNUST) |
| Country | Ghana |
| Sector | Academic/University |
| PI Contribution | environmental site selection and GIS data analysis Development of protocol Writing of paper Training of laboratories Data analysis |
| Collaborator Contribution | Sample collection and testing and analysis Data analysis Methods development |
| Impact | Paper on medrXiv Methodology shared with other groups in Fiji, Nigeria and Indonesia and will be used to support environmental surveillance for disease burden https://doi.org/10.1371/journal.pntd.0012373 https://doi.org/10.1371/journal.pone.0318840 https://doi.org/10.1371/journal.pntd.0012518 https://doi.org/10.1093/infdis/jiad427 https://verixiv.org/articles/1-26/v1 https://doi.org/10.1101/2024.07.25.24310996 |
| Start Year | 2019 |
| Description | Typhoid environmental surveillance |
| Organisation | Liverpool School of Tropical Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | environmental site selection and GIS data analysis Development of protocol Writing of paper Training of laboratories Data analysis |
| Collaborator Contribution | Sample collection and testing and analysis Data analysis Methods development |
| Impact | Paper on medrXiv Methodology shared with other groups in Fiji, Nigeria and Indonesia and will be used to support environmental surveillance for disease burden https://doi.org/10.1371/journal.pntd.0012373 https://doi.org/10.1371/journal.pone.0318840 https://doi.org/10.1371/journal.pntd.0012518 https://doi.org/10.1093/infdis/jiad427 https://verixiv.org/articles/1-26/v1 https://doi.org/10.1101/2024.07.25.24310996 |
| Start Year | 2019 |
| Description | Typhoid environmental surveillance |
| Organisation | University of Washington |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | environmental site selection and GIS data analysis Development of protocol Writing of paper Training of laboratories Data analysis |
| Collaborator Contribution | Sample collection and testing and analysis Data analysis Methods development |
| Impact | Paper on medrXiv Methodology shared with other groups in Fiji, Nigeria and Indonesia and will be used to support environmental surveillance for disease burden https://doi.org/10.1371/journal.pntd.0012373 https://doi.org/10.1371/journal.pone.0318840 https://doi.org/10.1371/journal.pntd.0012518 https://doi.org/10.1093/infdis/jiad427 https://verixiv.org/articles/1-26/v1 https://doi.org/10.1101/2024.07.25.24310996 |
| Start Year | 2019 |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | Avenir Health |
| Country | United States |
| Sector | Private |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | Centers for Disease Control and Prevention (CDC) |
| Department | Division of Global HIV/AIDS |
| Country | United States |
| Sector | Public |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | European Centre for Disease Prevention and Control (ECDC) |
| Country | Sweden |
| Sector | Public |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | Government of the United States of America |
| Department | U.S. Census Bureau |
| Country | United States |
| Sector | Public |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | International Epidemiologic Databases to Evaluate AIDS (IeDEA) |
| Country | Global |
| Sector | Charity/Non Profit |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | Joint United Nations Programme on HIV/AIDS (UNAIDS) |
| Country | Global |
| Sector | Public |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Department | Alpha Network |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | UNICEF |
| Country | United States |
| Sector | Public |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | United Nations (UN) |
| Department | UN Population Division |
| Country | United States |
| Sector | Public |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | United States President's Emergency Plan for AIDS Relief |
| Country | United States |
| Sector | Public |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | University of Cape Town |
| Department | Centre for Infectious Disease Epidemiology and Research |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | UNAIDS Reference Group on Estimates, Modelling, and Projections |
| Organisation | University of Stellenbosch |
| Department | South African Centre for Epidemiological Modelling and Analysis |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | - Co-chair activities of the UNAIDS Reference Group - Coordinate meetings of the UNAIDS Reference Group - Development of mathematical models and technical guidance to partners |
| Collaborator Contribution | - Technical guidance on mathematical models, statistical methods, and data for estimation and projection of global HIV epidemic trends. |
| Impact | - Multiple technical meetings: http://www.epidem.org/meetings - Multiple publications of related research: http://www.epidem.org/publications-reports - Methodological guidance on models and software used for global HIV epidemic estimates: https://avenirhealth.org/software-spectrum.php - Methodological guidance for global HIV estimates and projections published by UNAIDS: http://aidsinfo.unaids.org Updated 2021 WHO -HIV testing dashboard: https://www.who.int/hiv/mediacentre/news/hts-dashboard/en/ |
| Description | WHO Berlin hub collaboration on pandemic preparedness and epidemic response |
| Organisation | World Health Organization (WHO) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | Literature review on epidemic models and parameters for priority pathogens Co-organising of a workshop on how modelling informed policy during the pandemic - leading from the modelling side |
| Collaborator Contribution | Bringing together experts to expand the literature review on models and parameters, and collaboratively think about how to turn this into a dynamic database which can be useful in practice in future epidemics Co-organising of a workshop on how modelling informed policy during the pandemic - leading from the policy side |
| Impact | This collaboration informed the designed of the WHO GREPI (Global Repository of Epidemiological parameters) database, for which a minimal viable product is due to be released in 2026 |
| Start Year | 2022 |
| Description | WHO Global Arbovirus Initiative Technical Advisory Group |
| Organisation | World Health Organization (WHO) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | Expertise in arbovirus genomic surveillance and epidemiology. Discussion on the implementation of genomic surveillance programmes for arboviruses globally. |
| Collaborator Contribution | Country and regional expertise in arbovirus epidemiology. |
| Impact | Report of the third meeting of the WHO Technical Advisory Group on Arboviruses (?TAG-Arbovirus)?: hybrid meeting, Accra, Ghana, 20-22 June 2023 https://www.who.int/publications/i/item/9789240095830 Additional policy documents (including diagnostic guidelines and an updated list of priority arboviruses) and group publications are currently under preparation. |
| Start Year | 2024 |
| Description | WHO Global Malaria Programme |
| Organisation | World Health Organization (WHO) |
| Department | Global Malaria Programme |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Collaboration on modelling to inform policy across a range of areas. |
| Collaborator Contribution | Intellectual partners, developing questions relevant to support public health policy. |
| Impact | PMID: 29242750 PMID: 28588994 PMID: 28566213 PMID: 28837020 PMID: 30961603 PMID: 33253211 PMID: 38342107 PMID: 37080831 PMID: 34789253 PMID: 36400084 |
| Start Year | 2011 |
| Description | WHO Global Malaria Programme - pfhrp2/3 surveillance support |
| Organisation | World Health Organization (WHO) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | Malaria modelling support for the Update of the response plan to pfhrp2 gene deletions. |
| Collaborator Contribution | Technical and data-analytics support as well as project shaping. |
| Impact | Modelling results (https://doi.org/10.1101/2023.10.21.23297352) that underpin the WHO protocol for surveillance of pfhrp2/3 (https://www.who.int/publications/i/item/9789240099951) for the Response plan to pfhrp2 gene deletions (https://www.who.int/publications/i/item/9789240101838). |
| Start Year | 2023 |
| Description | WHO Virus Evolution Technical Advisory Group |
| Organisation | World Health Organization (WHO) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | Expertise in virus genomic epidemiology. |
| Collaborator Contribution | Country and regional expertise in mpox epidemiology. |
| Impact | Outcomes include an updated dashboard (https://worldhealthorg.shinyapps.io/mpx_global/) and a document regarding naming of mpox (under preparation). |
| Start Year | 2024 |
| Description | WHO Zika Taskforce Technical Advisory Group |
| Organisation | World Health Organization (WHO) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | Expertise in Zika virus genomic surveillance and evolution. |
| Collaborator Contribution | Expertise in laboratory diagnostics for detecting Zika virus across different settings. |
| Impact | Zika virus: advancing a priority research agenda for preparedness and response Lancet Infectious Diseases DOI: 10.1016/S1473-3099(24)00794-1 Zika virus vaccines and monoclonal antibodies: a priority agenda for research and development Lancet Infectious Diseases DOI: 10.1016/S1473-3099(24)00750-3 Specimen and data sharing to advance research and development on Zika virus Lancet Microbe DOI: 10.1016/j.lanmic.2024.101057 Role of non-human primate models in accelerating research and developing countermeasures against Zika virus infection Lancet Microbe DOI: 10.1016/j.lanmic.2024.101030 |
| Start Year | 2023 |
| Description | WHO polio collaborating institute for data analysis and modelling |
| Organisation | World Health Organization (WHO) |
| Country | Switzerland |
| Sector | Public |
| PI Contribution | epidemiological analysis and reports Assessing effectiveness of nOPV2 (new polio oral vaccine) during rollout |
| Collaborator Contribution | provision of data and requests for participation in advisory groups |
| Impact | several publications including New England Journal of Medicine and Lancet Infectious Diseases https://www.dx.doi.org/10.1056/NEJMoa1716677 https://dx.doi.org/10.1093/infdis/jiae614 https://dx.doi.org/10.1016/j.cmi.2025.01.019 https://dx.doi.org/10.3390/vaccines12121308 https://dx.doi.org/10.1016/s1473-3099(23)00505-4 https://dx.doi.org/10.1016/S1473-3099(23)00688-6 https://dx.doi.org/10.1093/infdis/jiad004 https://dx.doi.org/10.1016/j.vaccine.2021.09.037 https://dx.doi.org/10.15585/mmwr.mm7124a2 https://dx.doi.org/10.1371/journal.pmed.1002323 https://dx.doi.org/10.1371/journal.pmed.100214 https://dx.doi.org/10.1371/journal.ppat.1005728 https://dx.doi.org/10.3201/eid2203.151394 Update 2026: https://dx.doi.org/10.1038/s41564-025-02174-6 https://dx.doi.org/10.1016/j.cmi.2025.01.019 https://dx.doi.org/10.1093/infdis/jiae614 |
| Description | WaSPP - Wastewater Surveillance for Pandemic Prevention |
| Organisation | Congo National Institute of Biomedical Research |
| Country | Congo, the Democratic Republic of the |
| Sector | Academic/University |
| PI Contribution | Project Management Coordination of whole consortium Modelling expertise Expertise in lab method development Data analysis Bioinformatics and primer design |
| Collaborator Contribution | Ethics guidance GIS support Lab testing expertise |
| Impact | Publication in Lancet - https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00192-7/fulltext Publication of protocols: https://dx.doi.org/10.17504/protocols.io.j8nlkyj8wg5r/v2 https://dx.doi.org/10.17504/protocols.io.36wgq14qxvk5/v1 https://dx.doi.org/10.17504/protocols.io.rm7vzebq8vx1/v1 |
| Start Year | 2024 |
| Description | WaSPP - Wastewater Surveillance for Pandemic Prevention |
| Organisation | Gadjah Mada University |
| Country | Indonesia |
| Sector | Academic/University |
| PI Contribution | Project Management Coordination of whole consortium Modelling expertise Expertise in lab method development Data analysis Bioinformatics and primer design |
| Collaborator Contribution | Ethics guidance GIS support Lab testing expertise |
| Impact | Publication in Lancet - https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00192-7/fulltext Publication of protocols: https://dx.doi.org/10.17504/protocols.io.j8nlkyj8wg5r/v2 https://dx.doi.org/10.17504/protocols.io.36wgq14qxvk5/v1 https://dx.doi.org/10.17504/protocols.io.rm7vzebq8vx1/v1 |
| Start Year | 2024 |
| Description | WaSPP - Wastewater Surveillance for Pandemic Prevention |
| Organisation | Kwame Nkrumah University of Science and Technology (KNUST) |
| Country | Ghana |
| Sector | Academic/University |
| PI Contribution | Project Management Coordination of whole consortium Modelling expertise Expertise in lab method development Data analysis Bioinformatics and primer design |
| Collaborator Contribution | Ethics guidance GIS support Lab testing expertise |
| Impact | Publication in Lancet - https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00192-7/fulltext Publication of protocols: https://dx.doi.org/10.17504/protocols.io.j8nlkyj8wg5r/v2 https://dx.doi.org/10.17504/protocols.io.36wgq14qxvk5/v1 https://dx.doi.org/10.17504/protocols.io.rm7vzebq8vx1/v1 |
| Start Year | 2024 |
| Description | WaSPP - Wastewater Surveillance for Pandemic Prevention |
| Organisation | Pasteur Institute In Cambodia |
| Country | Cambodia |
| Sector | Public |
| PI Contribution | Project Management Coordination of whole consortium Modelling expertise Expertise in lab method development Data analysis Bioinformatics and primer design |
| Collaborator Contribution | Ethics guidance GIS support Lab testing expertise |
| Impact | Publication in Lancet - https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00192-7/fulltext Publication of protocols: https://dx.doi.org/10.17504/protocols.io.j8nlkyj8wg5r/v2 https://dx.doi.org/10.17504/protocols.io.36wgq14qxvk5/v1 https://dx.doi.org/10.17504/protocols.io.rm7vzebq8vx1/v1 |
| Start Year | 2024 |
| Description | WaSPP - Wastewater Surveillance for Pandemic Prevention |
| Organisation | University of Edinburgh |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project Management Coordination of whole consortium Modelling expertise Expertise in lab method development Data analysis Bioinformatics and primer design |
| Collaborator Contribution | Ethics guidance GIS support Lab testing expertise |
| Impact | Publication in Lancet - https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00192-7/fulltext Publication of protocols: https://dx.doi.org/10.17504/protocols.io.j8nlkyj8wg5r/v2 https://dx.doi.org/10.17504/protocols.io.36wgq14qxvk5/v1 https://dx.doi.org/10.17504/protocols.io.rm7vzebq8vx1/v1 |
| Start Year | 2024 |
| Description | WaSPP - Wastewater Surveillance for Pandemic Prevention |
| Organisation | University of Malaya |
| Country | Malaysia |
| Sector | Academic/University |
| PI Contribution | Project Management Coordination of whole consortium Modelling expertise Expertise in lab method development Data analysis Bioinformatics and primer design |
| Collaborator Contribution | Ethics guidance GIS support Lab testing expertise |
| Impact | Publication in Lancet - https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00192-7/fulltext Publication of protocols: https://dx.doi.org/10.17504/protocols.io.j8nlkyj8wg5r/v2 https://dx.doi.org/10.17504/protocols.io.36wgq14qxvk5/v1 https://dx.doi.org/10.17504/protocols.io.rm7vzebq8vx1/v1 |
| Start Year | 2024 |
| Description | xSTAR - multiplex Serology Testing and Analysis Platform (228185/Z/23/Z) |
| Organisation | Armauer Hansen Research Institute |
| Country | Ethiopia |
| Sector | Charity/Non Profit |
| PI Contribution | Leading the design and implementation of a new multiplex assay to evaluate arbovirus seroprevalence across 8 African countries and the development of mathematical models to interpret the assay results and generate risk maps of transmission intensity. Specifically, we are leading and managing the project, leading the development of the study design and mathematical models and coordinating the publication and communication of the results. |
| Collaborator Contribution | The partners of this project are: - Imperial College London, SPH building, White City Campus, Wood Lane, London (UK) -ARMAUER HANSEN RESEARCH INSTITUTE (Ethiopia). Address: ALERT Compound, Jimma Road, P. o. Box 1005, Addis Ababa, Ethiopia. Website: https://ahri.gov.et/about-2/location/. -UNIVERSITY OF CAMBRIDGE. Address: The Old Schools, Trinity Lane, Cambridge, CB2 1TN, United Kingdom. -UNIVERSITY OF ILORIN (Nigeria). Address: P.M.B 1515, Ilorin, Nigeria. Website: https://www.unilorin.edu.ng/. -IDRC - Infectious Diseases Research Collaboration (Uganda). Address: Plot 2C Nakasero Hill Road, P.O. Box 7475 Kampala, Uganda. Website: https://www.idrc-uganda.org/. -FORS - Fondation pour la recherche Scientifique (Benin). Address: ISBA, Département du Littoral, commune de Cotonou, BP : 88 Cotonou, Bénin. Website: https://forsbenin.org/. -NLoPH - NATIONAL LABORATORY OF PUBLIC HEALTH - Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF, Gabon) . Address: P.O. BOX: 769 1er Arrondissement, Ecole conventionnée Franceville-GABON. Website: https://www.cirmf-gabon.com/. -IPDK - FONDATION INSTITUT PASTEUR DE DAKAR (Dakar, Senegal). Address: 36 Avenue Pasteur BP220, Dakar, Senegal, NINEA 0230020A0. Website: https://institutpasteurdakar.sn/. -IPDM - INSTITUT PASTEUR DE MADAGASCAR. Address: B. P. 1274 Ambatofotsikely Avaradoha, 101 - Antananarivo, Madagascar. Website: https://www.pasteur.mg/. -KCMUCo - KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE (Tanzania). Address: Longuo B, within the Kilimamjaro Christian Medical Centre (KCMC) Hospital, opposite Sokoine Road, Moshi, Kilimanjaro, Tanzania. Website: https://kcmuco.ac.tz/. -UoL- UNIVERSITY OF LOME (Togo). Address: Campus Universitaire and the CFSRP, the research branch, PO BOX 1515, Lome, Togo. Website: https://univ-lome.tg/, -LSHTM - London School of Hygiene and Tropical Medicine. Address: Keppel Street, Londoon WC1E 7HT, United Kingdom. Website: https://www.lshtm.ac.uk/. -IPP - INSTITUT PASTEUR PARIS. Address: 28 rue due Docteur Roux, 75015, Paris France. Website: https://www.pasteur.fr/en IPP leads the assay development and laboratory implementation. The University of Cambridge contributed to the development of mathematical models. IPD will be responsible for cross-validation of the multiplex assay results by performing a Plaque Reduction Neutralization Test on a subset of the samples. All other partners contribute to the project by testing in-house blood samples using the multiplex assay developed at IPP. |
| Impact | The project has started in Feb 2024 (first spending Oct 2024). To date, all contracts are in place, the recruitment of a PM and modeller has been completed, we have set up regular meetings and scheduled monthly all-group and fortnightly group-specific meetings including meetings with the Steering Committee. |
| Start Year | 2024 |
| Description | xSTAR - multiplex Serology Testing and Analysis Platform (228185/Z/23/Z) |
| Organisation | Infectious Diseases Research Collaboration (IDRC) |
| Country | Uganda |
| Sector | Academic/University |
| PI Contribution | Leading the design and implementation of a new multiplex assay to evaluate arbovirus seroprevalence across 8 African countries and the development of mathematical models to interpret the assay results and generate risk maps of transmission intensity. Specifically, we are leading and managing the project, leading the development of the study design and mathematical models and coordinating the publication and communication of the results. |
| Collaborator Contribution | The partners of this project are: - Imperial College London, SPH building, White City Campus, Wood Lane, London (UK) -ARMAUER HANSEN RESEARCH INSTITUTE (Ethiopia). Address: ALERT Compound, Jimma Road, P. o. Box 1005, Addis Ababa, Ethiopia. Website: https://ahri.gov.et/about-2/location/. -UNIVERSITY OF CAMBRIDGE. Address: The Old Schools, Trinity Lane, Cambridge, CB2 1TN, United Kingdom. -UNIVERSITY OF ILORIN (Nigeria). Address: P.M.B 1515, Ilorin, Nigeria. Website: https://www.unilorin.edu.ng/. -IDRC - Infectious Diseases Research Collaboration (Uganda). Address: Plot 2C Nakasero Hill Road, P.O. Box 7475 Kampala, Uganda. Website: https://www.idrc-uganda.org/. -FORS - Fondation pour la recherche Scientifique (Benin). Address: ISBA, Département du Littoral, commune de Cotonou, BP : 88 Cotonou, Bénin. Website: https://forsbenin.org/. -NLoPH - NATIONAL LABORATORY OF PUBLIC HEALTH - Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF, Gabon) . Address: P.O. BOX: 769 1er Arrondissement, Ecole conventionnée Franceville-GABON. Website: https://www.cirmf-gabon.com/. -IPDK - FONDATION INSTITUT PASTEUR DE DAKAR (Dakar, Senegal). Address: 36 Avenue Pasteur BP220, Dakar, Senegal, NINEA 0230020A0. Website: https://institutpasteurdakar.sn/. -IPDM - INSTITUT PASTEUR DE MADAGASCAR. Address: B. P. 1274 Ambatofotsikely Avaradoha, 101 - Antananarivo, Madagascar. Website: https://www.pasteur.mg/. -KCMUCo - KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE (Tanzania). Address: Longuo B, within the Kilimamjaro Christian Medical Centre (KCMC) Hospital, opposite Sokoine Road, Moshi, Kilimanjaro, Tanzania. Website: https://kcmuco.ac.tz/. -UoL- UNIVERSITY OF LOME (Togo). Address: Campus Universitaire and the CFSRP, the research branch, PO BOX 1515, Lome, Togo. Website: https://univ-lome.tg/, -LSHTM - London School of Hygiene and Tropical Medicine. Address: Keppel Street, Londoon WC1E 7HT, United Kingdom. Website: https://www.lshtm.ac.uk/. -IPP - INSTITUT PASTEUR PARIS. Address: 28 rue due Docteur Roux, 75015, Paris France. Website: https://www.pasteur.fr/en IPP leads the assay development and laboratory implementation. The University of Cambridge contributed to the development of mathematical models. IPD will be responsible for cross-validation of the multiplex assay results by performing a Plaque Reduction Neutralization Test on a subset of the samples. All other partners contribute to the project by testing in-house blood samples using the multiplex assay developed at IPP. |
| Impact | The project has started in Feb 2024 (first spending Oct 2024). To date, all contracts are in place, the recruitment of a PM and modeller has been completed, we have set up regular meetings and scheduled monthly all-group and fortnightly group-specific meetings including meetings with the Steering Committee. |
| Start Year | 2024 |
| Description | xSTAR - multiplex Serology Testing and Analysis Platform (228185/Z/23/Z) |
| Organisation | Kilimanjaro Christian Medical University College |
| Country | Tanzania, United Republic of |
| Sector | Academic/University |
| PI Contribution | Leading the design and implementation of a new multiplex assay to evaluate arbovirus seroprevalence across 8 African countries and the development of mathematical models to interpret the assay results and generate risk maps of transmission intensity. Specifically, we are leading and managing the project, leading the development of the study design and mathematical models and coordinating the publication and communication of the results. |
| Collaborator Contribution | The partners of this project are: - Imperial College London, SPH building, White City Campus, Wood Lane, London (UK) -ARMAUER HANSEN RESEARCH INSTITUTE (Ethiopia). Address: ALERT Compound, Jimma Road, P. o. Box 1005, Addis Ababa, Ethiopia. Website: https://ahri.gov.et/about-2/location/. -UNIVERSITY OF CAMBRIDGE. Address: The Old Schools, Trinity Lane, Cambridge, CB2 1TN, United Kingdom. -UNIVERSITY OF ILORIN (Nigeria). Address: P.M.B 1515, Ilorin, Nigeria. Website: https://www.unilorin.edu.ng/. -IDRC - Infectious Diseases Research Collaboration (Uganda). Address: Plot 2C Nakasero Hill Road, P.O. Box 7475 Kampala, Uganda. Website: https://www.idrc-uganda.org/. -FORS - Fondation pour la recherche Scientifique (Benin). Address: ISBA, Département du Littoral, commune de Cotonou, BP : 88 Cotonou, Bénin. Website: https://forsbenin.org/. -NLoPH - NATIONAL LABORATORY OF PUBLIC HEALTH - Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF, Gabon) . Address: P.O. BOX: 769 1er Arrondissement, Ecole conventionnée Franceville-GABON. Website: https://www.cirmf-gabon.com/. -IPDK - FONDATION INSTITUT PASTEUR DE DAKAR (Dakar, Senegal). Address: 36 Avenue Pasteur BP220, Dakar, Senegal, NINEA 0230020A0. Website: https://institutpasteurdakar.sn/. -IPDM - INSTITUT PASTEUR DE MADAGASCAR. Address: B. P. 1274 Ambatofotsikely Avaradoha, 101 - Antananarivo, Madagascar. Website: https://www.pasteur.mg/. -KCMUCo - KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE (Tanzania). Address: Longuo B, within the Kilimamjaro Christian Medical Centre (KCMC) Hospital, opposite Sokoine Road, Moshi, Kilimanjaro, Tanzania. Website: https://kcmuco.ac.tz/. -UoL- UNIVERSITY OF LOME (Togo). Address: Campus Universitaire and the CFSRP, the research branch, PO BOX 1515, Lome, Togo. Website: https://univ-lome.tg/, -LSHTM - London School of Hygiene and Tropical Medicine. Address: Keppel Street, Londoon WC1E 7HT, United Kingdom. Website: https://www.lshtm.ac.uk/. -IPP - INSTITUT PASTEUR PARIS. Address: 28 rue due Docteur Roux, 75015, Paris France. Website: https://www.pasteur.fr/en IPP leads the assay development and laboratory implementation. The University of Cambridge contributed to the development of mathematical models. IPD will be responsible for cross-validation of the multiplex assay results by performing a Plaque Reduction Neutralization Test on a subset of the samples. All other partners contribute to the project by testing in-house blood samples using the multiplex assay developed at IPP. |
| Impact | The project has started in Feb 2024 (first spending Oct 2024). To date, all contracts are in place, the recruitment of a PM and modeller has been completed, we have set up regular meetings and scheduled monthly all-group and fortnightly group-specific meetings including meetings with the Steering Committee. |
| Start Year | 2024 |
| Description | xSTAR - multiplex Serology Testing and Analysis Platform (228185/Z/23/Z) |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Leading the design and implementation of a new multiplex assay to evaluate arbovirus seroprevalence across 8 African countries and the development of mathematical models to interpret the assay results and generate risk maps of transmission intensity. Specifically, we are leading and managing the project, leading the development of the study design and mathematical models and coordinating the publication and communication of the results. |
| Collaborator Contribution | The partners of this project are: - Imperial College London, SPH building, White City Campus, Wood Lane, London (UK) -ARMAUER HANSEN RESEARCH INSTITUTE (Ethiopia). Address: ALERT Compound, Jimma Road, P. o. Box 1005, Addis Ababa, Ethiopia. Website: https://ahri.gov.et/about-2/location/. -UNIVERSITY OF CAMBRIDGE. Address: The Old Schools, Trinity Lane, Cambridge, CB2 1TN, United Kingdom. -UNIVERSITY OF ILORIN (Nigeria). Address: P.M.B 1515, Ilorin, Nigeria. Website: https://www.unilorin.edu.ng/. -IDRC - Infectious Diseases Research Collaboration (Uganda). Address: Plot 2C Nakasero Hill Road, P.O. Box 7475 Kampala, Uganda. Website: https://www.idrc-uganda.org/. -FORS - Fondation pour la recherche Scientifique (Benin). Address: ISBA, Département du Littoral, commune de Cotonou, BP : 88 Cotonou, Bénin. Website: https://forsbenin.org/. -NLoPH - NATIONAL LABORATORY OF PUBLIC HEALTH - Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF, Gabon) . Address: P.O. BOX: 769 1er Arrondissement, Ecole conventionnée Franceville-GABON. Website: https://www.cirmf-gabon.com/. -IPDK - FONDATION INSTITUT PASTEUR DE DAKAR (Dakar, Senegal). Address: 36 Avenue Pasteur BP220, Dakar, Senegal, NINEA 0230020A0. Website: https://institutpasteurdakar.sn/. -IPDM - INSTITUT PASTEUR DE MADAGASCAR. Address: B. P. 1274 Ambatofotsikely Avaradoha, 101 - Antananarivo, Madagascar. Website: https://www.pasteur.mg/. -KCMUCo - KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE (Tanzania). Address: Longuo B, within the Kilimamjaro Christian Medical Centre (KCMC) Hospital, opposite Sokoine Road, Moshi, Kilimanjaro, Tanzania. Website: https://kcmuco.ac.tz/. -UoL- UNIVERSITY OF LOME (Togo). Address: Campus Universitaire and the CFSRP, the research branch, PO BOX 1515, Lome, Togo. Website: https://univ-lome.tg/, -LSHTM - London School of Hygiene and Tropical Medicine. Address: Keppel Street, Londoon WC1E 7HT, United Kingdom. Website: https://www.lshtm.ac.uk/. -IPP - INSTITUT PASTEUR PARIS. Address: 28 rue due Docteur Roux, 75015, Paris France. Website: https://www.pasteur.fr/en IPP leads the assay development and laboratory implementation. The University of Cambridge contributed to the development of mathematical models. IPD will be responsible for cross-validation of the multiplex assay results by performing a Plaque Reduction Neutralization Test on a subset of the samples. All other partners contribute to the project by testing in-house blood samples using the multiplex assay developed at IPP. |
| Impact | The project has started in Feb 2024 (first spending Oct 2024). To date, all contracts are in place, the recruitment of a PM and modeller has been completed, we have set up regular meetings and scheduled monthly all-group and fortnightly group-specific meetings including meetings with the Steering Committee. |
| Start Year | 2024 |
| Description | xSTAR - multiplex Serology Testing and Analysis Platform (228185/Z/23/Z) |
| Organisation | Pasteur Institute Dakar |
| Country | Senegal |
| Sector | Charity/Non Profit |
| PI Contribution | Leading the design and implementation of a new multiplex assay to evaluate arbovirus seroprevalence across 8 African countries and the development of mathematical models to interpret the assay results and generate risk maps of transmission intensity. Specifically, we are leading and managing the project, leading the development of the study design and mathematical models and coordinating the publication and communication of the results. |
| Collaborator Contribution | The partners of this project are: - Imperial College London, SPH building, White City Campus, Wood Lane, London (UK) -ARMAUER HANSEN RESEARCH INSTITUTE (Ethiopia). Address: ALERT Compound, Jimma Road, P. o. Box 1005, Addis Ababa, Ethiopia. Website: https://ahri.gov.et/about-2/location/. -UNIVERSITY OF CAMBRIDGE. Address: The Old Schools, Trinity Lane, Cambridge, CB2 1TN, United Kingdom. -UNIVERSITY OF ILORIN (Nigeria). Address: P.M.B 1515, Ilorin, Nigeria. Website: https://www.unilorin.edu.ng/. -IDRC - Infectious Diseases Research Collaboration (Uganda). Address: Plot 2C Nakasero Hill Road, P.O. Box 7475 Kampala, Uganda. Website: https://www.idrc-uganda.org/. -FORS - Fondation pour la recherche Scientifique (Benin). Address: ISBA, Département du Littoral, commune de Cotonou, BP : 88 Cotonou, Bénin. Website: https://forsbenin.org/. -NLoPH - NATIONAL LABORATORY OF PUBLIC HEALTH - Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF, Gabon) . Address: P.O. BOX: 769 1er Arrondissement, Ecole conventionnée Franceville-GABON. Website: https://www.cirmf-gabon.com/. -IPDK - FONDATION INSTITUT PASTEUR DE DAKAR (Dakar, Senegal). Address: 36 Avenue Pasteur BP220, Dakar, Senegal, NINEA 0230020A0. Website: https://institutpasteurdakar.sn/. -IPDM - INSTITUT PASTEUR DE MADAGASCAR. Address: B. P. 1274 Ambatofotsikely Avaradoha, 101 - Antananarivo, Madagascar. Website: https://www.pasteur.mg/. -KCMUCo - KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE (Tanzania). Address: Longuo B, within the Kilimamjaro Christian Medical Centre (KCMC) Hospital, opposite Sokoine Road, Moshi, Kilimanjaro, Tanzania. Website: https://kcmuco.ac.tz/. -UoL- UNIVERSITY OF LOME (Togo). Address: Campus Universitaire and the CFSRP, the research branch, PO BOX 1515, Lome, Togo. Website: https://univ-lome.tg/, -LSHTM - London School of Hygiene and Tropical Medicine. Address: Keppel Street, Londoon WC1E 7HT, United Kingdom. Website: https://www.lshtm.ac.uk/. -IPP - INSTITUT PASTEUR PARIS. Address: 28 rue due Docteur Roux, 75015, Paris France. Website: https://www.pasteur.fr/en IPP leads the assay development and laboratory implementation. The University of Cambridge contributed to the development of mathematical models. IPD will be responsible for cross-validation of the multiplex assay results by performing a Plaque Reduction Neutralization Test on a subset of the samples. All other partners contribute to the project by testing in-house blood samples using the multiplex assay developed at IPP. |
| Impact | The project has started in Feb 2024 (first spending Oct 2024). To date, all contracts are in place, the recruitment of a PM and modeller has been completed, we have set up regular meetings and scheduled monthly all-group and fortnightly group-specific meetings including meetings with the Steering Committee. |
| Start Year | 2024 |
| Description | xSTAR - multiplex Serology Testing and Analysis Platform (228185/Z/23/Z) |
| Organisation | Pasteur Institute of Madagascar |
| Country | Madagascar |
| Sector | Academic/University |
| PI Contribution | Leading the design and implementation of a new multiplex assay to evaluate arbovirus seroprevalence across 8 African countries and the development of mathematical models to interpret the assay results and generate risk maps of transmission intensity. Specifically, we are leading and managing the project, leading the development of the study design and mathematical models and coordinating the publication and communication of the results. |
| Collaborator Contribution | The partners of this project are: - Imperial College London, SPH building, White City Campus, Wood Lane, London (UK) -ARMAUER HANSEN RESEARCH INSTITUTE (Ethiopia). Address: ALERT Compound, Jimma Road, P. o. Box 1005, Addis Ababa, Ethiopia. Website: https://ahri.gov.et/about-2/location/. -UNIVERSITY OF CAMBRIDGE. Address: The Old Schools, Trinity Lane, Cambridge, CB2 1TN, United Kingdom. -UNIVERSITY OF ILORIN (Nigeria). Address: P.M.B 1515, Ilorin, Nigeria. Website: https://www.unilorin.edu.ng/. -IDRC - Infectious Diseases Research Collaboration (Uganda). Address: Plot 2C Nakasero Hill Road, P.O. Box 7475 Kampala, Uganda. Website: https://www.idrc-uganda.org/. -FORS - Fondation pour la recherche Scientifique (Benin). Address: ISBA, Département du Littoral, commune de Cotonou, BP : 88 Cotonou, Bénin. Website: https://forsbenin.org/. -NLoPH - NATIONAL LABORATORY OF PUBLIC HEALTH - Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF, Gabon) . Address: P.O. BOX: 769 1er Arrondissement, Ecole conventionnée Franceville-GABON. Website: https://www.cirmf-gabon.com/. -IPDK - FONDATION INSTITUT PASTEUR DE DAKAR (Dakar, Senegal). Address: 36 Avenue Pasteur BP220, Dakar, Senegal, NINEA 0230020A0. Website: https://institutpasteurdakar.sn/. -IPDM - INSTITUT PASTEUR DE MADAGASCAR. Address: B. P. 1274 Ambatofotsikely Avaradoha, 101 - Antananarivo, Madagascar. Website: https://www.pasteur.mg/. -KCMUCo - KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE (Tanzania). Address: Longuo B, within the Kilimamjaro Christian Medical Centre (KCMC) Hospital, opposite Sokoine Road, Moshi, Kilimanjaro, Tanzania. Website: https://kcmuco.ac.tz/. -UoL- UNIVERSITY OF LOME (Togo). Address: Campus Universitaire and the CFSRP, the research branch, PO BOX 1515, Lome, Togo. Website: https://univ-lome.tg/, -LSHTM - London School of Hygiene and Tropical Medicine. Address: Keppel Street, Londoon WC1E 7HT, United Kingdom. Website: https://www.lshtm.ac.uk/. -IPP - INSTITUT PASTEUR PARIS. Address: 28 rue due Docteur Roux, 75015, Paris France. Website: https://www.pasteur.fr/en IPP leads the assay development and laboratory implementation. The University of Cambridge contributed to the development of mathematical models. IPD will be responsible for cross-validation of the multiplex assay results by performing a Plaque Reduction Neutralization Test on a subset of the samples. All other partners contribute to the project by testing in-house blood samples using the multiplex assay developed at IPP. |
| Impact | The project has started in Feb 2024 (first spending Oct 2024). To date, all contracts are in place, the recruitment of a PM and modeller has been completed, we have set up regular meetings and scheduled monthly all-group and fortnightly group-specific meetings including meetings with the Steering Committee. |
| Start Year | 2024 |
| Description | xSTAR - multiplex Serology Testing and Analysis Platform (228185/Z/23/Z) |
| Organisation | Pasteur Institute, Paris |
| Country | France |
| Sector | Charity/Non Profit |
| PI Contribution | Leading the design and implementation of a new multiplex assay to evaluate arbovirus seroprevalence across 8 African countries and the development of mathematical models to interpret the assay results and generate risk maps of transmission intensity. Specifically, we are leading and managing the project, leading the development of the study design and mathematical models and coordinating the publication and communication of the results. |
| Collaborator Contribution | The partners of this project are: - Imperial College London, SPH building, White City Campus, Wood Lane, London (UK) -ARMAUER HANSEN RESEARCH INSTITUTE (Ethiopia). Address: ALERT Compound, Jimma Road, P. o. Box 1005, Addis Ababa, Ethiopia. Website: https://ahri.gov.et/about-2/location/. -UNIVERSITY OF CAMBRIDGE. Address: The Old Schools, Trinity Lane, Cambridge, CB2 1TN, United Kingdom. -UNIVERSITY OF ILORIN (Nigeria). Address: P.M.B 1515, Ilorin, Nigeria. Website: https://www.unilorin.edu.ng/. -IDRC - Infectious Diseases Research Collaboration (Uganda). Address: Plot 2C Nakasero Hill Road, P.O. Box 7475 Kampala, Uganda. Website: https://www.idrc-uganda.org/. -FORS - Fondation pour la recherche Scientifique (Benin). Address: ISBA, Département du Littoral, commune de Cotonou, BP : 88 Cotonou, Bénin. Website: https://forsbenin.org/. -NLoPH - NATIONAL LABORATORY OF PUBLIC HEALTH - Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF, Gabon) . Address: P.O. BOX: 769 1er Arrondissement, Ecole conventionnée Franceville-GABON. Website: https://www.cirmf-gabon.com/. -IPDK - FONDATION INSTITUT PASTEUR DE DAKAR (Dakar, Senegal). Address: 36 Avenue Pasteur BP220, Dakar, Senegal, NINEA 0230020A0. Website: https://institutpasteurdakar.sn/. -IPDM - INSTITUT PASTEUR DE MADAGASCAR. Address: B. P. 1274 Ambatofotsikely Avaradoha, 101 - Antananarivo, Madagascar. Website: https://www.pasteur.mg/. -KCMUCo - KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE (Tanzania). Address: Longuo B, within the Kilimamjaro Christian Medical Centre (KCMC) Hospital, opposite Sokoine Road, Moshi, Kilimanjaro, Tanzania. Website: https://kcmuco.ac.tz/. -UoL- UNIVERSITY OF LOME (Togo). Address: Campus Universitaire and the CFSRP, the research branch, PO BOX 1515, Lome, Togo. Website: https://univ-lome.tg/, -LSHTM - London School of Hygiene and Tropical Medicine. Address: Keppel Street, Londoon WC1E 7HT, United Kingdom. Website: https://www.lshtm.ac.uk/. -IPP - INSTITUT PASTEUR PARIS. Address: 28 rue due Docteur Roux, 75015, Paris France. Website: https://www.pasteur.fr/en IPP leads the assay development and laboratory implementation. The University of Cambridge contributed to the development of mathematical models. IPD will be responsible for cross-validation of the multiplex assay results by performing a Plaque Reduction Neutralization Test on a subset of the samples. All other partners contribute to the project by testing in-house blood samples using the multiplex assay developed at IPP. |
| Impact | The project has started in Feb 2024 (first spending Oct 2024). To date, all contracts are in place, the recruitment of a PM and modeller has been completed, we have set up regular meetings and scheduled monthly all-group and fortnightly group-specific meetings including meetings with the Steering Committee. |
| Start Year | 2024 |
| Description | xSTAR - multiplex Serology Testing and Analysis Platform (228185/Z/23/Z) |
| Organisation | University of Cambridge |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Leading the design and implementation of a new multiplex assay to evaluate arbovirus seroprevalence across 8 African countries and the development of mathematical models to interpret the assay results and generate risk maps of transmission intensity. Specifically, we are leading and managing the project, leading the development of the study design and mathematical models and coordinating the publication and communication of the results. |
| Collaborator Contribution | The partners of this project are: - Imperial College London, SPH building, White City Campus, Wood Lane, London (UK) -ARMAUER HANSEN RESEARCH INSTITUTE (Ethiopia). Address: ALERT Compound, Jimma Road, P. o. Box 1005, Addis Ababa, Ethiopia. Website: https://ahri.gov.et/about-2/location/. -UNIVERSITY OF CAMBRIDGE. Address: The Old Schools, Trinity Lane, Cambridge, CB2 1TN, United Kingdom. -UNIVERSITY OF ILORIN (Nigeria). Address: P.M.B 1515, Ilorin, Nigeria. Website: https://www.unilorin.edu.ng/. -IDRC - Infectious Diseases Research Collaboration (Uganda). Address: Plot 2C Nakasero Hill Road, P.O. Box 7475 Kampala, Uganda. Website: https://www.idrc-uganda.org/. -FORS - Fondation pour la recherche Scientifique (Benin). Address: ISBA, Département du Littoral, commune de Cotonou, BP : 88 Cotonou, Bénin. Website: https://forsbenin.org/. -NLoPH - NATIONAL LABORATORY OF PUBLIC HEALTH - Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF, Gabon) . Address: P.O. BOX: 769 1er Arrondissement, Ecole conventionnée Franceville-GABON. Website: https://www.cirmf-gabon.com/. -IPDK - FONDATION INSTITUT PASTEUR DE DAKAR (Dakar, Senegal). Address: 36 Avenue Pasteur BP220, Dakar, Senegal, NINEA 0230020A0. Website: https://institutpasteurdakar.sn/. -IPDM - INSTITUT PASTEUR DE MADAGASCAR. Address: B. P. 1274 Ambatofotsikely Avaradoha, 101 - Antananarivo, Madagascar. Website: https://www.pasteur.mg/. -KCMUCo - KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE (Tanzania). Address: Longuo B, within the Kilimamjaro Christian Medical Centre (KCMC) Hospital, opposite Sokoine Road, Moshi, Kilimanjaro, Tanzania. Website: https://kcmuco.ac.tz/. -UoL- UNIVERSITY OF LOME (Togo). Address: Campus Universitaire and the CFSRP, the research branch, PO BOX 1515, Lome, Togo. Website: https://univ-lome.tg/, -LSHTM - London School of Hygiene and Tropical Medicine. Address: Keppel Street, Londoon WC1E 7HT, United Kingdom. Website: https://www.lshtm.ac.uk/. -IPP - INSTITUT PASTEUR PARIS. Address: 28 rue due Docteur Roux, 75015, Paris France. Website: https://www.pasteur.fr/en IPP leads the assay development and laboratory implementation. The University of Cambridge contributed to the development of mathematical models. IPD will be responsible for cross-validation of the multiplex assay results by performing a Plaque Reduction Neutralization Test on a subset of the samples. All other partners contribute to the project by testing in-house blood samples using the multiplex assay developed at IPP. |
| Impact | The project has started in Feb 2024 (first spending Oct 2024). To date, all contracts are in place, the recruitment of a PM and modeller has been completed, we have set up regular meetings and scheduled monthly all-group and fortnightly group-specific meetings including meetings with the Steering Committee. |
| Start Year | 2024 |
| Description | xSTAR - multiplex Serology Testing and Analysis Platform (228185/Z/23/Z) |
| Organisation | University of Ilorin |
| Country | Nigeria |
| Sector | Academic/University |
| PI Contribution | Leading the design and implementation of a new multiplex assay to evaluate arbovirus seroprevalence across 8 African countries and the development of mathematical models to interpret the assay results and generate risk maps of transmission intensity. Specifically, we are leading and managing the project, leading the development of the study design and mathematical models and coordinating the publication and communication of the results. |
| Collaborator Contribution | The partners of this project are: - Imperial College London, SPH building, White City Campus, Wood Lane, London (UK) -ARMAUER HANSEN RESEARCH INSTITUTE (Ethiopia). Address: ALERT Compound, Jimma Road, P. o. Box 1005, Addis Ababa, Ethiopia. Website: https://ahri.gov.et/about-2/location/. -UNIVERSITY OF CAMBRIDGE. Address: The Old Schools, Trinity Lane, Cambridge, CB2 1TN, United Kingdom. -UNIVERSITY OF ILORIN (Nigeria). Address: P.M.B 1515, Ilorin, Nigeria. Website: https://www.unilorin.edu.ng/. -IDRC - Infectious Diseases Research Collaboration (Uganda). Address: Plot 2C Nakasero Hill Road, P.O. Box 7475 Kampala, Uganda. Website: https://www.idrc-uganda.org/. -FORS - Fondation pour la recherche Scientifique (Benin). Address: ISBA, Département du Littoral, commune de Cotonou, BP : 88 Cotonou, Bénin. Website: https://forsbenin.org/. -NLoPH - NATIONAL LABORATORY OF PUBLIC HEALTH - Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF, Gabon) . Address: P.O. BOX: 769 1er Arrondissement, Ecole conventionnée Franceville-GABON. Website: https://www.cirmf-gabon.com/. -IPDK - FONDATION INSTITUT PASTEUR DE DAKAR (Dakar, Senegal). Address: 36 Avenue Pasteur BP220, Dakar, Senegal, NINEA 0230020A0. Website: https://institutpasteurdakar.sn/. -IPDM - INSTITUT PASTEUR DE MADAGASCAR. Address: B. P. 1274 Ambatofotsikely Avaradoha, 101 - Antananarivo, Madagascar. Website: https://www.pasteur.mg/. -KCMUCo - KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE (Tanzania). Address: Longuo B, within the Kilimamjaro Christian Medical Centre (KCMC) Hospital, opposite Sokoine Road, Moshi, Kilimanjaro, Tanzania. Website: https://kcmuco.ac.tz/. -UoL- UNIVERSITY OF LOME (Togo). Address: Campus Universitaire and the CFSRP, the research branch, PO BOX 1515, Lome, Togo. Website: https://univ-lome.tg/, -LSHTM - London School of Hygiene and Tropical Medicine. Address: Keppel Street, Londoon WC1E 7HT, United Kingdom. Website: https://www.lshtm.ac.uk/. -IPP - INSTITUT PASTEUR PARIS. Address: 28 rue due Docteur Roux, 75015, Paris France. Website: https://www.pasteur.fr/en IPP leads the assay development and laboratory implementation. The University of Cambridge contributed to the development of mathematical models. IPD will be responsible for cross-validation of the multiplex assay results by performing a Plaque Reduction Neutralization Test on a subset of the samples. All other partners contribute to the project by testing in-house blood samples using the multiplex assay developed at IPP. |
| Impact | The project has started in Feb 2024 (first spending Oct 2024). To date, all contracts are in place, the recruitment of a PM and modeller has been completed, we have set up regular meetings and scheduled monthly all-group and fortnightly group-specific meetings including meetings with the Steering Committee. |
| Start Year | 2024 |
| Description | xSTAR - multiplex Serology Testing and Analysis Platform (228185/Z/23/Z) |
| Organisation | University of Lomé |
| Country | Togo |
| Sector | Academic/University |
| PI Contribution | Leading the design and implementation of a new multiplex assay to evaluate arbovirus seroprevalence across 8 African countries and the development of mathematical models to interpret the assay results and generate risk maps of transmission intensity. Specifically, we are leading and managing the project, leading the development of the study design and mathematical models and coordinating the publication and communication of the results. |
| Collaborator Contribution | The partners of this project are: - Imperial College London, SPH building, White City Campus, Wood Lane, London (UK) -ARMAUER HANSEN RESEARCH INSTITUTE (Ethiopia). Address: ALERT Compound, Jimma Road, P. o. Box 1005, Addis Ababa, Ethiopia. Website: https://ahri.gov.et/about-2/location/. -UNIVERSITY OF CAMBRIDGE. Address: The Old Schools, Trinity Lane, Cambridge, CB2 1TN, United Kingdom. -UNIVERSITY OF ILORIN (Nigeria). Address: P.M.B 1515, Ilorin, Nigeria. Website: https://www.unilorin.edu.ng/. -IDRC - Infectious Diseases Research Collaboration (Uganda). Address: Plot 2C Nakasero Hill Road, P.O. Box 7475 Kampala, Uganda. Website: https://www.idrc-uganda.org/. -FORS - Fondation pour la recherche Scientifique (Benin). Address: ISBA, Département du Littoral, commune de Cotonou, BP : 88 Cotonou, Bénin. Website: https://forsbenin.org/. -NLoPH - NATIONAL LABORATORY OF PUBLIC HEALTH - Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF, Gabon) . Address: P.O. BOX: 769 1er Arrondissement, Ecole conventionnée Franceville-GABON. Website: https://www.cirmf-gabon.com/. -IPDK - FONDATION INSTITUT PASTEUR DE DAKAR (Dakar, Senegal). Address: 36 Avenue Pasteur BP220, Dakar, Senegal, NINEA 0230020A0. Website: https://institutpasteurdakar.sn/. -IPDM - INSTITUT PASTEUR DE MADAGASCAR. Address: B. P. 1274 Ambatofotsikely Avaradoha, 101 - Antananarivo, Madagascar. Website: https://www.pasteur.mg/. -KCMUCo - KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE (Tanzania). Address: Longuo B, within the Kilimamjaro Christian Medical Centre (KCMC) Hospital, opposite Sokoine Road, Moshi, Kilimanjaro, Tanzania. Website: https://kcmuco.ac.tz/. -UoL- UNIVERSITY OF LOME (Togo). Address: Campus Universitaire and the CFSRP, the research branch, PO BOX 1515, Lome, Togo. Website: https://univ-lome.tg/, -LSHTM - London School of Hygiene and Tropical Medicine. Address: Keppel Street, Londoon WC1E 7HT, United Kingdom. Website: https://www.lshtm.ac.uk/. -IPP - INSTITUT PASTEUR PARIS. Address: 28 rue due Docteur Roux, 75015, Paris France. Website: https://www.pasteur.fr/en IPP leads the assay development and laboratory implementation. The University of Cambridge contributed to the development of mathematical models. IPD will be responsible for cross-validation of the multiplex assay results by performing a Plaque Reduction Neutralization Test on a subset of the samples. All other partners contribute to the project by testing in-house blood samples using the multiplex assay developed at IPP. |
| Impact | The project has started in Feb 2024 (first spending Oct 2024). To date, all contracts are in place, the recruitment of a PM and modeller has been completed, we have set up regular meetings and scheduled monthly all-group and fortnightly group-specific meetings including meetings with the Steering Committee. |
| Start Year | 2024 |
| Title | IMPERATIVE |
| Description | Intervention to distribute and promote men's use of HIV self-test kits and uptake of pre-exposure prophylaxis through their local peer networks. |
| Type | Preventative Intervention - Behavioural risk modification |
| Current Stage Of Development | Refinement. Non-clinical |
| Year Development Stage Completed | 2026 |
| Development Status | Under active development/distribution |
| Impact | Community-randomised control trial of the behavioural intervention is currently in progress |
| Title | Additional file 1 of BenchAMRking: a Galaxy-based platform for illustrating the major issues associated with current antimicrobial resistance (AMR) gene prediction workflows |
| Description | Supplementary Material 1 |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Open Source License? | Yes |
| URL | https://springernature.figshare.com/articles/software/Additional_file_1_of_BenchAMRking_a_Galaxy-bas... |
| Title | COVID-HIV study portal |
| Description | Portal to provide information for the survey management and access to real time results from the survey |
| Type Of Technology | Webtool/Application |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | Enabled research team to provide monthly reports on COVID and how COVID was preventing HIV risks and preventions to the Government of Zimbabwe on a real time basis |
| URL | http://www.manicalandhivproject.org/resources.html |
| Title | Coalescent.jl v 0.1.4 |
| Description | Coalescent.jl is a package for simulation of coalescent genealogical histories with a flexible markup language for conditioning on demographic history. This package can be used as a building-block in pipelines for simulation-based inference in population genetics research. The focus of this package is on support for simulation under demographic histories featuring nonlinear dynamics, potentially complex state spaces, and complex sampling over time. This makes the package especially relevent for studies of pathogen evolution, but other applications are possible. A design goal of Coalescent.jl is to enable fast and memory-efficient simulation of very large coalescent trees. |
| Type Of Technology | Software |
| Year Produced | 2024 |
| Open Source License? | Yes |
| Impact | This package is being used as a building block in novel simulation-based inference algorithms for phylodynamic inference. |
| URL | https://emvolz.github.io/Coalescent.jl/dev/intro/ |
| Title | DAEDALUS Explore - A pandemic simulation tool |
| Description | DAEDALUS Explore is an interactive dashboard tool that allows users to simulate the health, education and economic impacts of hypothetical future pandemic scenarios for 7 pandemics of varying severity in 67 countries. The 7 pandemics are informed by the characteristics of pathogens that have caused historic pandemics. The dashboard provides estimates of Infections, Hospitalisations, Deaths, Vaccinations, and Economic losses. DAEDALUS Explore allows users to choose a country, a pandemic, and a response amongst four options (no closures, school closures, business closures, and elimination). Response is the mitigation that policy makers can choose once the pandemic strikes. DAEDALUS Explore allows users to explore the inherent trade-off between different response strategies. For example, business closures may result in higher economic costs, but lower deaths compared to a response that does not mandate closures. The losses associated with pandemics can be influenced by investments into global vaccine R&D and manufacturing, and into hospital capacity. Users can explore the impact of such investments on health, education and economic pandemic impacts by comparing the outcomes of scenarios with different investments. The impacts of all pandemic scenarios for the countries are projected in terms of GDP loss (absolute, and in % of pre-pandemic GDP), the long-term income loss caused by the interruption of education in schools, and in terms of lost life years, valued in monetary terms. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2024 |
| Open Source License? | Yes |
| Impact | The dashboard was used for a pre-conference workshop for academics and policy makers at the first South-East Asian Infectious Disease Modelling Conference in November 2024 in Bangkok, Thailand. It was also used for a workshop for policy makers and advisors that we held together with the Institute for Government in January 2025. Both are reported elsewhere. |
| URL | https://daedalus.jameel-institute.org/about |
| Title | EpiControl |
| Description | The first R package allowing optimal control and learning methods to be used for to improve stochastic and real-time epidemic scenario analyses under interventions. |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | None yet, a paper is under review. |
| URL | https://doi.org/10.1101/2025.11.17.25340271 |
| Title | HIV mortality study management portal |
| Description | Portal to provide information for the survey management and access to real time results from the survey |
| Type Of Technology | Webtool/Application |
| Year Produced | 2024 |
| Impact | Provision of real-time information to support effective implementation and management of the complex data collection procedures required for the HIV mortality and healthcare seeking behaviours study in Manicaland, Zimbabwe |
| Title | IMPERATIVE trial study management portal |
| Description | Portal to provide information for the trial management and access to real time results from the study |
| Type Of Technology | Webtool/Application |
| Year Produced | 2024 |
| Open Source License? | Yes |
| Impact | Provision of real-time information to support effective implementation and management of the complex data collection procedures required for the HIV mortality and healthcare seeking behaviours study in Manicaland, Zimbabwe |
| Title | MINT - Malaria Intervention Tool |
| Description | Tool to guide malaria control decision-making. Prediction of epidemiological benefit and cost-effective analysis allowing the user to explore the optimum allocation of resources across multiple administrative areas. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2024 |
| Impact | Has been used to support planning of national malaria programmes in multiple African countries including Burkina Faso, Ghana and Cameroon |
| URL | https://www.sciencedirect.com/science/article/pii/S2214109X24003292 |
| Title | Malariaverse |
| Description | A suite of software packages to support context-specific modelling using the malariasimulation model |
| Type Of Technology | Software |
| Year Produced | 2024 |
| Open Source License? | Yes |
| Impact | Open-access tools enable a wider user base to access context specific modelling using the malariasimulation model |
| URL | https://mrc-ide.github.io/malariaverse/ |
| Title | Naomi |
| Description | Mathematical model and web-interface for developing district-level estimates of people living with HIV, antiretroviral treatment coverage, and new HIV infections in sub-Saharan Africa. |
| Type Of Technology | Software |
| Year Produced | 2019 |
| Open Source License? | Yes |
| Impact | - Used to develop official district-level estimates for US Government PEPFAR planning and budget allocation in 2020. - Estimates to be publicly released by UNAIDS in June 2020. |
| URL | http://naomi.unaids.org |
| Title | Optimal Scheduling for COVID |
| Description | This capsule contains the code for running the Optimized Schedule and Standard Policies as described in the related paper submitted to Nature Computational Science (Journal Reference: NATCOMPUTSCI-21-0204). Please refer to the README folder for detailed instructions regarding running the different scenarios. |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Impact | Code to reproduce D'Aeth, J.C., Ghosal, S., Grimm, F. et al. Optimal national prioritization policies for hospital care during the SARS-CoV-2 pandemic. Nat Comput Sci 1, 521-531 (2021). https://doi.org/10.1038/s43588-021-00111-1 |
| URL | https://codeocean.com/capsule/3593902/tree/v1 |
| Title | Optimizing social and economic activity while containing SARS-CoV-2 transmission using DAEDALUS |
| Description | An integrated epidemiological-economic model to optimise social/economic activity while containing disease transmission |
| Type Of Technology | Software |
| Year Produced | 2022 |
| Impact | Code for reproducing the findings of the paper Haw, D.J., Forchini, G., Doohan, P. et al. Optimizing social and economic activity while containing SARS-CoV-2 transmission using DAEDALUS. Nat Comput Sci 2, 223-233 (2022). https://doi.org/10.1038/s43588-022-00233-0 |
| URL | https://codeocean.com/capsule/6499343/tree/v1 |
| Title | PopART-IBM |
| Description | PopART-IBM is a computationally efficient modular individual-based simulation of HIV transmission for use in sub-Saharan Africa, with the current release developed for Zimbabwe. |
| Type Of Technology | Software |
| Year Produced | 2023 |
| Open Source License? | Yes |
| Impact | PopART-IBM is being used as part of the MIHPSA collaboration to inform the Zimbabwean Ministry of Health and Child Care's next 5 year plan, and as part of multi-model comparisons to understand sources of HIV transmission and AIDS-related mortality in sub-Saharan Africa. |
| Title | The departure between constant-rate birth-death and empirically inferred diversification processes |
| Description | Birth-death models (BDMs) are stochastic processes describing the processes of speciation and extinction through time and across taxa and are widely used in biology for inference of evolutionary timescales. Previous research has highlighted how the expected trees under BDMs tend to differ from empirical trees with respect to indices such as the amount of phylogenetic imbalance. However, our understanding of how trees differ between BDMs and empirical inferences remains incomplete. In this study, we demonstrate how four different constant-rate BDM scenarios influence tree shape and branch-length characteristics of phylogenetic trees, using a wide range of topology and branch-length indices. Comparison of BDM expectations against a comprehensive empirical dataset of 1,189 empirical trees shows that the dominant form of model inadequacy in BDMs is in failing to accommodate large amounts of phylogenetic imbalance in empirical processes. We also find that empirical trees tend to have significantly greater depth, lower stemminess, and longer shortest pendant edge lengths than BD-simulated trees. The results also indicate that accounting for the sampling fraction is the single most important parameter for accommodating empirical stemminess and branch lengths. Overall, our findings demonstrate the limitations of BDM priors when inferring the shape and structural characteristics of phylogenetic trees, highlighting the importance of novel methods that account for a broader tree space and secondarily reduce any possible bias in branch length estimation. |
| Type Of Technology | Software |
| Year Produced | 2023 |
| Impact | n/a |
| URL | https://zenodo.org/record/7609119 |
| Title | Treestsructure v 0.6.0: Detect Population Structure Within Phylogenetic Trees |
| Description | Algorithms for detecting population structure from the history of coalescent events recorded in phylogenetic trees. This method classifies each tip and internal node of a tree into disjoint sets characterized by similar coalescent patterns |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | We have demonstrated the role ofhuman demography and transmission patterns in shaping the evolution ofHIV-1, and our method has shown distinct outbreaks of HIV-1 in speci?c groups de?ned by age, race, and behaviour. Package updated in May 2020 Paper published in Systematic Biology |
| URL | https://cran.r-project.org/web/packages/treestructure/index.html |
| Title | acme-buddy |
| Description | acme-buddy automatically renews TLS certificates from Let's Encrypt, allowing for easy certificate management of self-hosted web applications. |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | This package significantly eases the manual overheads of maintaining websites and web applications developed and hosted in the centre, e.g. wodin and packit. |
| Title | cod v 0.2.7 |
| Description | Provides models for inferring variation in coalescent rates across branches in a phylogenetic tree, identifying growing lineages, adjusting for biased sampling, computing phylogenetic clusters, optimising cluster thresholds, & summarising variation in rates. |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | These methods are being used to study emergence of drug resistance in N. gonorrhoea, outbreak detection in HIV-1, and antigenic evolution of SARS-CoV-2 and seasonal influenza. |
| URL | https://github.com/emvolz/cod |
| Title | daedalus: Model health, social, and economic costs of a pandemic using DAEDALUS |
| Description | Model the health, education, and economic costs of directly transmitted respiratory virus pandemics, under different scenarios of prior vaccine investment and reactive interventions, using the _DAEDALUS_ integrated health-economics model adapted from Haw et al. (2022) . |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Impact | The software underlies the dashboard 'DAEDALUS Explore', and several collaborative projects that are reported elsewhere |
| URL | https://zenodo.org/doi/10.5281/zenodo.14747626 |
| Title | daedalus: Model health, social, and economic costs of a pandemic using DAEDALUS |
| Description | Model the health, education, and economic costs of directly transmitted respiratory virus pandemics, under different scenarios of prior vaccine investment and reactive interventions, using the _DAEDALUS_ integrated health-economics model adapted from Haw et al. (2022) . |
| Type Of Technology | Software |
| Year Produced | 2024 |
| Impact | Code to reproduce and adapt the code underlying the pandemic simulation tool DAEDALUS Explore https://daedalus.jameel-institute.org/scenarios/new |
| URL | https://zenodo.org/doi/10.5281/zenodo.14024722 |
| Title | dust2 0.3.16 |
| Description | The dust2 package provides an engine for running dynamical systems in discrete or continuous time and where the processes are stochastic or deterministic. We focus on Markov models where the problem reduces to describing how model state changes as a function of its current state (and possibly time) but without reference to where it has come from. |
| Type Of Technology | Software |
| Year Produced | 2024 |
| Open Source License? | Yes |
| Impact | This package powers the simulations used in the Imperial College mpox response, and is being used in several upcoming publications from the Centre. |
| Title | grout |
| Description | Grout serves map tiles (mbtiles) and region metadata which can be consumed in web front ends by Leaflet etc. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | Grout is a web service which enables easier development of interactive web applications visualising geographical data (e.g. model estimates) by providing tiling shapes at multiple levels, which makes it feasible to change zoom level while maintaining responsiveness compared to GeoJSON or shapefiles. |
| URL | https://mrcdata.dide.ic.ac.uk/grout/test |
| Title | hipercow v1.0.56 |
| Description | This package represents our user-friendly HPC platform, used by most researchers within the centre for running jobs our cluster. |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | This package was used by millions of jobs over the reporting period, providing the compute framework for many projects across the centre. |
| Title | hipercow v1.1.8 |
| Description | This package represents our user-friendly HPC platform, used by most researchers within the centre for running jobs our cluster. The latest version enables jobs to be run on Linux nodes (previously only Windows nodes were supported). |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | This package has been used by millions of jobs over the reporting period, providing the compute framework for many projects across the centre. Supporting Linux enables a greater range of jobs and packages to utilise the cluster. |
| Title | hipercow-py |
| Description | This package extends the capabilities of hipercow, by allowing hipercow jobs written in Python (previously only R jobs were supported). It was used to run the Thanzi la Onse model. |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | This package has extended the capabilities of our high-performance compute resource by supporting Python programming language, which is favoured by an increasing number of tools and researchers. |
| Title | malariasimulation |
| Description | Imperial College London's next malaria simulation. The main goals are make an extensible, maintainable and fast simulation to evaluate and report on malaria intervention strategies. In continual development. |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | Not yet recognised |
| Title | mlesky v 0.1.8 |
| Description | This is software for maximum likelihood inference of an epidemic history from pathogen sequence data. |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | This software has facilitated evaluation of SAR-CoV-2 variants (BA.4/BA.5 and XBB 1.5) in situations where standard surveillance data is sparse or missing. |
| Title | mlscluster v 0.2.3 |
| Description | mlscluster is an algorithm that computes three statistics (ratio of descendant clade sizes, ratio of persistence times, and logistic growth rates) for sister clades in huge time-scaled phylogenies. Clade-defining homoplasies are matched with these statistics and results for different cluster thresholds are produced. Therefore, this method highlights mutations (or transmission fitness polymorphisms [TFPs]) which likely present different selective pressures within and between hosts (multilevel selection). This package contains functions to (i) compute the multilevel selectives pressures across thresholds, (ii) perform statistical analysis and graphical visualisation for all thresholds to identify lineages and genomic regions enriched for TFPs, (iii) quantify the false discovery rate for each threshold, (iv) generate multiple lineage and gene-specific plots of TFPs for the threshold selected by the user. |
| Type Of Technology | Software |
| Year Produced | 2023 |
| Open Source License? | Yes |
| Impact | This method has been used to identify putative transmission fitness sites in SARS-CoV-2 |
| URL | https://github.com/mrc-ide/mlscluster |
| Title | monty v0.3.28 |
| Description | monty is a toolbox for Monte Carlo methods. It is designed to help run MCMC with models that do not fit closely within the paradigms of packages such as stan - for example some likelihood you have written by hand. |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | This package is being used to support the Imperial College mpox response, providing the statistical framework for the analyses. It powers other software (dust2, odin2) reported on here. |
| Title | musseco v 0.1.1 |
| Description | Methods for simulating genealogies and estimating parameters for a speciation and extinction coalescent process such that 1) disadvantageous alleles appear continuously in a population and are present in mutation/selection balance; 2) non-equilibrium dynamics of advantageous alleles which appear continuously and grow in frequency. |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | These methods have been used to study the selective effects influencing evolution of HIV-1 co-receptor switching. |
| URL | https://emvolz-phylodynamics.github.io/musseco/ |
| Title | odin2 v0.3.19 |
| Description | odin2 implements a high-level language for describing and implementing ordinary differential equations and difference equations in R. It provides a "domain specific language" (DSL) which looks like R but is compiled directly to C++, using dust2 to solve your system and to provide an interface to particle filters. You can then use monty to fit your models using MCMC. This is the next generation of our "odin" package. |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | This package is being used in the Imperial College mpox response and many other projects within the centre. This package, and its predecessor, are now being used widely within the epidemiological community. |
| Title | orderly2 v1.99.60 |
| Description | orderly2 is a package designed to help make analysis more reproducible. Its principal aim is to automate a series of basic steps in the process of writing analyses, making it easy to: track all inputs into an analysis (packages, code, and data resources) store multiple versions of an analysis where it is repeated track outputs of an analysis create analyses that depend on the outputs of previous analyses |
| Type Of Technology | Software |
| Year Produced | 2024 |
| Open Source License? | Yes |
| Impact | This package is the reporting and reproducible research framework used by the centre COVID response, mpox response and other research projects within the centre. |
| Title | packit |
| Description | Web application for surfacing packet data and metadata. Packets are sets of files with related metadata conforming to the outpack format. Packets are produced as the result of running analysis scripts, typically using a package which supports outpack format, such as orderly or pyorderly, which also add their own custom metadata to the packets produced. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | Used to provide a web front-end and API for orderly2-using projects across the centre. Deployed for 3 projects at present. |
| Title | pfhrp2/3 Deletion Risk Explorer |
| Description | The tool allows users to explore how changes in the underlying modelling assumptions impact the risk of pfhrp2/3 continuing to spread and . |
| Type Of Technology | Webtool/Application |
| Year Produced | 2023 |
| Open Source License? | Yes |
| Impact | The tool accompanies recent WHO protocols for surveillance of pfhrp2/3 (https://www.who.int/publications/i/item/9789240099951) for the response plan to pfhrp2 gene deletions (https://www.who.int/publications/i/item/9789240101838). |
| URL | https://worldhealthorg.shinyapps.io/DeletionRiskExplorer/ |
| Title | phydynR v 0.2.5 |
| Description | This package provides functions for defining infectious disease models or ecological process models in terms of ODEs (ordinary differential equations) or SDEs (stochastic differential equations); functions for simulating trees conditional on process models; and functions for computing likelihoods of trees conditional on a process model. |
| Type Of Technology | Software |
| Year Produced | 2024 |
| Open Source License? | Yes |
| Impact | This method has been used in more than a dozen studies of pathogen dynamics and evolution. |
| URL | http://emvolz-phylodynamics.github.io/phydynR/ |
| Title | rdhs: API Client and Dataset Management for the Demographic and Health Survey (DHS) Data |
| Description | Provides a client for (1) querying the DHS API for survey indicators and metadata (), (2) identifying surveys and datasets for analysis, (3) downloading survey datasets from the DHS website, (4) loading datasets and associate metadata into R, and (5) extracting variables and combining datasets for pooled analysis. |
| Type Of Technology | Software |
| Year Produced | 2019 |
| Open Source License? | Yes |
| Impact | - Published and maintained rOpenSci foundation |
| URL | https://ropensci.github.io/rdhs/ |
| Title | skadi-chart |
| Description | skadi-chart is a highly flexible charting library built on d3.js which enables easy development of customised charts. |
| Type Of Technology | Software |
| Year Produced | 2025 |
| Open Source License? | Yes |
| Impact | skadi-chart enables more custom and specialised visualisation than standard charting libraries, which will allow web applications built to demonstrate research output to be fine-tuned for the best user experience. We use skadi-chart for static wodin, supporting a wide range of model visualisations out of the box. |
| Title | static wodin |
| Description | This development of wodin extends its use cases by allowing a mode of execution which builds static web applications from fixed odin models, and allows wodin components (e.g. charts and parameter sliders) to be embedded in arbitrary HTML. Where previously wodin could only be used as a fully integrated teaching application, it can now be used to build a wide range of narrative sites with any level of interactivity as appropriate for the use case. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2026 |
| Open Source License? | Yes |
| Impact | Static wodin enables easy development of web applications surfacing odin models - odin is widely used within the epidemiological community. |
| Title | wodin |
| Description | Wodin is a java-script based web application used for teaching dynamical modelling. It allows users to write model code in the odin dsl and then explore these models or fit them to data in their browser. |
| Type Of Technology | Webtool/Application |
| Year Produced | 2024 |
| Open Source License? | Yes |
| Impact | Wodin was used in 8 teaching courses, both internal and external, over the reporting period. |
| URL | https://epimodels.dide.ic.ac.uk/ |
| Description | "Théorie et pratique de la modélisation mathématique du VIH/SIDA et des Virus du papillome humain (VPH)/Cancer du col de l'utérus : Outil d'analyse et d'aide à la décision" |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Policymakers/politicians |
| Results and Impact | "Théorie et pratique de la modélisation mathématique du VIH/SIDA et des Virus du papillome humain (VPH)/Cancer du col de l'utérus : Outil d'analyse et d'aide à la décision" ('Theory and Practice of Mathematical Modeling of HIV/AIDS and Human Papillomavirus (HPV)/Cervical Cancer: A Tool for Analysis and Decision Support'), organized by the Imperial College of London (Romain Silhol was the lead and main organiser' ) and Programm PAC-CI (https://web.pac-ci.org/). The workshop took place in Abidjan, Ivory Coast, from June 25 to 27, 2025, and brought together around fifty decision-makers and students in the field of HIV/AIDS and HPV/cervical cancer prevention. Following the workshop we conducted a survey and received positive feedback: participants reported that the workshop had been useful for their current and future work, and that the sessions allowed to improve their understanding and interpretation of mathematical modelling results. There was also some interest for similar events to take place. |
| Year(s) Of Engagement Activity | 2025 |
| URL | https://hptnmodelling.org/resources/workshop-de-modelisation-mathematique-2025/ |
| Description | 2023 ICLR First Workshop on Machine Learning & Global Health |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | My student presented our bijection approach at this machine learning conference |
| Year(s) Of Engagement Activity | 2023 |
| Description | A talk at a meeting funded by the HPRU to link infectious diseases modellers in the UK to support community building |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Postgraduate students |
| Results and Impact | As part of efforts to foster collaboration among infectious disease modellers in the UK, we presented our work on the odin-monty package at a meeting funded by the Health Protection Research Unit (HPRU) or organised by the London School of Hygiene and Tropical Medicine. This event aimed to strengthen community ties by facilitating knowledge exchange and promoting open-source tools that enhance computational workflows in epidemiological modelling in particular in the context of pandemic preparedness. Our presentation focused on the ongoing development of odin-monty, a R package designed to improve model specification and inference by integrating the odin DSL for defining dynamic models and monty as a flexible inference framework. We outlined key features, including enhanced hierarchical modelling support, automatic differentiation for improved parameter estimation, and scalable inference techniques. Additionally, we demonstrated how odin-monty streamlines the modelling pipeline, reducing technical overhead while maintaining flexibility for different infectious disease applications. The talk generated valuable discussion around usability, adoption within existing workflows, and potential extensions. Participants expressed particular interest in how the package could facilitate multi-region modelling, real-time applications, and reproducibility in public health decision-making. These insights will inform our next development steps and future community engagement efforts, including the upcoming odin-monty workshop. This meeting reinforced the importance of building an engaged and collaborative modelling community. By presenting odin-monty in this setting, we aimed to highlight the benefits of open-source, transparent, and reproducible approaches in infectious disease modelling, ensuring that modellers across the UK can leverage cutting-edge tools to address pressing public health challenges. |
| Year(s) Of Engagement Activity | 2025 |
| Description | AI European Exposome Symposium |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Kaustubh Chakradeo, employed on my grant presented a poster on our research and won best poster award |
| Year(s) Of Engagement Activity | 2023 |
| Description | APPG on vaccines - panel member at meeting |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Panel member for discussion about the role of vaccination to prevent endemic diseases |
| Year(s) Of Engagement Activity | 2024 |
| Description | Air pollution horizon-scanning: Seven potential risks of relevance to the UK |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Horizon scanning is used to help identify potentially significant societal, economic or technological shifts which if they occurred would have major impacts on society. AQEG generally approaches the science and technology of air pollution either through retrospective analyses - what has happened to air quality and why, - or via future projections. These future projections are generally short to medium term and bounded by well-established science, but it is also AQEG's role to identify evidence gaps that include uncertainties. It is valuable to periodically look beyond established evidence, towards emerging science to identify potential perturbations and assess risks that might plausibly lead to unexpected and large future air quality changes, for example those arising from climatological, technological and behavioural shifts. The horizon-scanning was commissioned by the Chief Scientific Officer Angela McLean |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://uk-air.defra.gov.uk/assets/documents/reports/cat05/2411071332_horizon_scan_AQEG_v5.pdf |
| Description | Alternative Treatment Strategies Guideline Development Group of the WHO |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | The Guideline Development Group for Alternative Treatment Strategies for Filariases aims at identifying treatments and treatment regimens to accelerate onchocerciasis and lymphatic filariasis elimination. The first step was to identify PICO questions for a systematic review of the published evidence, reports, grey literature, and clinical trials. The proposed PICO questions have now been submitted to the WHO. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Article in New Scientist |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Article in the New Scientist on future science to achieve malaria elimination. |
| Year(s) Of Engagement Activity | 2025 |
| URL | https://www.newscientist.com/article/mg26535261-600-whats-next-in-the-fight-against-malaria/ |
| Description | Assistant Professor Frederick Lyngse Talk at the Phylodynamics seminar and the Statens Serum Insitut |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | This was a large seminar on genetics and time and Frederik presented work in progress here on household analysis, it was well received. |
| Year(s) Of Engagement Activity | 2024 |
| Description | BBC Health Check - A step closer to a Chikungunya vaccine |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Invited to talk about chikungunya, its spread in the Americas, and the new promising Valneva vaccine, reaching an audience of thousands. |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://www.bbc.co.uk/sounds/play/w3ct4pd1 |
| Description | Bridging the Gap Hackathon (Nairobi January 2025) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Organised the "Bridging the Gap Hackathon" in partnership with the Center for Epidemiological Modelling and Analysis (CEMA) at the University of Nairobi. This was a 5-day event that brought together 56 public health decision-makers, developers, technical experts, and academics and researchers, including 8 staff from MRC-GIDA, to create free, open-source resources to support and facilitate evidence-informed decision making and address health policy needs in Kenya. |
| Year(s) Of Engagement Activity | 2025 |
| URL | https://cema-mrc-hackathon.github.io/ |
| Description | Capacity training workshop at UKHSA away day |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | The team ran an afternoon exercise at the UKHSA Directorate of Analysis and Intelligence Assessment annual away day. The away day was attended by senior policy leadership from within the directorate, academics, and operational staff. The activity involved running a pandemic preparedness simulation exercise using the DEADALUS Explore online dashboard. The feedback collected from away-day participants showed the activity sparked new ways of thinking, such as how to apply the away-day exercise's learnings to their own in-house pandemic exercises. The engagement opportunity was also impactful in that it made attendees identify the value of integrated modelling, for example recognising it as a tool to consider areas beyond their own specialism. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Centre for Health Economics Policy Forum (York November 2023) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Third sector organisations |
| Results and Impact | Katharina was invited to discuss CHE's policy-focused global health economics research program |
| Year(s) Of Engagement Activity | 2023 |
| Description | Collaborative Surveillance Investment Case Workshop for Informal WHO Technical Working Group (Berlin December 2024) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Katharina was invited to an expert working group on how to build an investment case for collaborative surveillance for infectious disease threats. The working group and the workshop was convened by the WHO Hub for Pandemic and Epidemic Intelligence in Berlin, Germany. |
| Year(s) Of Engagement Activity | 2024 |
| Description | Conference presentation |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Oral presentation at the annual meeting of the American Society for Tropical Medicine and Hygiene |
| Year(s) Of Engagement Activity | 2024 |
| Description | Contribution to news and science coverage on Times Radio and LBC though live broadcast interviews |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Contribution to news and science coverage on Times Radio and LBC though live broadcast interviews - using the media as a channel to wider audiences |
| Year(s) Of Engagement Activity | 2025 |
| Description | Diagnostics workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Over 100 diagnostics developers, policymakers, and other interested parties attended this workshop; it also resulted in a (soon-to-be-published) Declaration on Infectious Disease Diagnostics |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.imperial.ac.uk/events/171376/infectious-diseases-novel-diagnostics-workshop/ |
| Description | Digital Twins in Healthcare |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk at special event at Royal College of Physicians |
| Year(s) Of Engagement Activity | 2026 |
| Description | EEA-ESEM conference, Barcelona |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | My assistant professor spoke at this conference on Causal Effects of Early Career Sorting on Labor and Marriage Market Choices: A Foundation for Gender Disparities and Norms. |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://www.eea-esem-congresses.org/ |
| Description | EU4Health SHIELD: Multi-Country Technical Engagement |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Multiple talks and steering committee meetings on modelling approaches for infection-related cancers and communicable disease preparedness. Engaged directly with EU public health agencies and technical experts, development of shared modelling protocols and cross-country technical consultations. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Economic-epidemiological models: Optimizing lockdowns for the mitigation of pandemics (Capetown July 2023) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Katharina, together with WHO, organized a workshop with invited international speakers at the International Health Economics Association Global Conference. |
| Year(s) Of Engagement Activity | 2023 |
| Description | Economics of Pandemic Preparedness: Trade-offs in peacetime and pandemics (London April 2024) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | The objective of this workshop was to debate the policy and research priorities for pandemic prevention and preparedness, recognizing that budgets are limited, and tough choices must be made in the trade-offs between population health and the economy. Bringing speakers together from finance and economics, public health, epidemiology and infectious diseases, we discussed the investments needed to equip countries to effectively prevent, prepare for, and respond to pandemics; the investments with the highest returns in terms of lives saved and economic and wider societal outcomes, in both the global north and the global south. The discussion raised many fundamental questions. What are the outcomes we should aim for, and how should we measure them? How can we reconcile the cost to public health with the cost to the economy? And lastly, what action is needed now, to make the most impact next time round, in three key areas: Vaccinations, Effective governance on both a national and international level, and infrastructure (health systems, surveillance and data). Looking forwards, the workshop outputs will be leveraged to further the programme of research under the Jameel Institute-Kenneth C. Griffin Initiative for the Economics of Pandemic Preparedness (EPPI). Established by the Jameel Institute in 2022, EPPI uses integrated economic-epidemiological modelling to provide critical data and analysis to inform public health decisions related to pandemic preparedness and disease outbreaks. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.imperial.ac.uk/media/imperial-college/research-centres-and-groups/jameel-institute/publi... |
| Description | Educational board game design run at various venues (festivals, schools) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Schools |
| Results and Impact | Created a board game to reconstruct transmission chains using pathogen genomic sequences (2025); successfully deployed at the Great Exhibition Road Festival (GERF) and in a school, introducing complex concepts in an accessible, hands-on format. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Engagement focused website, blog or social media channel - Video podcast series - Science in Context |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | As part of a press release for my article "Historical and current spatiotemporal patterns of wild and vaccine-derived poliovirus spread" published in Nature Microbiology, I recorded a "Science in Context" video, summarising the study and asking questions in more accessible language. The video was posted to all the MRC social media accounts and to mine as well. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Epidemics conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | This is the biggest conference on infectious diseases, several of my team presented posters and we won 3'rd best poster for this paper https://www.nature.com/articles/s42005-023-01265-2 which develops a novel architecture based on branching. |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://www.elsevier.com/events/conferences/all/international-conference-on-infectious-disease-dynam... |
| Description | Estimating the value of CEPI's 100-day mission in terms of public health, economic and educational benefits (UKHSA Online September 2024) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Katharina Hauck gave a presentation to UKHSA on the work of EPPI, specifically on modelling the value of advance investments into broadly protective and specific vaccine R&D and manufacturing capacity for a future SARS-X pandemic that is undertaken in collaboration with the Coalition for Epidemic Preparedness Innovation (CEPI). |
| Year(s) Of Engagement Activity | 2024 |
| Description | Expert workshop on integrated economic-epidemiological modelling (LSHTM London January and October 2024) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Katharina gave an invited talk on the ongoing work of the EPPI team at these two multidisciplinary workshops on economic-epidemiological modelling that were organized by Prof John Edmunds at the London School of Hygiene and Tropical Medicine in January and October 2024. |
| Year(s) Of Engagement Activity | 2024 |
| Description | Festival Fever - Great Exhibition Road Festival |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Public/other audiences |
| Results and Impact | The annual MRC Centre 'Festival Fever' stand at the Great Exhibition Road Festival is a great success with multiple activities offered to visitors (35.000 people). Visitors will learn about infectious diseases in a playful way. They learn about the many disease areas our centre focusses on, and the research themes that make our centre stand out (pandemic preparedness, vaccines, global health analytics and genomics). They will also be able to do some modelling themselves through the games and ask our scientists questions. Activities include: 1. updated pandemic potential playing cards (top-trump style card game), 2. higher-or-lower game using a real-life version of the pandemic potential cards based on facts of outbreaks and infectious diseases, 3. Zombie outbreak game (using tablets the player can input disease specific details such as transmission, severity and response details such as vaccination level etc and see on a big screen how the outbreak would play out - great conversation starter on modelling outbreaks) 4. Animal matching game (matching microbe causing disease in humans and animals that carry them - intend to update this game for the new year), |
| Year(s) Of Engagement Activity | 2023,2025 |
| URL | https://www.greatexhibitionroadfestival.co.uk/ |
| Description | Festival Fever Stand at Great Exhibition Road Festival |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Public/other audiences |
| Results and Impact | 2023 - about 20 volunteers trained in public engagement, developed and delivered activities. Over 50,000 visitors to the festival, with our stand visited by families with young children mostly (https://www.imperial.ac.uk/news/245553/all-festival/) 2025 - about 20 volunteers, trained in public engagement, developed and delivered activities, all trained volunteers received Imperial Certificate for Public Engagement following the activities development workshop and delivery of activities. Over 55,000 visitors to the festival, with our stand visited by families with young children mostly (https://www.imperial.ac.uk/news/266933/festival-continues-attract-inspire-audiences/) |
| Year(s) Of Engagement Activity | 2023,2025 |
| Description | Festival Fever Stand at Science Week |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | 2024 - about 15 volunteers, trained in public engagement, developed and delivered activities, around 200 students. Festival Fever Activities to deliver School Science Fair for Science Week at primary school (St Lukes CofE Bournemouth), as well as 'I'm a Scientist Get Me Out Of Here' meet and greets with each class individually during the week (https://www.imperial.ac.uk/news/252055/british-science-week-takes-imperial-scientists/) 2025 - about 12 volunteers, trained in public engagement, developed and delivered activities, all trained volunteers received Imperial Certificate for Public Engagement following the activities development workshop and delivery of activities. Festival Fever Activities to deliver School Science Fair for Science Week at primary school (Salisbury Primary School, London) with around 300 students. |
| Year(s) Of Engagement Activity | 2024,2025 |
| Description | Future Resilience Forum (London October 2023) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Katharina participated in a discussion panel on Global Health Security |
| Year(s) Of Engagement Activity | 2023 |
| Description | Global Fund Investment Case Modelling |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Supporters |
| Results and Impact | Closed technical briefings, iterative consultation meetings, and written technical summaries tailored for non-modelling policy audiences. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Global Fund Modelling Guidance Group (MGG) meeting (Geneva April 2024) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Katharina was invited to attend the Global Fund Modelling Guidance Group (MGG) meeting to receive guidance on the approach for the Global Fund Investment Case for the 8th Replenishment |
| Year(s) Of Engagement Activity | 2024 |
| Description | Great Exhibition Road Festival |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Public/other audiences |
| Results and Impact | Participated in public engagement activities, interacting with hundreds of visitors and showcasing infectious disease modelling to the wider public. |
| Year(s) Of Engagement Activity | 2022,2023,2024,2025 |
| URL | https://www.greatexhibitionroadfestival.co.uk |
| Description | Guest talk at Talking Heads - HEADS, University of Copenhagen |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | I gave a talk on AI and infectious diseases |
| Year(s) Of Engagement Activity | 2024 |
| Description | HIV Modelling Consortium Executive Committee |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | The HIV Modelling Consortium aims to improve scientific support for policy decision-making by coordinating and facilitating mathematical modelling to inform HIV programmes in sub-Saharan Africa. We enable mutual support between mathematical modellers and engagement between modellers and policy stakeholders. The Consortium is hosted at University of South Africa with Executive Committee members spanning Europe, Africa, North America and Australia. |
| Year(s) Of Engagement Activity | 2020,2021,2022,2023,2024,2025 |
| URL | http://hivmodeling.org |
| Description | Hamburg Center for Health Economics (HCHE) - Frederick Lyngse gave a talk here |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Hamburg Center for Health Economics (HCHE) - Frederick Lyngse gave a talk here on the topic of health economics |
| Year(s) Of Engagement Activity | 2024 |
| Description | Health Economics and Policy Unit Think Tanks |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | The Think Tanks are an invitation-only workshop series which brings together researchers, non-governmental organisations and government officials working together on issues of public health in Malawi. The Think Tanks are often themed, e.g. health technology assessment (HTA) or HIV sustainability options and HTA mandate for institutionalization. |
| Year(s) Of Engagement Activity | 2018,2020,2021,2023,2024 |
| Description | Health economics for HIV decision making |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Third sector organisations |
| Results and Impact | Delivered a coordinated 30-35 minute session on HIV programme simplification under funding constraints. Presentations covered: principles of cost-effectiveness and implications of funding cuts and TLO model analyses of programme simplification and HIV drug supply chain scenarios. The session informed policy discussions on efficiency gains and strategic adaptation of HIV programmes within constrained budgets. |
| Year(s) Of Engagement Activity | 2025 |
| Description | High-level forum "Pandemics - no time for neglect" (Berlin September 2023) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Katharina was invited to participate in teh two day workshop organiaed by the Federal Ministry for Economic Cooperation and Development (BMZ) |
| Year(s) Of Engagement Activity | 2023 |
| Description | Highschool experience placement |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Schools |
| Results and Impact | Co-hosted two high-school students (one from London, one from Paris, France) for a one week experience placement. |
| Year(s) Of Engagement Activity | 2024 |
| Description | House of Commons science innovation and technology committee |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Broadcast of interview with House of Commons Parliamentary Science, Innovation and Technology Committee on theme of 'Harnessing the Power of Fungi'. Six expert international witnesses were invited to Westminster and questioned on matters such as "Zombie apocalypse or environmental saviours?" with ourselves providing input on environmental issues including evolution of antifungal resistance in plant and animal pathogens |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://parliamentlive.tv/event/index/91a56a91-27ee-4f7a-883a-443dd46f9bb2 |
| Description | Imperial College London/ University of Copenhagen Formal Partnership Event |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | I was heavily involved in establishing a meeting and connection between Imperial College London and the University of Copenhagen. We held strategic talks as well as a large event at the British Embassy. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.imperial.ac.uk/news/253653/imperial-explores-closer-research-ties-with/ |
| Description | Imperial Malaria Network of Excellence Networking Event |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | 50 staff and students from Imperial College attended a 1-day networking event to engage with international visiting researchers from malaria endemic regions. Early career researchers discussed collaboration opportunities. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Imperial and Moderna Long-Covid Roundtable (London July 2024) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Industry/Business |
| Results and Impact | Katharina contributed to the roundtable discussion with an analysis of the economic impact of Long-Covid |
| Year(s) Of Engagement Activity | 2024 |
| Description | Institute for Government/Imperial College London roundtable on epi-econ modelling and pandemic response (London January 2025) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | The Institute for Government co-hosted this workshop in collaboration with researchers from the Jameel Institute, Imperial College London. This workshop involved an epidemic response exercise in the UK, where the Jameel Institute team used their integrated epi-econ model, DAEDALUS, to simulate an unfolding pandemic caused by a novel respiratory pathogen. The team projected in real time the health, short-term economic and educational impacts of alternative mitigation strategies. As the pandemic progressed, participants interrogated the model outputs, as well as the information they assimilated about the nature of this novel pathogen, to decide when, how and why they should take action. The exercise enabled us to gain insights into how policymakers interpret integrated epi-econ model evidence, how this evidence is then processed to inform policy choice selection, and the main questions policymakers have on integrated models when used as a tool to support decision-making. In turn, this guided us towards improved communication of model results to better inform and support government pandemic preparedness and response decision-making. We also hoped that the workshop provided the participants with an opportunity to find out more about integrated epi-econ modelling, consider how it could support your decision-making, and engage directly with the researchers who are designing these tools. This was an event under Chatham House Rules, but a report will be published summarizing the findings. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Interview for JameelCast - Mpox |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Spoke with Dr Thom Rawson for Jameelcast, to give an update on latest mpox outbreaks. Sparked discussion with colleagues who heard the podcast and led to intra-group collaborations. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://jameelcast.pinecast.co/episode/def666b8/lilith-whittles-mpox |
| Description | Interview for The Briefing Room - What we know (and don't know) about the new Mpox outbreak |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | I was interviewed, as part of a panel of experts, by David Aaronovitch to brief the general pulblic on what scientists do (and don't) know about the ongoing mpox outbreaks in central Africa. Synopsis: The first human cases of MPox were detected in 1970. But a new strain detected in Congo in 2023 has got scientists confused. How worried should we be and are we prepared for it? |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.bbc.co.uk/sounds/play/m0022cm7 |
| Description | Interview for website article |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Interviewed for an article discussing the impact and potential future impact of wastewater surveillance in supporting global public health. |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://www.exemplars.health/stories/the-james-webb-telescope-for-population-health |
| Description | Invitation for consultancy on health system integration |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | The activity involved a series of consultations with partners to advise on the design and implementation of a pilot integration study, leveraging modelling evidence to inform key decisions. Our team provided expert guidance on the integration strategy, evaluation framework, and measurement methods. As a result, we supported the development of an evaluation proposal, now approved by the Gates Foundation, and helped shape the integration implementation plan. This collaboration has also facilitated further coordination, with plans for an in-person meeting with FCDO in early February to advance the project. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Invited Lecture at the P1 pioneer center |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | I was invited to talk about AI and infectious diseases in a broad lecture. https://www.aicentre.dk/events/talk-on-ai-and-infectious-disease-modelling |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.aicentre.dk/events/talk-on-ai-and-infectious-disease-modelling |
| Description | Invited Speaker - University of Oxford Data Science Seminar at Mathematics Instutute |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | I have been invited to speak at the mathematics institute at the university of oxford on 29th January 2024. I am reporting this now. This seminar series only invites established field leaders and I will be giving an overview talk on modelling in health. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.maths.ox.ac.uk/events/list/3428 |
| Description | Invited Talk - WHO Global Arbovirus Initiative |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | 50 WHO members and industry representatives attended a WHO meeting, which instigated questions around the importance of using genomic sequencing as a toolkit to improve preparedness against arboviral threats, and WHO reported increased interest in including genomic surveillance analytics in the WHO Global Arbovirus Initiative dashboard (https://worldhealthorg.shinyapps.io/dengue_global/). |
| Year(s) Of Engagement Activity | 2024 |
| Description | Invited panellist at FCDO Workshop on Mpox |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Invited to be a panellist at a scientific and technical workshop for FCDO Health Advisers based in mpox affected African countries, with an interdisciplinary expert panel to discuss the latest scientific and technical evidence on mpox and discuss Health Advisers' questions, covering all clades but focusing on clade Ib. I presented a high-level summary of our group's work and current findings, followed by a Q&A style format with Health Advisers posing their questions to the panel. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Invited talk on Branching Processes, at Department of Mathematics, University of Oxford |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | I gave a technical talk on my research, that was conducted in this grant, on branching processes |
| Year(s) Of Engagement Activity | 2024 |
| Description | Key Note Speaker Swiss Meeting for Infectious Disease Dynamics |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | This conference is probably one of the biggest meetings for infectious disease modelling in Europe. I gave a key note as well as a panel discussion on the future of modelling and how governments should react to future crisis. Governmental officials from Switzerland were present at this meeting. |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://www.smiddy.ch/ |
| Description | Malaria Eradication Film |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Using research from our team, we worked with a film media production company and advocacy charity to illustrate the past and future impact of malaria control globally. The output was projected on a large screen and launced at a private event at the Outernet in Tottenham Court Road. A short professional film was also made involving David Beckham to increase the impact of the research, and released through his social media channels reaching several million people worldwide. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.youtube.com/watch?v=cTL9RoqPIv8 |
| Description | Malaria vaccine news piece |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Broadcast media with ITV news on malaria vaccines and their impact |
| Year(s) Of Engagement Activity | 2025 |
| Description | Mathematics of Evolution Workshop on Algorithms and Software in Phylogenetics |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | We presented our new algorithms at this talk |
| Year(s) Of Engagement Activity | 2023 |
| Description | Media engagement |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Below we highlight some media engagements including op-eds, science media centre, imperial news items and other media mentions. A recent study (https://doi.org/10.1186/s12961-024-01236-1) showed that 16% of all Imperial news items on the work of the Imperial COVID19 Response Team during the first two years of the pandemic, were cited in policy documents globally. OpEds 26-06-2024 https://www.telegraph.co.uk/global-health/science-and-disease/h5n1-bird-flu-avian-influenza-farms-agriculture-biosecure/ 15-01-2025 https://www.newscientist.com/article/mg26535261-600-whats-next-in-the-fight-against-malaria/ Science Media Centre contributions 02-10-2023 https://www.sciencemediacentre.org/expert-reaction-to-the-world-health-organization-recommending-the-r21-matrix-m-vaccine-for-malaria-prevention/ 16-11-2023 https://www.sciencemediacentre.org/expert-reaction-to-study-looking-at-an-epidemic-economic-model-of-covid-based-on-data-from-new-york-city/ 09-01-2024 https://www.sciencemediacentre.org/expert-reaction-to-a-study-claiming-that-epidemic-modelling-needs-to-be-overhauled-to-include-social-networks/ 30-10-2024 https://www.sciencemediacentre.org/expert-reaction-to-the-news-that-ukhsa-has-detected-the-first-case-of-clade-ib-mpox-in-the-uk-in-an-individual-whod-been-on-holiday-in-africa/ Imperial news items 12-06-2023 https://www.imperial.ac.uk/news/245413/imperial-experts-provide-economic-perspective-infected/ 21-07-2023 https://www.imperial.ac.uk/news/246116/citizen-science-shows-widespread-exposure-drug-resistant/ 10-08-2023 https://www.imperial.ac.uk/news/246793/imperial-seeks-expand-partnerships-southeast-asia/ 29-09-2023 https://www.imperial.ac.uk/news/247457/professor-azra-ghani-takes-reins-renewed/ 9-02-2024 https://www.imperial.ac.uk/news/251218/new-malaria-vaccine-substantial-public-health/ 06-03-2024 https://www.imperial.ac.uk/news/251877/imperial-opens-major-building-school-public/ 15-03-2025 https://www.imperial.ac.uk/news/252055/british-science-week-takes-imperial-scientists/ 17-04-2024 https://www.imperial.ac.uk/news/252616/meningococcal-vaccine-cost-effective-protecting-against/ 22-04-2024 https://www.imperial.ac.uk/news/252199/imperial-launches-online-courses-virology-vaccinology/ 21-05-2024 https://www.imperial.ac.uk/news/253397/seven-imperial-researchers-awarded-academy-medical/ 30-05-2024 https://www.imperial.ac.uk/news/253653/imperial-explores-closer-research-ties-with/ 08-07-2024 https://www.imperial.ac.uk/news/254677/search-begins-architects-design-fleming-centre/ 22-08-2024 https://www.imperial.ac.uk/news/255693/mpox-who-experts-respond-questions-current/ 02-10-2024 https://www.imperial.ac.uk/news/256794/singapores-deputy-prime-minister-celebrates-collaboration/ 17-10-2024 https://www.imperial.ac.uk/news/257893/david-beckham-joins-scientists-video-launched/ 04-11-2024 https://www.imperial.ac.uk/news/257893/david-beckham-joins-scientists-video-launched/ 16-12-2024 https://www.imperial.ac.uk/news/259333/zoological-society-award-fungi-expert/ 31-12-2024 https://inews.co.uk/news/politics/bird-flu-next-covid-uk-preparing-3441046 10-01-2025 https://www.imperial.ac.uk/news/259813/united-states-sees-significant-increase-orphanhood/ 19-02-2025 https://www.imperial.ac.uk/news/261314/ai-could-save-lives-transform-pandemic/ 08-03-2025 https://www.imperial.ac.uk/news/261859/women-global-health-challenges-progress-leadership/ Media 16-05-2023 https://www.telegraph.co.uk/global-health/science-and-disease/scientists-amr-warning-government-pharmacy-first-policy/ 11-07-2023 https://www.theguardian.com/uk-news/2023/oct/17/communication-with-ministers-was-poor-scientist-tells-covid-inquiry-neil-ferguson 23-08-2023 https://www.ft.com/content/97847d9f-f5b2-4ed8-83f9-3bcfab7dac68 17-10-2023 https://www.bbc.co.uk/news/health-67125232 29-04-2024 https://www.ft.com/content/2df0ad08-65b6-483a-a59c-2af40d8afc23 06-06-2024 https://english.alarabiya.net/News/world/2024/06/06/what-is-disease-x-experts-say-most-people-will-see-another-pandemic-this-lifetime- |
| Year(s) Of Engagement Activity | 2023,2024,2025 |
| Description | Modelling and economics workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Delivered technical workshops on infectious disease modelling and health economics. Workshops included interactive sessions to interpret scenario analyses and discuss policy implications for health system planning. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Modelling sexually transmitted infections (STIs), Institut Pasteur |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited speaker for the workshop organised by the STI Working Group of the ANRS-MIE "Modelling" coordinated action. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://sti2024.sciencesconf.org/?forward-action=index&forward-controller=index&lang=en |
| Description | NNF Challenge Symposium 2023 |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | We spoke and attended the NNF Challenge Symposium 2023 speaking about our new deep learning approaches |
| Year(s) Of Engagement Activity | 2023 |
| Description | NTU Singapore - Academic workshop on STI modelling |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Third sector organisations |
| Results and Impact | Workshop for ~30 researchers and postgraduate students to share recent work, and develop nascent STI modelling community in Singapore. |
| Year(s) Of Engagement Activity | 2024 |
| Description | National newspaper article |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Contributed to a Guardian article describing the potential impact of the Direct molecular Detection and Nanopore Sequencing (DDNS) method for the detection of poliovirus which was developed in collaboration with our research group. The method has the potential to half the time taken to detect poliovirus and could provide a valuable tool to support global poliovirus eradication. |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://www.theguardian.com/society/2023/aug/17/polio-sewage-detection-study |
| Description | Networking event coordinated by the Imperial Malaria Network |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Organised a networking event with the Imperial malaria research community to connect with visiting malaria researchers from African countries |
| Year(s) Of Engagement Activity | 2025 |
| Description | Nordic AI Meet |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | my student won best poster at Nordic AI Meet |
| Year(s) Of Engagement Activity | 2023 |
| Description | Nordic Ai meet 2023 - PhD student Kaustubh Chakradeo (best poster award) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Kaustubh Chakradeo won best poster award here for our work done on Images |
| Year(s) Of Engagement Activity | 2023 |
| Description | Northern Lights Deep Learning Conference |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | My student presented a poster at this conference |
| Year(s) Of Engagement Activity | 2023 |
| Description | Onchocerciasis Technical Subgroup Membership, by election, from 2024 |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | The Onchocerciasis Technical Subgroup (OTS) is an expert group advising the WHO, and its NTD STAG (Scientific and Technical Advisory Group). Membership is by requested application and selection. The OTS meets at least once per year. It reaches WHO officers, implementation partners (e.g., Sighsavers, Helen Keller International and others), stakeholders (e.g. Bridges to Development) and funders (e.g. Gates Foundation), in addition to remaining members. It revises policy on guidelines for control and elimination programmes. |
| Year(s) Of Engagement Activity | 2024 |
| Description | PAX Sapiens Steering Group |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Attendance at regular meetings as a member of the Pandemic Compensation Initiative Working Group. The Working Group was set up by the non-profit foundation, PAX Sapiens, to guide their Pandemic Compensation Initiative. The initiative is a multi-year project which intends to design, advocate for, and ultimately help implement an economic mechanism to reduce economic disincentives to rapid disease reporting. Once the Working Group has reached consensus on the optimal design for a compensation mechanism, the Initiative will advocate for its implementation and, if that advocacy is successful, assist the implementing parties in standing up a new mechanism to help reduce barriers to rapid and transparent epidemic reporting. |
| Year(s) Of Engagement Activity | 2025,2026 |
| Description | Panel Presentation - Forum on Microbial Threats, National Academies of Sciences, Engineering, and Medicine, USA |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | 80 policy makers and researchers attended a workshop entitled "Mitigating arboviral threats and strenghtening public health preparedness" at the National Academies of Sciences, Engineering and Medicine, USA, to explore the role of arbovirus mitigation within the context of public health preparedness and capacity building. Outcomes include the Meeting Proceedings published afterwards. |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://www.nationalacademies.org/our-work/mitigating-arboviral-threats-and-strengthening-public-hea... |
| Description | Panellist at the European Health Forum panel on security |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Panelist in panel talk at the European Health Forum in Gastein. The session explored health security from multiple perspectives, focusing on necessary public health interventions and actions, the economic impact of inaction, policy decisions, and the power of cross-sectoral collaboration. Particular focuses were 'how can we keep prevention and preparedness high on the agenda, even as Member States face competing priorities?' and 'How do we clearly demonstrate the return on investment?'. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Participation in a Simons Foundation workshop on microbial diversity |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Supporters |
| Results and Impact | This was a workshop convened by the Simons Foundation in New York to understand how they can support a research programme to better understand the diversity and ecology of microbial populations. |
| Year(s) Of Engagement Activity | 2024 |
| Description | Participation in an activity, workshop or similar - Academy of Medical Sciences (UK and Brazil) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Abuot 70 policymakers participated in a workshop entitled "Advancing a One Health approach to support the challenge of infectious diseases in Brazil', between 28-29 March 2023, organised by the Brazilian Academy of Sciences, the National Academy of Medicine and the UK Academy of Medical Sciences. Outcomes included a workshop report. |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://acmedsci.ac.uk/file-download/86263830 |
| Description | Participation in the FNIH annual gene drive symposium |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Participated in the annaul gene drive symposium sponsored by the Foundation of the National Institutes of Health (FNIH) and chaired an expert panel session. |
| Year(s) Of Engagement Activity | 2024 |
| Description | Phyloseminar invited speaker |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Phyloseminar is one of the top international avenues for the dissemination of phylogenetic methods. Following our new method architectures I gave a talk on these developments. The talk is online and has a permanent youtube link |
| Year(s) Of Engagement Activity | 2023 |
| URL | http://phyloseminar.org/ |
| Description | Preparedness and Resilience for Emerging Threats (PRET) WHO Global Meeting (Geneva April 2023) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Katharina participated in Preparedness and Resilience for Emerging Threats (PRET): A Call to Action and Global Meeting on Future Respiratory Pathogen Pandemics, organized by the World Health Organization (WHO), Department of Epidemic and Pandemic Preparedness and Prevention (EPP). |
| Year(s) Of Engagement Activity | 2023 |
| Description | Presentation at annual HPTN meeting |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | This is an annual event bringing together hundreds of researchers, collaborators, community representatives, and government health officials to engage in meaningful discussions regarding the Network's scientific agenda and current & planned HIV prevention research studies. |
| Year(s) Of Engagement Activity | 2024 |
| Description | Presentation at the European AIDS Conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Presentation of a critical review of the mathematical modelling analyses undertaken to estimate the public health impact of cuts in HIV funding |
| Year(s) Of Engagement Activity | 2025 |
| URL | https://anrs.fr/en/all-news/eacs-2025-european-conference/ |
| Description | Presentation at the French national public health agency |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Invited by the French national public health agency to talk about the societal and epidemiological impacts of scaling-up the distribution of HIV self-testing among most vulnerable populations in Western Africa |
| Year(s) Of Engagement Activity | 2024 |
| Description | Presentation for WHO about the future of HIV testing in Western and Central Africa |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Presentation of HIV modelling work about HIV testing and diagnosis during a meeting with WHO |
| Year(s) Of Engagement Activity | 2024 |
| Description | Presentation of the Case for Investment to Combat AIDS TB and Malaria |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Presentation, on behalf of The Global Fund, of the Case for Investment in Combatting AIDS, TB and Malaria |
| Year(s) Of Engagement Activity | 2025 |
| Description | Presentation to Singapore policy makers (Singapore May 2023 and June 2024) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Katharina presented the work of EPPI on integrated economic-epidemiological modelling to policy makers and policy advisors from the Ministry of Manpower, the Ministry of Health and Treasury |
| Year(s) Of Engagement Activity | 2023,2024 |
| Description | Presentation to the E-TAG group of Sightsavers |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Presentation on Alternative Strategies to accelerate onchocerciasis elimination in Sightsavers-assisted countries, including Moxidectin treatment and community-directed vector control. |
| Year(s) Of Engagement Activity | 2024 |
| Description | Primary school fair |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Schools |
| Results and Impact | Led a one-day infectious disease fair in Brent, London, engaging ~670 children from nursery to Year 6 through interactive activities designed to spark curiosity about science and health. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Provided work experience placement for two Y12 students at MRC GIDA |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Schools |
| Results and Impact | Dr Anne Cori and I provided a week-long work experience placement for two Y12 students (one from a local London school, one from Paris) who learnt skills in mathematical modelling, wet lab safety, and presentation techniques. The students reported enthusiasm to study degrees in related subject areas and both wish to apply to the department for postgraduate study. |
| Year(s) Of Engagement Activity | 2024 |
| Description | Public Involvement - Community Partner Steering Group |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Patients, carers and/or patient groups |
| Results and Impact | We established the first Community Partner steering group consisting of people 18 years and older to share their valuable lived experience of their health with researchers who work on the epidemiological analysis and modelling of infectious diseases to help improve the use of this science for better health. Up to date, we have had an inaugural meeting, partners have provided feedback into funding applications. |
| Year(s) Of Engagement Activity | 2024,2025 |
| Description | Research on Measles published by the Independent, including interview comments |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Health article published by the Independent focused on Katharina's measles research, and featuring interview comments |
| Year(s) Of Engagement Activity | 2026 |
| URL | https://www.independent.co.uk/news/health/measles-vaccine-cost-england-parents-children-b2912424.htm... |
| Description | School visit (Salusbury Primary School) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | Participation to "career month" - introduction to infectious disease epidemiology and epidemic modelling for three Year 2 classes |
| Year(s) Of Engagement Activity | 2025 |
| Description | Science Fair - |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Schools |
| Results and Impact | We brought a science fair to an underpriviledged school in Bournemouth. The school community of St. Luke's in Bournemouth serves a multicultural sector of the local population, including 29.6% of pupils coming from deprived backgrounds, 18.5% with English as a second language, and 16% with special educational needs. Attending big science fests by leading STEM universities in London, Oxford or Cambridge is usually not feasible for many pupils in this area, as it is the case for most early-stage education pupils throughout the UK. The aim was to bridge a gap in access to meaningful and inspirational experiences in STEM disciplines for pupils in early-stage education. - We collaborated with a primary schools outside of the traditional area of influence of the country's leading STEM universities (ie. London, Oxford, Cambridge) and successfully delivered a Mini-Science Festival to pupils who would normally not have access to such events. We adjusted existing activities and developed new activities to suit this particular audience and evaluated the activities with the students. By delivering these activities the kids (and their parents and teachers) engaged in skills and learnings of Imperial. The activities included a science fair with multiple activities (pandemic potential card game, higher-or-lower game, animal matching game, zombie outbreak game, play-doh create your own pathogen activity), and during the week, each class got to speak to one of our experts and ask any questions they may have in a 'I'm a scientist get me out of here' style. |
| Year(s) Of Engagement Activity | 2024 |
| URL | http://www.imperial.ac.uk/news/252055/british-science-week-takes-imperial-scientists/ |
| Description | Science Journal For Teens Publications |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Schools |
| Results and Impact | Feb 2023 Science Journal For Teens publication on our work entitled : What was the impact of a delayed second COVID-19 vaccine? https://www.sciencejournalforkids.org/articles/what-was-the-impact-of-a-delayed-second-covid-19-vaccine/ Jan 2026 Science Journal For Teens publication on our work entitled: How did scientists share their findings during the COVID-19 pandemic? https://www.sciencejournalforkids.org/articles/how-did-scientists-share-their-findings-during-the-covid-19-pandemic/ |
| Year(s) Of Engagement Activity | 2023,2026 |
| Description | Science Media Centre - Media Training Day |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Other audiences |
| Results and Impact | Member of a panel supporting media training for new researchers. Discussion on experience in scientists engaging with the media. |
| Year(s) Of Engagement Activity | 2023 |
| Description | Science in Context (video) |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | -Ep 103. Science in Context - short video on ATLAS project looking at HIV self testing for key populations (presented by Dr Romain Silhol (09-10-2024)) - Video to inform a wide range of audience |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://x.com/MRC_Outbreak/status/1843997656626209117 |
| Description | Science in Context - (short video) |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Ep 88. Science in Context - UNAIDS estimates with Dr Romain Silhol & Oliver Stevens (15-02-2024). This work lead to changes in how the contribution of key population on HIV is derived by UNAIDS |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://x.com/MRC_Outbreak/status/1758110233015030209?s=20 |
| Description | Science in Context Video Podcast Series |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | 82 Episodes published on across our platforms ( YouTube, LinkedIn, X, Instagram, Bluesky, Facebook) on a wide range of topics including international awareness days, methodology, disease specific, research projects and international collaborations. Of the 109 speakers, 48% were women. Overall these episodes received close to a million engagements / views across platforms. |
| Year(s) Of Engagement Activity | 2023,2024,2025,2026 |
| URL | https://www.youtube.com/playlist?list=PLNzrUckV9eSIMXK5kVx7JlM29NIGs-xzD |
| Description | Sundheden er nær - fremtidens forebyggelse, ny teknologi og samarbejde på tværs |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | The assistant professor on this grant attended and spoke at this meeting. Participants: >500 guests signed up (online+in person), rector, the dean, the prodean for research and innovation. Planning and execution: University of Copenhagen + Local Government Denmark (KL) (the Danish municipalities' organization) |
| Year(s) Of Engagement Activity | 2023 |
| Description | The Economics of Pandemic Preparedness (LSHTM London October 2024) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Third sector organisations |
| Results and Impact | Katharina Hauck gave an invited talk at the London School of Hygiene and Tropical Medicine on the work of EPPI on the economics of pandemic preparedness. |
| Year(s) Of Engagement Activity | 2024 |
| Description | The economics of pandemic preparedness (Barcelona December 2023) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Third sector organisations |
| Results and Impact | Katharina was invited to present the work of EPPI on the economics of pandemic preparedness at the workshop 'The Contribution of Health Economics to Vector-Borne Disease Control and Elimination: Current Status and Improving the Policy Impact of Health Economics Research' organized by IS Global |
| Year(s) Of Engagement Activity | 2023 |
| Description | USA Environmental Protection Agency Finalizes Framework for Interagency Collaboration on Resistance Risks Associated with Antibacterial and Antifungal Pesticides |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Our research on antifungal resistance and dual-use was highly influential in the EPA report - our group responded to the Request for Information Released on October 9, 2024 The U.S. Environmental Protection Agency (EPA) finalized its framework for expanding federal collaboration on the review of antibacterial and antifungal pesticides. To develop the framework, EPA coordinated with the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA), under the oversight of the White House Office of Science and Technology Policy. The framework establishes a process for EPA to consider input from the other federal agencies when evaluating whether antibacterial or antifungal pesticides might result in the development or spread of resistance and reduce the effectiveness of some human and animal antibacterial and antifungal drugs. "This framework will strengthen the shared goals of EPA, HHS, USDA, and the White House in protecting relevant human and animal drugs while ensuring growers can continue to have access to important tools to protect their crops from fungal and bacterial diseases," said the Director of EPA's Office of Pesticide Programs Ed Messina. "The Biden-Harris Administration is committed to protecting public health and the environment. The rise of antimicrobial resistance poses a growing global health challenge," said Deputy Assistant to the President for the Cancer Moonshot and White House Office of Science and Technology Policy Deputy Director for Health Outcomes Danielle Carnival. "Integrating the best available human, plant, and environmental science in future decision making about how and what antibacterial and antifungal pesticides we use is an important step forward to improving health outcomes for all Americans." Through the framework, EPA aims to recognize the benefits of these pesticides to agriculture while minimizing their impact on public and animal health and considering a One Health approach. One Health is a multidisciplinary approach to improve health outcomes by analyzing linkages between humans, animals, and the global environment. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.epa.gov/pesticides/epa-finalizes-framework-interagency-collaboration-resistance-risks-as... |
| Description | Video podcast series - Science in Context |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Overall, current 119 episodes have over 1.7 million engagements across social media platforms (X, LinkedIn, YouTube, Instagram, Facebook, Bluesky). Traditional media outlets occasionally reference these videos or get in touch to gain further background on the work highlighted in the episode. 13/03/2025 Episode 119 https://youtu.be/S6sxqLIUQlk 04/03/2025 Episode 118 https://youtu.be/8D_v7ldBW9k 20/02/2025 Episode 117 https://youtu.be/Ib5dBunDPN0 10/02/2025 Episode 116 https://youtu.be/ocHGHCLk-L0 30/01/2025 Episode 115 https://youtu.be/CLGS7j9kMEM 24/01/2025 Episode 114 https://youtu.be/B0spuTWEF2c 20/01/2025 Episode 113 https://youtu.be/3vJwBtuGoI4 10/01/2025 Episode 112 https://youtu.be/m-_vPyEFfxY 19/12/2024 Episode 111 https://youtu.be/Ycu0CWJoYTc 04/12/2024 Episode 110 https://youtu.be/dZgtOgDyIUs 25/11/2024 Episode 109 https://youtu.be/9xkV8Yk8uX0 15/11/2024 Episode 108 https://youtu.be/Ux6yDWO_c8I 07/11/2024 Episode 107 https://youtu.be/EiulWRnyrZE 29/10/2024 Episode 106 https://youtu.be/p6aS_fNG77A 21/10/2024 Episode 105 https://youtu.be/OGn132c89mo 17/10/2024 Episode 104 https://youtu.be/sts4wOMotJw 09/10/2024 Episode 103 https://youtu.be/ZyjTEKVdBVg 01/10/2024 Episode 102 https://youtu.be/8pmsow9w3Tw 27/09/2024 Episode 101 https://youtu.be/A-kyTqZpLNg 20/09/2024 Episode 100 https://youtu.be/ZZ5OEh3N_zU 20/08/2024 Episode 99 https://youtu.be/Eaqz1Pju9uU 21/06/2024 Episode 98 https://youtu.be/1LsqXJxGN_Q 07/06/2024 Episode 97 https://youtu.be/IgzubfHl3cs 04/06/2024 Episode 96 https://youtu.be/ZKVrr7SNVxk 24/05/2024 Episode 95 https://youtu.be/fN8I258vm2Y 21/05/2024 Episode 94 https://youtu.be/tL2a14xy7zc 03/05/2024 Episode 93 https://youtu.be/K6oLtUtplNc 26/04/2024 Episode 92 https://youtu.be/5hdgjWixkaA 22/03/2024 Episode 91 https://youtu.be/YQVnPUTKE3A 15/03/2024 Episode 90 https://youtu.be/iZdQ82DRS0Y 22/02/2024 Episode 89 https://youtu.be/S5PSM3OzIvo 15/02/2024 Episode 88 https://youtu.be/H10WG2u_fl4 09/02/2024 Episode 87 https://youtu.be/CiVYARrJWpY 26/01/2024 Episode 86 https://youtu.be/rqYGP32BPOE 11/01/2024 Episode 85 https://youtu.be/xG0HUXHpQso 08/12/2023 Episode 84 https://youtu.be/sb4BaFGnjhY 29/11/2023 Episode 83 https://youtu.be/5ja50Od2J98 26/10/2023 Episode 82 https://youtu.be/5jdwjcL_c8M 29/09/2023 Episode 81 https://youtu.be/ha7ru_rFf9E 20/09/2023 Episode 80 https://youtu.be/C0bFwVGu3R0 14/09/2023 Episode 79 https://youtu.be/1hb3GECZ0Mo 08/09/2023 Episode 78 https://youtu.be/vfQRfbJKjeE 04/08/2023 Episode 77 https://youtu.be/cdAXbN1kX5o 27/07/2023 Episode 76 https://youtu.be/VvpYHhFDIjI 21/07/2023 Episode 75 https://youtu.be/OTf8-jH_DkU 18/07/2023 Episode 74 https://youtu.be/15pmy0qEFis 14/07/2023 Episode 73 https://youtu.be/HoNlk_m8Crc 12/06/2023 Episode 72 https://youtu.be/qhQwEzLceI8 |
| Year(s) Of Engagement Activity | 2023,2024,2025 |
| URL | https://www.youtube.com/playlist?list=PLNzrUckV9eSIMXK5kVx7JlM29NIGs-xzD |
| Description | WHO EPI-WIN Webinar Pathogen Genomics in Health Emergencies: Spotlight Dengue |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | With 1233 unique attendees from 144 countries, this webinar sparked 63 questions and discussion. WHO EpiWin team reported it to be the second most viewed webinar to date. It was attended by > Ministry of Health members from 29 countries, CDC members from 11 countries, WHO members from 37 countries, and Universities from 49 countries. 95% found it very useful or quite useful. Attendees' feedback included "enhances my ability to contribute to surveillance efforts by keeping me informed", "every information acquired in the webinars was very relevant for my work", "the webinar has equipped me with knowledge and understanding of dengue surveillance and the need for collaboration across sectors". |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.youtube.com/watch?v=kKO19Rt8RoI&ab_channel=WHOEPI-WIN |
| Description | Women of Science: Changing the Equation - |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Undergraduate students |
| Results and Impact | Screening of " the Electrion Libre (6 high profile scientific researchers, technological leaders, mathematical or engineering share their journey, their groundbreaking work and reveal the obstacles they have overcome as girls and women in STEM) follow by a panel discussion (to share experiences and discuss progress and challenges for equality in the STEM). Objectives to encourage young girls to pursue a career in science if they wish to and Audience: Year 10 to Year 13 students and join the Francophonie UK group for a special event highlighting women in science. More than 50 pupils and some organisation promoting STEM for women attended the event. The session was followed by questions from interesting questions from the pupils. This event was organised in collaboration with the General Representation of Wallonia-Brussels to the United Kingdom, the Embassy of Switzerland in the United Kingdom, the Québec Government Office in London, and Institut français du Royaume-Uni. We are hoping that it changed the views of the pupils who attended (which it seems to based on informal feedback) but real impact will only be known in future when they make choices |
| Year(s) Of Engagement Activity | 2025 |
| URL | https://www.institut-francais.org.uk/events-agenda/women-of-science-changing-the-equation/#/ |
| Description | Workshop event running an integrated modelling exercise for policymakers and academics |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | In 2025, the team attended a roundtable event, hosted at the Institute for Government, which brought together senior academics and policymakers in the pandemic preparedness modelling space. The team using DAEDALUS, their integrated modelling tool, to run a pandemic preparedness simulation exercise, which required attendees to balance the health, economic and educational costs of making different decisions in a pandemic under uncertainty. The exercise was particularly impactful in that it led to our invitation to attend a UKHSA away-day, re-running the simulation for a much larger audience. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Workshop on Economic-Epidemiological Modelling with DAEDALUS Explore (Bangkok November 2024) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Third sector organisations |
| Results and Impact | The Jameel Institute hosted a workshop alongside colleagues from the National Centre for Infectious Diseases, Singapore, in the lead up to the inaugural Infectious Disease Modelling Conference. At the event, some of the world's leading infectious disease researchers, modellers and policymakers came together to put the pandemic planning tool "DAEDALUS Explore" to the test. At the workshop, which was held on the 5th of November 2024 in Bangkok, attendees were the first cohort ever to receive access to and training on integrated modelling, and on DAEDALUS Explore. The workshop was also be used to gather invaluable feedback on whether DAEDALUS Explore and the information it communicates is straightforward, transparent and useful. This workshop therefore represented a key stepping stone in the Jameel Institute's journey to ensuring DAEDALUS Explore is the best it can be before launch in autumn 2025. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://daedalus.jameel-institute.org/scenarios/new |
| Description | Workshop on the Economics of Pandemic Preparedness |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | In partnership with Umea University, the team organised and hosted a workshop on the economics of pandemic preparedness in Stockholm, Sweden. The workshop was attended by academics, notably early career researchers, who were working at the intersection of pandemic preparedness and economics. At the workshop, attendees presented their work-in-progress research, and the collective group provided feedback on how it could be strengthened. Following its success, a second workshop is planned for 2026. |
| Year(s) Of Engagement Activity | 2025 |
| Description | Workshop on the Genomic Epidmeiology of Arboviruses |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Organised a workshop on Genomic epidemiology of arboviruses in Campinas Brazil in February 2026. The workshop had 50 in-person participants, 35 speakers/organisers, and 50 online participants. Participants were from 14 different countries. All expenses for participants and speakers were paid for to ensure equal access to the workshop. Participants were trained on several aspects of virology, bioinformatics, genome sequencing and phylogenetic analysis and had the opportunity to interact with policy makers and leaders in the fiels. |
| Year(s) Of Engagement Activity | 2026 |
| URL | https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/opportunities/workshop/ |
| Description | Workshop on the economics of pandemic preparedness (Stockholm June 2024) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Third sector organisations |
| Results and Impact | The very first two-day workshop on the Economics of Pandemic Preparedness, organised jointly by Umea University, Sweden and the Jameel Institute, Imperial College London, was held in Stockholm from 19th-20th June, 2024. This interactive workshop provided a platform for sharing and discussing ongoing and future research, ideas and projects with a focus on integrated economic and epidemiological modelling tools for improving pandemic preparedness. The Economics of Pandemic Preparedness Initiative (EPPI) team from the Jameel Institute and Umeå University, along with over 20 academics participated in the workshop. We were delighted to welcome two fantastic keynote speakers for our inaugural workshop, Edith Patouillard from WHO and Aditya Goenka from the University of Birmingham. We were also delighted to be able to sponsor two participants from middle-income countries (LMICs) to participate in the workshop, Elvira de Lara-Tuprio from Ateneo University in the Philippines, and Utkarsh Choudhary from KREA University in India. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.imperial.ac.uk/media/imperial-college/medicine/jameel-institute/Stockholm-report-2024.pd... |
| Description | Workshop on the modelling and analysis of serological data, Ho Chi Minh, Vietnam |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Approximately 30 individuals from research institutions and government ministries from across South East Asia (Vietnam, Cambodia, Malaysia, Thailand, Indonesia, Singapore) attended the training workshop on modelling to support their professional development. The course received positive feedback and will be re-delivered by some of the local participants within their national teams. |
| Year(s) Of Engagement Activity | 2025 |
| Description | World Health Summit Regional Meeting (Washington DC April 2023) |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Katharina participated in the regional meeting of the World Health Summit |
| Year(s) Of Engagement Activity | 2023 |
| Description | Written multiple articles published in The Times, Daily Mirror and Daily Express |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Written multiple articles published in The Times, Daily Mirror and Daily Express - using the media as a channel to wider audiences |
| Year(s) Of Engagement Activity | 2025 |